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Abstract 
 
Methanotrophic bacteria can grow on methane as their sole source of carbon 
and energy. Methylosinus trichosporium OB3b is a Gram negative, 
methanotrophic bacterium, which can convert methane to methanol by either 
particulate (pMMO) or soluble (sMMO) methane monooxygenase. The sMMO 
comprises three polypeptides; hydroxylase (αȕȖ)2, regulator/coupling protein 
(protein B), and reductase. The hydroxylase contains the diiron active site.  
The three components of sMMO are found to be indispensable for full enzyme 
activity. In the present study, the sMMO hydroxylase was purified by anion 
exchange chromatography and protein B fused with GST was purified by using 
affinity chromatography. Attempts to purify the reductase were unsuccessful 
although the reductase was detected during the purification steps. To shorten 
the long purification protocol of the hydroxylase and minimize the loss of its 
activity during multiple purification steps, a new system was developed by 
inserting a His-tag in the wild type hydroxylase ȕ-subunit. The His-tag 
hydroxylase was then purified in one step by using an affinity column. The new 
His-tag system yields hydroxylase with detectable activity when it was tested 
toward propylene. Solid phase microextraction (SPME) was used for the first 
time in the present study to detect the product propylene oxide from propylene 
oxidation for the wild type His-tagged hydroxylase.     
Crystallographic studies have suggested roles for a number of amino acids 
within and around the active site. The present study used site-directed 
mutagenesis to create four new mutants in addition to performing further 
characterization of another two. The mutation C151S preserved activity toward 
a range of substrates, and indicated that radical chemistry at this position is not 
  xviii 
 
essential for monooxygenase activity toward a number of aliphatic and aromatic 
hydrocarbons. Results from other mutations included stabilising a previously 
unstable mutant (C151Y) with a secondary mutation to gain the double mutant 
E114D C151Y. The mutant R98L showed activity toward the monoaromatic 
substrate ethyl benzene and the diaromatic substrate naphthalene. Mutation of 
one of the diiron site coordinating residues E114D resulted in a stable 
hydroxylase with activity toward naphthalene. In terms of the oxidation of the 
triaromatic hydrocarbons anthracene and phenanthrene, no activity could be 
detected for the mutants tested in the present study or the wild type.  
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Chapter 1: Introduction and literature 
review 
1 Introduction 
 
1.1 Methanotrophic bacteria 
 
 
The term methanotroph refers to bacteria that can grow on methane as their 
sole source of carbon and energy. Currently known methanotrophs are gram 
negative that show substantial diversity. Various examples are mesophilic, 
neutrophilic, psychrophilic, thermophilic, halophilic and moderate acidophilic 
(Hanson and Hanson, 1996).  Methanotrophs are rod or cocci shaped; in 
addition, two filamentous methanotrophs have also been described Crenothrix 
polyspora (Stoecker et al., 2006) and Clonothrix fusca (Vigliotta et al., 2007). A 
facultative methanotroph Methylocella silvestris, which can grow on either 
methane or multicarbon compounds, has also been isolated (Theisen et al., 
2005). Methanotrophs have been isolated from various sites including; soils, 
peat lands, rice paddies, sediments, fresh water and marine, acidic hot springs, 
mud pots, alkaline soda lakes, cold environments and tissues of higher 
organisms (Smith and Murrell, 2009), as well as from even more extreme 
environments, since three thermoacidophilic methanotrophs belonging to the 
phylum Verrucomicrobia named Methylacidiphilum infernorum V4T (Dunfield et 
al., 2007), Methylacidiphilum fumariolicum SolV (Polet al., 2007) and 
Methylacidiphilum kamchatkense Kam1 (Islam et al., 2008), were isolated from 
an environment with pH 1.5 and 65oC. 
  2 
 
Methanotrophic bacteria were also detected from animal tissues, though they 
have not been grown on culture media (Cavanaugh, 1993). There is 
considerable evidence that methanotrophs can form a symbiotic relationship 
with other organisms. For example, Luo et al. (2007) found that up to 99% of 
phenol at a concentration 600 mg/ L could be oxidized during the first 11 h of 
growth of a consortium including Methylosinus trichosporium (OB3b) and 
methane as unique source for carbon and energy.  
Although, pure cultures capable of anaerobic methane oxidation have not been 
obtained, there is a strong evidence to support the presence of such bacteria in 
environments rich with sulphate which suggests sulfate as the terminal accepter 
of electrons (Dalton 2005).  
The high diversity of places where the methanotrophic bacteria have been 
identified may indicate that there are many other methanotrophs that have not 
been isolated yet. 
The isolation of over 100 new methane-utilizing bacteria as pure cultures by 
Whittenbury et al. (1970) established the fundamental construction of current 
classification of these organisms. Whittenbury et al. divided methanotrophic 
bacteria initially into two types depending on the cell morphology and 
intracytoplasmic membrane structure; type I and type II methanotrophs. Type 1 
methanotrophs have intracytoplasmic membrane arranged in a vesical like form 
(Figure  1.1A). This type can assimilate formaldehyde into biomass through the 
ribulose monophosphate pathway (RuMP). This type includes the genera: 
Methylococcus, Methylobacter and Methylomonas, which belong to gamma 
proteobacteria. Type II methanotrophs contain intracellular membrane 
organised as peripheral concentric layers (Figure  1.1B). This group contains the 
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genera Methylosinus and Methylocystis, which belong to the 
alphaproteobacteria. The pathway this group uses in assimilation of 
formaldehyde into biomass is the serine pathway (Hanson and Hanson, 1996). 
Type X was added to include the methanotrophs which can assimilate the 
formaldehyde into biomass via the RuMP and sometimes by the serine pathway 
such as Methylococcus capsulatus (Bath) (Whittenbury, 1981; Whittenbury and 
Dalton 1981; Whittenbury and Krieg, 1984). 
Cultured methanotrophs from the phylum Verrucomicrobia as mentioned above, 
are able to oxidize methane under extreme conditions (pH 1.5 and temperature 
65oC) suggesting that these bacteria should be a third group of methanotrphs. 
Dunfield et al., (2007) have found that the verrucomicrobial Methylacidiphilum 
infernorum constitute a sac like structure inside the cell containing a tubular 
membrane. In addition it contains intracytoplasmic membranes arranged in 
parallel layers which are similar to that in other methanotrophs. The 
intracytoplasmic membrane may accommodate the particulate methane 
monooxygenase (pMMO), which is produced, by almost all methanotrophic 
bacteria except Methylocella. The other enzyme in methanotrophs named 
soluble methane monooxygenase (sMMO) which is produced by a sub-set of 
methanotrophic bacteria such as Methylococcus capsulatus (Bath), 
Methylosinus trichosporium (OB3b) and others (Dalton, 2004).  
The filamentous methanotrophs Crenothrix polyspora (Stoecker et al., 2006) 
and Clonothrix fusca (Vigliotta et al., 2007) were classified as a new subgroup 
of methanotrops belonging to the Gammproteobacteria. They are able to 
oxidize methane with an inner membrane arrangement similar to that in Ȗ-
proteobacteria methanotrophs. The other details about the methanotrophs can 
be found in (Table  1.1).  
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Figure  1.1 Two distinct arrangements of intercellular membranes in 
methanotrophs shown by electron microscopy. 
A: shows the arrangement of intracytoplasmic membrane in type I methanotrophs as vesical 
discs. 
B: shows the stacks of intracytoplasmic membrane in type II methanotrophs as paired 
peripheral layers. 
The intracytoplasmic membrane isindicated by red arrow. Taken from Green (1992). 
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       Table  1.1  Classification of aerobic methanotrophic bacteria. 
 
 
 
 
 
 
Type Phylum Genus C1 assimilation MMO type Tropic niche 
Type I Ȗ-Proteobacteria Methylobacter 
Methylomonas 
Methylosoma 
Methylomicrobium 
Methylothermus 
Methylohalobius 
Methylosarcina 
Methylosphaera 
RuMP 
RuMP 
not known 
RuMP 
RuMP 
RuMP 
RuMP 
RuMP 
pMMO 
pMMO+/-sMMO 
pMMO 
pMMO+/-sMMO 
pMMO 
pMMO 
pMMO 
pMMO 
 
some psychrophilic 
some psychrophilic 
not extreme 
Halotolerant;alkaliphilic 
thermophilic 
halophilic 
not extreme 
psychrophilic 
Type II α-Proteobacteria Methylcystis 
Methylosinus 
Methylocapsa 
Methylocella 
Serine 
Serine  
Serine  
Serine 
pMMO+/-sMMO 
pMMO+/-sMMO 
pMMO 
sMMO 
some acidophilic 
not extreme 
acidophilic 
acidophilic 
Type X Ȗ-Proteobacteria Methylococcus 
Methylocaldum 
RuMP/Serine 
RuMP/Serine 
pMMO+/-sMMO 
pMMO 
thermophilic 
thermophilic 
Others Ȗ-Proteobacteria 
Ȗ-Proteobacteria 
Verrucomicrobia 
Crenothrix polyspora 
Clonothrix fusca 
Methylacidiphilum 
RuMP/Serine? 
RuMP/Serine? 
RuMP/Serine? 
pMMO 
pMMO 
pMMO 
not extreme 
not extreme 
acidophilic 
RuMP: Ribulose mono phasphate, pMMO: particulate methane monooxygenase, sMMO: soluble methane monooxygenase. 
 
Adapted from Smith and Murrell, (2010) and Jiang et al., (2010) 
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1.1 The role of methane in the environment 
 
Methane, a one-carbon compound with a formula CH4, is one of the most 
important gases in atmosphere. It causes a global warming due to its high 
ability to absorb the infrared and then re-emitt radiation causing reduction of the 
ozone layer leading to global warming (Lelieveld et al., 1993). During the last 
320 years, the concentration of methane has increased from 0.75 to 1.75 ppm 
and it may reach to 4.0 ppm by 2050 (Ramanathan et al., 1985). The global 
warming potential of methane which is 25 times more than CO2, makes 
methane more severe global warming factor (IPPC Fourth assessment report: 
Climate Change 2007: 2.10.2). The methane arrives to the atmosphere via 
many sources including natural, anthropogenic sources, wetlands, rice paddies, 
intestines of ruminants, lakes, oceans, soils, oil and even termites (Dalton 
2005). 
The unique step of the CH4 oxidation pathway is the conversion of methane to 
methanol by methane monooxygenase (MMO) from methanotrophic bacteria. 
Methanotrophs oxidize methane to methanol via two important enzymes; 
particulate methane monooxygenase and soluble methane monooxygenase by 
incorporation of an oxygen molecule across the C-H bond to produce methanol 
(Dalton, 1980; Feig & Lippard, 1994; Lipscomb, 1994; Wallar & Lipscomb, 1996; 
Merkx et al., 2001) as in the equation below: 
 CH4 + NAD (P) H+ H+ + O2                                         CH3OH + NAD (P)+ + H2O 
 
This important reaction has attracted considerable interest from many 
researchers for many reasons; methane can serve as a source for energy and 
MMO 
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as a chemical feedstock in industry Smith and Dalton, 2004). The major 
problem with methane is the difficulty of transport since methane is a gas. This 
problem can be overcome by converting methane to more easy transportable 
liquid methanol (Periana et al., 1993). The conversion of methane (which has a 
very unreactive C-H bond) to methanol chemically needs a high energy >100 
kcal mol-1, hence the conversion of methane to methanol by methane 
monooxygenase makes this enzyme potentially interesting commercially 
(Rosenzweig et al., 1997). Also an understanding of how MMO can oxidize 
methane could inform the design of small-molecule catalysts to perform the 
reaction more effectively on an industrial scale. It is known that methane causes 
an increasing in global warming; methanotrophs via their methane 
monooxygenase can be considered as one of the most important natural routes 
for decreasing global warming (Dalton 2005). The widespread occurance of 
methanotrphic bacteria is believed to help in minimizing the amount of methane 
released to the atmosphere (Semrau et al., 2010; Jiang et al., 2010). The 
improvement of methane monoxygenase in oxidation of methane to methanol 
has become the aim of many studies to enhance the removal of methane from 
the environment and in oxidation of other toxic substances, as will be explained 
in more detail in below.  
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1.2 Bioremediation of toxic substances by methane 
monooxygenase 
 
It is known that methane monooxygenases (MMOs) from methanotrophs have 
the ability to co-oxidize many hydrocarbons ranging from simple molecules such 
as methane including alkanes, alkenes, heterocyclic compounds. 
Trichloroethylene (TCE), which is considered as a toxic and carcinogenic 
pollutant in water is also one of the substrates that can be oxidized by MMO 
(Smith and Dalton 2004). It has been found that MMO can oxidize hydrocarbons 
other than methane even though they do not use them as a source for carbon 
and energy. The oxidation of methane or the other diverse hydrocarbons by 
MMO takes place by the action of one of the two MMO; either pMMO or sMMO 
(Smith and Dalton 2004; Jiang et al., 2010).  
Yoon et al. (2011) showed that pMMO from the facultative methanotroph, 
Methylocystis strain SB2 was able to oxidize chlorinated ethanes. Im and 
Semrau (2011) also found that Methylocystis strain SB2 has the ability to 
oxidize chlorinated hydrocarbons such as vinyl chloride (VC), trans-
dichloroethylene (t-DCE), TCE, 1,1,1,-trichloroethene (1,1,1,TCA) and 
chloroform (CF), when they grow on methane. sMMO was found to have a 
wider range of substrates extending to involve large di- and triaromatic 
compounds such as naphthalene, biphenyl, but not anthracene and 
phenanthrene (Colby et al., 1997; Fox et al., 1990; Smith and Dalton 2004), 
more details about sMMO substrates can be seen in Table  1.2. Many studies 
have attempted to increase its ability to oxidize larger toxic hydrocarbons by 
molecular modification of this enzyme. The rationale of these studies is to 
  9 
 
understand the mechanism of this enzyme and if possible construct modified 
enzymes that can be employed in industry. 
In addition to hydrocarbons, chromium VI which is a highly toxic, mutagenic, 
soluble metal that has been widely used in tanning and paper making 
(Cervantes et al., 2001; Zayed and Terry, 2003) has been found to be reduced 
by methanotrophic bacteria. Methylococcus capsulatus (Bath) has been able to 
reduce the toxic form of chromium VI to the less toxic, more easily adsorbed by 
soil, form of chromium III across a wide range of concentrations which extend 
the list for the substrates of group of bacteria (Al-Hasin et al., 2010).  
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Table  1.2 The most common substrates oxidized by sMMO and the oxidation products.  
Adapted from Smith and Dalton 2004; Jiang et al., 2010 
Substrate Major detected products; relative molar proportions of multiple products 
are shown in brackets 
Specific activity 
(nmol of product 
min -1 mg-1)1 
Reference  
(type of assay)2 
1- Alkanes 
Methane 
Ethane 
Propane 
Butane 
Pentane 
Hexane 
Heptane 
Octane 
2- Methylopropane 
2,3-Dimethylpentane 
 
Methanol 
Ethanol 
Propan-1-ol (39); propan-2-ol (61) 
Butan-1-ol (54); butan-2-ol(46) 
Pentan-1-ol (28); pentan-2-ol (72) 
Hexan-1-ol (63); hexan-2-ol (37) 
Heptan-1-ol (22); heptan-2-ol (78) 
Octan-1-ol (9); octan-2-ol (91) 
2-Methylpropa-1-ol (70); 2-methylpropan-2-ol (30) 
3,4-Dimethypentan-2-ol 
 
84 
68 
69 
77 
73 
40 
27 
9 
33 
20 
 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
2 (PP) 
2 (PP) 
 
2- Alkenes 
    Ethene 
    Propene 
    But-1-ene 
cis-But-2-ene 
trans-But-2-ene  
 
Epoxyethene 
Epoxypropene 
1,2-Epoxybutane 
cis-2,3-Epoxybutane (47); cis-2-butane-1-ol (53) 
trans-2,3-Epoxybutane (27); trans-2-butan-1-ol (73) 
 
148 
83 
49 
33 
39 
 
1 (SE) 
1 (SE) 
1 (SE) 
2 (PP) 
2 (PP) 
 
3- Alicyclic hydrocarbons 
Cyclohexane 3 
Methylenecyclohexane 
 
Cyclohexanol 
1-Cyclohexane-1-methanol (13.7)methylene cyclohexane oxide (75.8); 
4- hydroxymethylene cyclohexane (10.5) 
 
 
25 
3 
 
 
3 (SE) 
2 (PP) 
2 (PP) 
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Substrate Major detected products; relative molar proportions of multiple products 
are shown  in brackets 
Specific activity 
(nmol of product 
min -1 mg-1)1 
Reference  
(type of assay)2 
ȕ-Pinene 
 
Adamantane 
cis-1, 4- Dimethyl 
cyclohexan 
cis-1,3-dimethyl 
cyclohexane 
6,6-Dimethylbicyclo [3.1.1] hept-2-ene-2-methanol (7β.γ); ȕ-pinene 
oxide (27.7) 
1- Adamantol (50); 2-adamantol (50). 
1-ci-4-Dimethylcyclohexanol (35); 1-trans-4-dimethylcyclohexanol (61); 
cis-2, 5-dimethylcyclohexaneol (4). 
3,5-Dimethylcyclohexanol (80); 1-trans-3-dimethylcyclohexanol (6). 
 2 (PP) 
4- Halogenated aliphatics 
Vinyl chloride 3 
Trichloroethylene 3 
 
1,1-Dichloroethene3 
Trifluoroethene 3 
 
Chlorotrifluoroethylene 3 
Tribromoethylene 3 
 
 
Formate (35); CO (53); glyoxylate (5); dichloroacetate(5); chloral (6) 
 
Glycolate (80); dichloroacetaldehyde (3) 
Glycolate (53); difluoroacetate (43); fluoral (5) 
 
Oxalate 
Formate (80); bromal (5) 
 
748 
682 
 
 
684 
79 
179 
 
 
4 (PP) 
4 (PP) 
 
 
4 (PP) 
4 (PP) 
4 (PP) 
4 (PP) 
 
5- Monoaromatic 
Benzene 
Toluene 
Ethylbenzene 3 
Styrene 3 
Pyridine 
 
 
 
 
 
Phenol 
Benzyl alcohol; 4- cresol 
1-Phenyl ethanol (30); 4- hydroxyethylbenzene (70) 
Styrene oxide 
Pyridine N-oxide 
 
74 
53 
18.7 
82 
29 
 
 
 
 
3 (SE) 
1 (SE) 
3 (SE) 
3 (SE) 
3 (SE) 
  12 
 
Substrate Major detected products; relative molar proportions of multiple products 
are shown  in brackets 
Specific activity 
(nmol of product 
min -1 mg-1)1 
 
Reference  
(type of assay)2 
 
6- Diaromatics 
Naphthalene 
Biphenyl3 
2- Hydroxybiphenyl3 
2- Methylbiphenyl3 
2- Chlorobiphenyl 3 
2- Bromobiphenyl3 
2- Iodobiphenyl 
 
1- Naphthol; 2-naphthol 
2- Hydroxybiphenyl (9); 3-hysroxybiphenyl(1); 4-hydroxybiphenyl (90) 
Dihydroxybiphenyls  
Ring (56) and side chain(44) hydroxylated products 
Hydroxycholrobiphenyls 
Hydroxybromobiphenyls (41); 2-hydroxybiphenyl (59)  
Hydroxyiodobiphenyl (18); 2-hydroxbiphenyls (82) 
 
 
 
5 (W) 
6 (W) 
6 (W) 
6 (W) 
6 (W) 
6 (W) 
6 (W) 
 
7- Substituted methane 
derivatives 
Chloromethane 
Dichloromethane 
Chloroform 
Bromomethane 
Nitromethane 
Methanethiol 
Methanol 
 
 
 
 
84 
82 
35 
66 
45 
64 
246 
 
 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
1 (SE) 
8- Others 
Diethyl ether 
Carbon monooxide 
 
Ethanol (47); acetaldehyde (53) 
Carbon dioxide 
 
 
61 
 
1 (SE) 
1 (SE) 
1 Specific activities are as reported in the original publications.2 Type of enzyme preparation used for assay: PP, purified protein; SE, soluble extract; W, whole cells.3 
sMMO of Ms. trichsporiumOB3b; other entries refer to Mc. capsulatus Bath.  
References:   1; Colby et al., 1977.  2; Green and Dalton 1989.   3; Burrows et al., 1984.  4; Fox et al., 1990.   5; Brusseau et al., 1990.   6; Lindner et al., 2000 
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1.3 Methanotrophs in Biotechnology 
 
 
Methanotrophs have also been used in biotechnology, since methane 
monooxygenase from methanotrophs has been proposed as a biocatalyst to 
produce methanol from methane. Methanol has been used as an important bulk 
chemical and solvent in industry for a long time (Dalton 2005). It has been used 
as an alternative to methane as a carbon source for food production in the form 
of Single Cell Protein (SCP) (Dalton and Stirling, 1982; Davies and Whittenbury, 
1970; Hanson, 1992; Large and Bamforth 1988). Methanol is widely available, 
readily stored and transported, safer to utilize than methane and there are 
biotechnologically versatile bacteria which can use methanol as their sole 
source of carbon and energy. This has led to research to enable production of 
methanol from methane, derived from either fossil or biological sources 
(Anthony 1986; Dijkhuizen et al., 1992; Large and Bamforth.1988; Lidstrom, 
1991; Lidstrom and Stirling 1990). Zuniga et al. (2011) used methanotrophs to 
produce the bioplastic polyhydroxybutryate (PHB) from methane. These authors 
isolated and identified Methylobacterium organophilum from a PHB-producing 
consortium and then described its ability to use methane as a carbon source to 
produce PHB, both in the consortium and as the isolated Mlb. organophilum 
strain.  
Pfluger et al. (2011), found that when a laboratory-scale fluidized bed reactor 
was inoculated with a Methylocystis-like strain (type II methanotroph, producing 
polyhydroxybutyrate), as the starter culture under conditions of dissolved 
oxygen 9 mg/L, pH of 6.2-6.5 with nitrate as the N-source, a Methylobacter-like 
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type I methyanotrophs that did not produce PHB became prevalent within 
biofilms in the reactor. Re-inoculating with another type II methanotroph culture 
(Methylosinus), providing dissolved N2 as the nitrogen source and keeping 
dissolved oxygen (DO) at a low level (2.0 mg/L) resulted in a biofilm dominated 
by type II methanotrophs that produced PHB and contained at the same time 
some type I organisms. It was concluded that provision of N2 as the nitrogen 
source was a limiting factor for growth of type I methanotrophs that did not 
produce PHB whereas it enhanced growth of type II methanotrophs that 
produced PHB.  
Astaxanthin is a type of caroteniod which is added to the diet of farmed salmon 
to improve the colour of the fish produced (Torrissen and Christiansen 1995).  
In addition carotenoids such as astaxanthin have antioxidant activity (Hussein et 
al., 2006). Ye et al. (2007) have constructed a genetically modified 
Methylomonas sp. strain known as strain 16a to produce the caroteniod 
astaxanthin which estabilished proof of concept for employing molecular 
engineering to synthesise new small-molecule products by methanotrophic 
bacteria.  
The ability to use a combination of a tractable genetic system and a cheap 
carbon source such as methane may motivate researchers toward use of 
methanotrophs for production of pharmaceutical precursors, enzymes for 
bioremediation and other valuable products (Smith and Murrell, 2009). Site-
directed mutagenesis has been employed previously in this research group and 
also that of J. Collin Murrell (currently at the University of East Anglia) to 
engineer the hydroxylase component of sMMO from Methylosinus trichosporium 
OB3b. 
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1.4 Methane monooxygenase enzyme  
 
It was well known that the Methylosinus trichosporium OB3b and 
Methylococcus capsulatus Bath can produce sMMO or pMMO (Hanson and 
Hanson, 1996). Until a few years ago, the methanotrophs belonging to the 
genus Methylocystis were believed to be obligate methanotropic bacteria. Two 
new facultative methanotrophs were isolated which produced both pMMO and 
sMMO. These bacteria are able to grow on methane and methanol when other 
C1 substrates are not available in addition to slow growth on acetate and 
ethanol in the absence of the other C1 source. They were classified as 
Methylocystis bryophila sp. strains H2sT and S2854. Each of these, like the 
other methanotrophs, was found to produce pMMO enzyme in two forms named 
as pMMO1 and pMMO2. The identity of the pmoA2 DNA sequence of strains 
H2sT and S2854 with pmoA2 from other methanotrophs was 89.0-91.8% 
respectively (Belova et al., 2011; Im et al., 2011; Belova et al., 2012). It was 
also found that some Methylomonas species produce sMMO, since Ogiso et al. 
(2012) were able to characterize an obligate methanotroph from Japan that can 
grow on methane and methanol as a sole source for carbon; it was named as 
Methylomonas koyamae. Recently in 2015, Smith's group were able to isolate 
Methylomonas koyamae that also produces sMMO in addition to being able to 
reduce chromium VI to chromium III. The sMMO enzyme was also found to be 
produced by the marine methanotrophic bacteria, Methylomicrobium (Fuse et 
al., 1998). Unlike the sMMO which is produced by certain species of 
methanotrophic bacteria as it was explained above, it is well known that pMMO 
is produced by almost all methanotrophs except the genus Methylocella and 
  16 
 
Methyloferula (Hanson and Hanson, 1996; Theisen et al., 2005; Vorobev et al., 
2011). 
Despite the fact that both pMMO and sMMO oxidize methane to methanol; 
there is no detectable significant amino acid sequence similarity between them 
and metal content at the active site (Smith and Dalton, 2004; Dalton 2005). The 
pMMO is membrane associated whereas sMMO is soluble in the cytoplasm. 
There are also major differences in the substances which they can oxidize and 
their requirments for electron donors (Dalton 2005). Stanley et al. (1983) proved 
that the production of MMO in the methanotrophs which contains both types of 
MMO, such as Methylosinus trichsporium and Methylococcus capsulatus, 
depends on copper-to-biomass ratio since pMMO is expressed when the ratio 
of copper to biomass is high whereas sMMO is produced when the copper 
starts to deplete from the medium and the ratio of copper to the biomass 
becomes low.  
1.4.1 Particulate methane monooxygenase  
 
1.4.1.1 Purification and structure of pMMO 
 
The major catalyst in bioconversion of methane to methanol in the environment 
is the particulate methane monooxygenase (pMMO) from methanotrophic 
bacteria (Stanley et al., 1983; Hakemian and Rosenzweig, 2007). 
DNA sequencing studies showed that pMMO is encoded by three genes pmoC, 
pmoA, and pmoB organised as an operon pmoCAB. The genes pmoC, pmoA, 
and pmoB encode for pMMO Ȗ (ββ kDa), ȕ (β4 kDa), and α (45 kDa) subunits 
respectively (Semrau et al., 1995).  
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The precise crystal structure for pMMO was not avialable until 2005 owing to 
difficulties with obtaining the enzyme in a suitable purified form. The purification 
was complicated owing to problems with solubilizing the pMMO from lipid 
bilayer in the membrane without complete loss of activity (Smith and Dalton, 
2004; Kühlbrandt, 1988; Michel, 1991). Among many non denaturing detergents 
tested for solubilization of pMMO, Dodecyl-ȕ-D-maltoside was found to be most 
effective whilst minimising loss of activity, and most subsequent work with 
isolated pMMO has relied on this detergent (Smith and Dalton, 1989; Liberman 
and Rosenzweig, 2004). A number of different groups have reported somewhat 
different conditions as optimal for purification of pMMO; Choi et al. (2003) found 
that to keep the enzyme active, the purification is better in the absence of 
oxygen, whereas Nguyen et al. (1998) indicated that aerobic circumstances are 
acceptable and Basu et al. (2003) found the oxygen is actually advantageous in 
pMMO purification. Lieberman et al. (2003) were able to purify active pMMO 
from Methylococcus capsulatus (Bath) with molecular mass about 200 kDa 
which may correspond to α2ȕ2Ȗ2 subunits of pMMO hydroxylase. The purified 
enzyme from the same study contained 4.8 ± 0.8 copper ions and 1.5 ± 0.7 Fe 
ions (Figure 1.2). Analysis of the pMMO complex by electron paramagnetic 
resonance spectroscopy showed that 40-60% of the total copper corresponded 
to mononuclear type 2 Cu sites. In the same study X-ray absorption 
spectroscopy of the pMMO complex revealed the presence of both Cu (I) and 
Cu (II) oxidation state. Choi et al. (2003) improved the purification of pMMO by 
changing the growth conditions to stabilize pMMO and the amount of detergent 
used to maintain the metal composition of the pMMO. It was found that addition 
of type 2 NADH: quinone oxidoreductase complex (NADH dehydrogenase 
[NDH]), keeping a high ratio between duroquinol/ duroquinone, led to a highly 
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active purified pMMO with an activity of 130 nmol min-1 mg of protein-1 
compared to < 50 nmol min-1 mg of protein-1 obtained by Basu et al. (2003) from 
partially purified pMMO. By using electron microscopy in combination with 
single-particle analysis (SPA), Kitmitto et al. (2005) were able to characterise 
the three dimensional structure of the pMMO hydroxylase and show that it was 
a trimer.  
The purification of pMMO was also achieved by other studies from Mc. 
capsulatus Bath (Nguyen et al., 1994; Zahn and DiSpirito, 1996) and Ms. 
trichosporium OB3b (Miyaji et al., 2002; Takeguchi et al., 1998). All these 
studies agreed that pMMO contains copper at the active site, although there 
has been a considerable controversy about the number and nature of the metal 
ions. One model suggested that pMMO contained up to 10-15 Cu atoms and 2 
iron atoms. In this model, it was found that 8-13 Cu atoms were attached to a 
small peptide (1,218 Da) which named as copper binding compound (cbc) that 
appeared in the purified pMMO (DiSpirito et al., 1998; Zahn and DiSpirito, 
1996). The second proposed model is an enzyme with 15-21 copper atoms, in 
this model 5-7 copper atoms arranged in trinuclear copper atom cluster, in 
which 2-3 cluster are catalytic and 3-4 transfer an electron from NADH to the 
active site centre (Nguyen et al., 1994; Nguyen et al., 1996; Nguyen et al., 
1998). The last model suggested the presence of 2 copper atoms and 1-2 iron 
atoms in the active centre of the pMMO enzyme (Basu et al., 2002; Lieberman 
et al., 2003; Tukhavatullin et al., 2000). 
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In other studies (Lieberman and Rosenzweig, 2005; Balasubramanian and 
Rosenzweig, 2007) three different metal centres positions were proposed for 
particulate MMO of Ms. trichosporium. In the first metal position, a dicopper 
centre lies in the soluble domain of PmoB subunit (spmoB), with shortened Cu-
Cu stretch of 2.5-2.7 Å accompanied with highly conserved residues (histidines) 
(Hakemian and Rosenzweig, 2007; Hakemian et al., 2010). In the second 
position, one copper centre lies alongside the conserved residues, His48 and 
His72. The third metal centre, which in this crystal structure appears to be 
occupied by zinc, lies attached to the membrane and coordinated with two 
residues from pmoB, one from pmoC and probably one from pmoA (Figure  1.3) 
(Lieberman and Rosenzweig, 2005). In a study by Hakemian et al. (2008) 
 
Figure 1.2  Structure of pMMO from Methylococcus capsulatus (Bath). The 
α-subunit (PmoA), ȕ-subunit (PmoB), and Ȗ-subunit (PmoC) are coloured lilac, yellow, and 
green, respectively. Metal atoms shown as spheres, copper red, and zinc orange. (a) (α ȕ 
ɣ)3 enzyme; (b) view looking down on (a) from above; (c) one promoter showing the 
mononuclear and dinuclear copper and zinc (Smith and Murrell, 2010). 
 
  20 
 
where pMMO was purified from Methylosinus trichosporium OB3b, it was found 
that the mononuclear copper centre in Mc. capsulatus Bath was absent in Ms. 
trichsporium OB3b and a third copper centre in the latter replaced the zinc in 
Mc. capsulatus pMMO. This indicates that there is a difference in function 
between the two enzymes from the bacteria or maybe the difference came from 
the preparation of the two enzymes. By using the suicide substrate acetylene in 
a radiolabelled form, the copper active site was proposed to lie in PmoB or 
between PmoB and PmoA subunits (Zahn et al., 1996; Prior and Dalton, 1985), 
which was then confirmed by a molecular study where a recombinant fragment 
of soluble part of PmoB which was able to bind copper and have activity toward 
propylene (Balasubramanian et al., 2010). In addition to the pMMOH (pMMO 
hydroxylase), Dalton and co-workers purified another protein which they 
proposed to be pMMOR (pMMO reductase), which consisted of 63 and 8 kDa 
polypeptides (Basu et al., 2003). It was found that the pMMOR and pMMOH did 
not give activity when they were tested separately towards propylene. However, 
mixing them together resulted in an active enzyme with 2.6 nmol min-1 mg-1. 
The N-terminal sequences for the 63 kDa subunit was then shown to be a 
methanol dehydrogenase by Adeosun et al. (2005). Myronova et al. (2006) 
were able to purify and characterise a complex between pMMO-H and methanol 
dehydrogenase (MDH). In this study it was suggested that MDH can play a role 
as a reductase. 
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Figure  1.3 Structure of single protomer of pMMO purified from Mc. 
capsulatus Bath. 
The Ȗ-subunit is in a faint light green (encoded by pmoC), ȕ-subunit in a faint light blue 
(encoded by pmoA) and α-subunit (encoded by pmoB) shown in three colours: green (represent 
the carboxy-terminal domain), blue (two transmembrane-helices) and purple colour (represent 
the amino-terminal domain). Three suggested metal centres; mono-copper, di-copper, tri-copper 
(in the figure, the proposed tri-copper site is marked with star and the di-iron site is indicated by 
red arrows). In addition there is a Zinc ion (proposed to have di-iron centre in another study) 
(Balasubramanian et al., 2010). 
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1.4.1.2 Molecular genetics of pMMO 
 
Two copies of the pmoCAB operon with approximately identical structures have 
been identified in Methylosinus trichosporium OB3b, Methylocystis sp. strain M 
(Gilbert et al., 2000) and in Methylococcus capsulatus Bath (Semrau et al., 
1995). The two copies were found to be indispensable for reliable activity for 
pMMO by applying chromosomal insertion mutations (Stoylar et al., 1999). In 
addition to a third copy of pmoC (pmoC3) was identified in Mc. capsulatus Bath 
with a different sequence in each the N-terminal and C-terminal from the other 
two pmoC copies in the same bacterium. A proposed role in growth on methane 
was suggested for pmoC3, since a mutant was not able to grow on media with 
methane (Stoylar et al., 1999). It was known that pMMO from cultured 
methanotrophic bacteria oxidizes methane only when it is in a high 
concentration >600 ppmv in the environment and not in low concentration. In a 
study by Yimga et al. (2003) using newly designed primers, a second copy of 
pmoA encoding the active polypeptide was characterized in Methylocyctis sp. 
strain SC2. It was then refered to as pmoA2 to distinguish it from the pmoA1. By 
using the same primers, they were able to characterise pmoA2 in a wide range 
of type II methanotophic bacteria such as Methylosinus-Methylocystis group.  
Furthur study by Ricke et al. (2004) showed that pmoA1 and pmoA2 belong to 
different operons refered to as pmoCAB1 and pmoCAB2. The DNA analysis 
showed that the identity between these two gene clusters was 67.4-70.9%. The 
first copy was able to oxidize methane in a high level >600 ppmv. The second 
copy pmoCAB2 encodes for a different pMMO (called as pMMO2) that has a 
higher affinity for methane and is able to oxidise methane at lower concentration 
(< 1.75 ppmv) than any other pMMO investigated (Baani and Liesack 2008). 
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Interestingly, three different copies of the pmoCAB operons were isolated from 
the extremophilic verrucomicrobial, Methyloacidophilum kamchatkense kam1. 
Each operon codes for the αȕȖ subunits of the pMMO. In addition to the above 
operons, this bacterium possesses a pmoCA cluster, i.e. a third operon 
encoding only the alpha and beta subunits (Dunfield et al., 2007; Pol et al., 
2007; Op den Camp et al., 2009). By using qPCR analysis, Islam et al. (2008) 
were able separately to measure the expression of the four pmoA genes. One 
gene named pmoA2 was transcribed 35 times more than any one of the other 
pmoA. Changing temperature and pH was found not affect the rate of 
expression of this gene whereas altering the carbon source from methane to 
methanol reduced the transcription of pmoA2 ten times. This may refer to a 
specific role for substitution carbon source in gene regulation (Erikstad et al., 
2012). 
 
As mentioned earlier, by using molecular genetic methods Balasubramanian et 
al. (2010) were able to prove that pMMO activity relies on copper and not iron. 
These authors firstly detected an activity for purified pMMO towards propylene. 
No detectable activity was obtained when purified pMMO was treated with 
cyanide. Reapplying 2-3 equiv. of copper per 100 kDa pMMO protomer led to 
restoration of nearly 70% of pMMO activity towards propylene oxidation and 
more than 90% as measured by methane oxidation activity. In contrast, when 
they applied iron, there was no effect on recombinant pMMO activity, which 
indicates that Cu is at the active site of pMMO. The position of the Cu active-
site was then identified in the soluble part of the recombinant α-subunit 
expressed in E. coli, which was called spmoB, rather than in bacterial cell 
membrane (Balasubramanian et al., 2010; Smith et al., 2011). By site directed 
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mutagenesis it was also shown that the di-copper centre is responsible for 
substrate oxygenation, since the disruption by mutagenesis of the putative 
ligands for the mono-copper, di-copper and tri-copper centres separately 
resulted in lost the enzyme activity towards propylene and methane only for the 
eliminated dicopper in spmoB of pMMO enzyme, whereas the mutants with 
remoal of the mono- and tri-copper were active. However, Chan's group have 
suggested based on biophysical and biochemical studies that the tri-copper site 
(Figure  1.3) which lies between PmoA and PmoC may have a role in 
hydrocarbon oxidation activity (Chan et al., 2008; Chan et al., 2004; Chan et al., 
2013), since PmoA and PmoC were able to oxidise methane and propene 
oxidation at room temperature (Chan et al., 2013). By combining high- 
resolution mass spectrometry with computational studies, Chan's group were 
able to confirm that pMMO oxidizes acetylene to ketene (CH2═C═O) which then 
interacts with an amino acid within the PmoC subunit leading to covalent 
modification of amino acid that resulted in loss of enzyme activity. Further 
analysis of the digested peptide from in-gel proteolysis by using labelled 
acetylene and high resolution mass spectrometry showed that K196 of PmoC is 
the position that is modified. No evidence was found for chemical changes in 
the PmoB or PmoA subunits (Chan et al., 2015). In same study, it was 
suggested a putative role for PmoC in controlling the entry and egression of 
hydrophobic substrates to and from the active site. Zinc was also implicated as 
an inhibitor of pMMO by replacing the copper in the active site or altering the 
copper at another site implicated in providing a proton to the active site to 
initiate the catalytic cycle (Chen et al., 2004; Cook and Shiemke, 1996; 
Takeguchi et al., 1999). Sirajuddin et al. (2014), in a study on pMMO from 
Methylococcus capsulatus and Methyocystis species strain Rockwell, found via 
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crystallography that there are two putative site for zinc binding in PmoC; the first 
sites is in the PmoC subunit, it was found that when zinc binds here, ten 
residues were rearranged which may lead to conformational changes. These 
conformotional changes might affect the binding site for the quinol that (acts as 
the reductant for pMMO) consequently led to release of a proton to start the 
catalytic cycle. The second zinc site was found in the soluble part of PmoC.  
Although controversy remains about the the exact role for the copper, iron and 
zinc in pMMO, substantial progress in purification of active pMMO, identification 
of the active site and other functional features have been made recently. 
 
1.4.2 Soluble methane monooxygenase (sMMO) 
 
 
sMMO is among the most important diiron active site monooxygenase enzymes 
that can incorporate molecular oxygen to methane and convert it to methanol. 
As in the case of methanotrophs growing using pMMO, the methanol produced 
from oxidation of methane by sMMO is then further oxidized by methanol 
dehydrogenase to formaldehyde which either is used to build cell mass or 
further oxidized. The sMMO also has ability to oxidize a wide range of other 
substrates (for more information, see Table  1.2) (Woodland et al., 1986; 
Myronova et al., 2006). 
The sMMO enzyme from two methanotroph model organisms have been 
identified and investigated in detail. One is produced by Mc. capsulatus Bath 
(Colby and Dalton, 1978) that works at 45oC and the second is produced by Ms. 
trichosporium OB3b (Fox et al., 1989) which has optimal activity at 30oC. The 
  26 
 
previous studies showed that sMMO from Ms. trichosporium and Mc. 
capsulatus are comparable in their subunit and prosthetic group composition, 
catalytic properties and the substrates which they oxidize (Smith and Dalton, 
2004). The sMMO enzyme consists of three components “hydroxylase, the 
regulatory/coupling protein and the reductase”. These components of sMMO 
are sometimes referred to as proteins A, B, and C respectively. The sMMO 
operon is made up of six genes, mmoXYBZDC. The structure and function of 
the sMMO enzyme components will be explained in greater detail in the next 
section. 
The sMMO gene cluster also harbours two additional genes known as mmoG 
and mmoR (Figure 1.4) encoding a GroEL homologue and a σ54- specific 
transcriptional regulator. mmoX, Y, Z, B and C are the structural genes that 
encode the sMMO enzyme. The mmoD gene codes for protein of previously 
unknown function (Csaki et al. 2003; Scanlan et al. 2009).  
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Figure 1.4   Soluble methane monooxygenase gene cluster from three different  
methanotrophs; Methylococcus capsulatus (Bath) (A), Methylosinus 
trichosporium OB3b (B) and Methylocystis sp (C). 
A) sMMO operon from Methylococus capsulatus (Bath) showing the sMMO-encoding genes in 
addition to genes mmoR and mmoG, mmoS and mmoQ. B) sMMO operon from Methylosinus 
trichosporium OB3b showing genes mmoR and mmoG in different positions from those 
recognized in Bath. No mmoS and mmoQ were indenitified in OB3b strains while C) shows the 
sMMO operon from Methylocystis sp. strain M which does not have genes mmoR and mmoG, 
mmoS and mmoQ. 
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1.4.3 Components of sMMO 
 
1.4.3.1 Hydroxylase (Protein A) 
 
The hydroxylase may be considered to be the most important and critical part of 
sMMO, a part of group of active versatile hydrocarbon oxygenases with 
binuclear iron centres. The family also includes hemerythrin, the R2 subunit of 
class I ribonucleotide reductase, purple acid phosphatase (Que Jr and True., 
1990), and others (Rosenzweig et al., 1999).The hydroxylase component (250 
kDa) which comprises α2 ȕ2 Ȗ2 subunits arranged in a heart shape (Figure  1.5 
A), is encoded by mmoX, Y and Z and contains the active site in the α-subunit. 
The active site contains two iron atoms connected by µ-(hydro) oxo-bridge 
buried deeply in the α- subunit, where the oxygen is activated, surrounded by 
four glutamic acid and two histidine side chains in addition to the bridging OH, a 
terminal H2O ligand, and an acetate at 4oC swapped with a H2O molecule at -
160oC (Figure 1.5) (Rosenzweig et al., 1999). It has been found from the study 
of Elango et al. (1997) that there are substantial differences in the active site 
structure in various redox states of the diiron centre.  
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Figure  1.5 The structure and the geometry of active site within the hydroxylase 
from Methylococcus capsulatus Bath. 
A) hydroxylase (MMOH), gray: α subunit, teal: ȕ subunit, wheat: Ȗ subunit and orange spheres: 
diiron centre.  The structure of MMOH was determined by single crystal X-ray diffraction 
B) The image shows the diiron centre surrounded with four Glutamates 114, 144, 209, 243, two 
histidines 147 and 246 (A; taken from Sirajuddin and Rosenzweig, 2015 and B; from Lippard 
2005). 
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Crystallography studies of MMOH have indicated that there are a number of 
cavities that form a potential route from the upper surface of the enzyme toward 
the active site, but no direct evidence for the role for any of them in substrate 
entry and product exit (McCornick and Lippard, 2011). Molecules ranging in size 
from methane to 2, 2-diphenyl-1-methylcyclopropane can reside in cavity one 
(Liu et al, 1993). The proposed function of large cavities, 3 and 4, is a pathway 
for entrance of the substrates to the active site, egression of the product via 
these cavities, or could be both (Figure  1.6) (Rosenzweig et al., 1997). In 
addition to that there is a pore region between the protein exterior and the 
active site, the presence of this route was first observed by (Rosenzweig et al., 
1997; Rosenzweig et al., 1993; Matthew et al., 2006; Murray and Lippard 2007).  
According to these studies it might have a role in proton shuttling or dioxygen 
activation in the active site (Murray and Lippard 2007; Song et al., 2010; 
Tinberg and Lippard, 2009; Lee and Lipscomb, 1999). Another role was 
suggested for these cavities in allowing substrate entrance to the active site of 
phenol hydroxylase enzyme (PHH) which has considerably bigger pore region 
than the other monooxygenase enzymes (Sazinsky et al., 2004; Sazinsky et al., 
2006). 
Also a channel has been found between cavities one and two in toluene/ o-
xylene monooxygenase (ToMOH), when protein B attaches to the hydroxylase, 
this causes a conformational change leading to pluging of the channel (Bailey et 
al., 2008). In MMOH a channel of this type could not be identified.  A number of 
amino acids with hydrophobic side chains were found such as F188, F236, and 
L110 preventing the formation of an analogous channel and this might have a 
role in providing a hydrophobic ambient environment to facilitate the 
accommodation of hydrophobic hydrocarbon substrates in sMMO (Tinberg et 
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al., 2009; Lee et al., 1999; Song et al., 2011; Song et al., 2010). As such, a role 
for Leu110 was suggested in controlling the access or egression of the 
substrates and product in and out from the active site (Rosenzweig et al., 1997). 
This hypothesis was investigated by site directed mutagenesis by Borodina et 
al. (2007). It was shown that this residue is important in controlling the 
regioselectivity more than access of substrate to the active site. Also, there are 
specific cavities with certain characteristics and specific side chains that form a 
route for passage of dioxygen to the active site of sMMO and other bacterial 
multi-component monooxygenases (Song et al., 2011). Crystallographic studies 
in which xenon was used as a surrogate for methane substrate were consistent 
with the previously proposed location of the substrate-binding site in both 
sMMO and toluene/o-xylene monoxygenase (Song et al., 2011; McCormick and 
Lippard, 2011).  
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Figure  1.6 Hydroxylase cavities and some changing during MMOH-MMOB 
complex formation. 
The diagram shows the cavities from outside toward the active site of MMOH; Cavity 3 
(magenta), cavity 2 (blue) and cavity 1 (green). The orange colour represents the pore region. 
Amino acids residues corresponding to each cavity depicted as sticks with the same colour for 
the contributed cavity. The dirion centre represented with black and gray colour. The image is 
for the diiron centre in oxidation and reduction state; A and B respectively. In the reduction state 
where the MMOH-MMOB complex formed, the pore region become completely plug and cavity 
one as a consequence is open access to allow the entrance of CH4 (other substrates) and 
oxygen to start the catalytic cycle.   
(Lee et al., 2013)  
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1.4.3.2 Coupling/ Regulator protein (protein B) 
 
 
The protein B (effector/ regulator) component is a single polypeptide of 16 kDa 
with no metal group (Green and Dalton 1985). Many roles also have been 
proposed for protein B involving regulating electron transfer to the sMMO 
hydroxylase from the reductase to start the catalytic cycle of the sMMO enzyme 
(Green and Dalton 1985; Fox et al., 1991). In addition, the formation of a 
complex between protein B and the hydroxylase changes the activity and 
regioselectivity of the enzyme (Lee et al., 1993; Paulsen et al., 1994; 
Kazlauskaite et al., 1996). 
Chang et al. (1999) and Walters et al. (1999),  demonstrated by NMR 
spectroscopy the structure of protein B from both Ms. trichosporium and Mc. 
capsulatus, the core of MMOB, residual 35-127 in Mc. capsulatus, comprised of 
7 ȕ-strands arranged it two antiparallel ȕ-sheets organised almost perpendicular 
to each other. Three α-loops bridge the cleft and separate the two ȕ-sheets to 
form the spherical core of the protein. Although, NMR could not identify the first 
35 and the last 12 amino acids of the regulatory protein, NMR and CD 
experiments showed that section of the N- terminus might form a helical 
construction (Figure 1.7). 
 
It has been suggested that interaction between protein B and the hydroxylase 
opens the blocked active site allowing entrance of oxygen and methane 
(Brazeau& Lipscomb 2000; Chang et al., 2001). Many other roles have been 
proposed for protein B in the sMMO complex. Astier et al. (2003) revealed that 
H2O2 was being created in their experiment, but when the protein B was added, 
H2O2 disappeared, this result provided evidence for an additional  role for 
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protein B namely by preventing H2O2 formation as an accidental by-product 
when dioxygen reacts with the sMMO diiron- centre. The exact role for the 
protein B during the formation of a complex between MMOH and MMOB was 
unclear, largely due to the lack of crystallographic study data for the MMOH-
MMOB complex. A crystal structure of this complex has now been obtained and 
reveals that MMOB has a core region (Asp36-Leu129), that binds to the canyon 
between the α and ȕ subunits of MMOH, and a disordered N-terminal tail which 
forms a regular ring-shape structure after connecting with α-subunit. Both these 
structural features have been shown to be indispensable in MMO activity (Lee 
et al., 2013). The important role for the N-terminal region was firstly discovered 
by (Green et al., 1985; Brandstetter et al., 1999; Chang et al., 2001) and proved 
recently by mutation study which revealed a decrease in the activity of mutated 
MMOB (∆1-8, ∆1-17 and ∆1-33) comparing to the activity of non-mutated 
MMOB (Lee et al., 2013). 
It has been found also that the ring shaped structure interacts with the α-subunit 
of MMOH via the α-helix (Gly17-Phe 25) from MMOB that could make the 
complex difficult to reduce by MMOR. The interaction also leads to a structural 
changes in certain residues within the α-subunit around the active site such as 
Thr 213 and Glu 240 leading to closure of the pore region which is implicated in 
proton supply during the catalytic cycle (some of the conformational changes 
will be explained in more detail later) (Tinberg et al., 2009; Wallar and 
Lipscomb, 1996; Merkx et al., 2001). Another important role of the formation of 
the MMOB-MMOH complex is that when this complex forms in the diferric 
oxidation state of MMOH, the cavities 2 and 3 become connected and 
presumbly are able to allow dioxygen and methane to pass to the active site, 
whereas in the absence of MMOB these two cavities are separate. This opening 
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of the channel between cavities 1 and 2 is brought about by movement of a 
number of residues including Phe188 and L110 which then allow passage of 
substrates, O2 and protons to the diiron active site (Figure  1.8) (Lee et al., 
2013). 
 
 
 
Figure  1.7  Structure of protein B from M. capsulatus 
Coupling/regulator protein (MMOB), MMOB was showed by NMR spectroscopy to be comprised 
of ȕ-strands arranged it two antiparallel ȕ-sheets (shown in magenta and green colour in a 
shape likes arrows). Three α-loops bridge the cleft and separate the two ȕ-sheets to form the 
spherical core of the protein.  
(Lee et al., 2013) 
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Figure  1.8  Conformational changes in the formation of complex MMOH-
MMOB. 
A; Protein B in magenta attached in the canyon between MMOH protomers, B; the diiron 
centre in the α-subunit of MMOH and the pore region is open for solvent and cavities 1&2 are 
disconnected by Phe 188 and L110. C; The pore region is closed and geometry alteration 
leads to open cavities 1&2 to allow substrate to enter the active site. Cavities are represented 
in a green net (Sirajuddin and Rosenzweig, 2015). 
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1.4.3.3 Reductase (protein C) 
 
The third component of the sMMO, responsible for electron transferfrom NADH 
to the hydroxylase is known as protein C or the reductase (MMOR) (Smith and 
Dalton, 2004). The reductase from Mc. capsulatus is a single polypeptide of 
38.5 kDa with an Fe2S2 prosthetic group and FAD (Flavin adenine dinucleotide) 
(Colby and Dalton 1979).  The existence of the Fe2S2 prosthetic group was 
proved by means of electron paramagnetic resonance (EPR) (Figure  1.9), and 
NADH was suggested as the electron donor. Protein C was found to be 
inactivated by copper ions that disrupt the Fe2S2 centre, inhibiting the electron 
transfer from the reductase to the hydroxylase (Green et al., 1985). Also it was 
shown that the reductase attached to the ȕ-subunit of MMOH, suggesting other 
roles for protein C in sMMO activity: (i) The formation of a complex between 
MMOR and MMOH causes changes in product distribution (Froland et al., 
1992); (ii) protein C could be attached to MMOH in various positions with 
different affinity, which make it a competetor to MMOB (Fox et al., 1991); and 
(iii) the redox potential of the diiron centre in MMOH are changed (Paulsen et 
al., 1994; Liu et al., 1997). There is a strong functional analogy between sMMO 
and cytochrome P450, since P450 is also a complex of monooxygenases 
utilizing NAD (P) H and oxygen to catalyse the oxygenation of various C-H 
compounds).  It was found in cytochrome P450 that hydrogen hydroxide H2O2 
can substitute for O2 as an oxidant in the absence of the reductase component 
(White & Coon 1980). In later studies it was found that methane oxidation was 
observed when H2O2 was added to the MMOH components of methane 
monooxygenase from Ms. trichosporium (Andersson et al., 1991) or Mc. 
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capsulatus (Jiang et al., 1993), even in the absence of the other two 
components of sMMO.  
 
Figure  1.9    Structure of reductase protein from Mc. capsulatus Bath. 
Methane monoxygenase reductase (MMOR), as shown in image consists of ȕ-sheet 
polypeptide with red and yellow balls pointed by arrow represented the flavin adenine 
dinucleotide FAD. MMOR was modelled based on the structure of benzoate dioxygenase 
reductase enzyme from another study which showed similar domins for MMO reductase by 
NMR. (Lippard, 2005; Karlsson et al., 2002). 
 
Although some studies revealed that reductase binds in the ȕ-subunit as just 
mentioned above, it is still unclear where the reductase binds to the MMOH. In 
an investigation on sMMO from Ms. trichosporium by using 1-ethyl-3-(3- 
(dimethylamino) propyl) carbdiimide (EDC) it was suggested that MMOR 
adheres to the MMOH ȕ-subunit whereas MMOB appeared to attach to the α-
subunit (Fox et al., 1991). In contrast, a study on Mc. capsulatus, also using 
EDC suggested that MMOR binds to the α-subunit of MMOH (Kopp et al., 
2003). Recently, it has been found by using hydrogen-deuterium exchange 
coupled to mass spectrometry (HDX-MS) that MMOR attaches to the canyon 
between the  α and ȕ subunits of MMOH where protein B was shown via x-ray 
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crystallography to bind (Wang et al., 2014). The crystallographic study by 
(Wang et al., 2014) also suggested that due to competetion between MMOB 
and MMOR on the binding site, MMOB may inactivate electron transfer to the 
active site when it displaces MMOR from the MMOH. 
As detailed above, many studies have proved that all parts of sMMO are 
indispensable and critical for the enzyme activity in vivo and in vitro. As such an 
attempt to purify the three components of soluble methane monooxygenase 
was performed in the present study to achieve the full activity of the enzyme. 
 
1.5 Copper effect in switching between pMMO and sMMO 
 
As mentioned above some species of methanotrophic bacteria produce two 
types of methane monooxygenase, pMMO and sMMO. For these 
methanotrophs, switching between pMMO and sMMO takes place depending 
on the amount of copper in the media or in the environment. The pMMO is 
expressed in the cell when the ratio of copper to biomass is high, whereas 
sMMO is elaborated at low copper to biomass ratio (Stanley et al., 1983; 
Hanson and Hanson, 1996). It was found that pMMO activity is enhanced by the 
presence of Cu outside the bacterial cell, and more activity was observed when 
more copper was added (Nguyen et al., 1994). However, there is an effect of 
Cu on sMMOR which inhibits the sMMO reductase and inactivates the sMMO 
enzyme (Green et al., 1985). Understanding the effect of copper in 
methanotrophic bacteria that produce pMMO and sMMO is valuable in 
biotechnology and bioremediation. For instance, due to its wide substrate 
range, sMMO has a wide potential role in oxidation of toxic substances in the 
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environment but is not expressed in high copper conditions which may exist 
frequently in nature. Many proposals for regulation of pMMO and sMMO by 
copper have been suggested as the precise mechanism for the copper switch is 
not well understood. Murrell et al. (2000) proposed a model for this switching 
between pMMO and sMMO in Methylosinus trichosporium OB3b depending on 
the presence of a regulator protein as described below; according to this model 
there is a putative regulator protein called copper binding regulator protein 
(CBR) that binds to a putative repressor molecule (R). The complex CBR-R-Cu 
then binds to a putative sMMO activator protein (A).  When the copper ratio is 
high, this complex is formed and holds the repressor protein and activator 
protein to allow the transcription of the pmo genes and production of pMMO. In 
the opposite condition namely when the copper to biomass ratio is low, the 
complex containing CBR-Cu, as well as the activator (A) and repressor (R), 
cannot be established. This leaves the R protein to supress transcription of 
pmo. Meanwhile, the activator protein will bind to the upstream-activating 
sequence of mmoX and initiate sMMO transcription. The initiation of sMMO 
transcription in Methylosinus trichosporium OB3b starts from a ϭN promoter 
upstream of mmoX. As was mentioned previously, the sMMO operon contains 
mmoX, mmoY, mmoZ which encode for α, ȕ, Ȗ subunit of sMMO hydroxylase. 
mmoB encode for protein B and mmoC encode for protein C. In addition to 
mmoD (OrfY) with a proposed role for MmoD in assembly of the diiron centre in 
soluble methane monooxygenase was suggested by Merkx and Lippard (2002). 
Initiation of transcription from the promoter upstream from the mmoX gene 
requires the presence of the ϭN subunit of RNA polymerase and the enhancer-
binding-proteins (EBPs) which activate the start of transcription from a specific 
enhancer area upstream from the promoter (Merrick 1993).  
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In another model suggested by Stafford et al. (2003) on Methylosinus 
trichosporium OB3b, two more genes were included, which were, identified 
upstream from the sMMO operon named as mmoR and mmoG. These two 
genes were implicated in the regulation of operon by copper. According to the 
model hypothesised by Stafford et al. (2003); at the low copper to biomass ratio, 
the transcription of mmoR and mmoG will take place. The MmoR protein is 
thought to work as an enhancer binding protein which binds to ϭN (encoded by 
the rpoN gene) to start transcription of the sMMO operon from the ϭN dependent 
promoter. The role of MmoG was believed to work as a chaperon (GroEL) to 
help in folding of the MmoR protein or other polypeptides responsible for 
inhibition of MmoR. By mutagenesis of the rpoN, mmoR and mmoG genes, the 
sMMO expression under the low copper conditions was abolished, which may 
reflect an important role for these genes.  
In another study by Cśaki et al. (2003) on Methylococcus capsulatus Bath 
another model was proposed involving two additional proteins. Sequencing of 
9.5 kb near to the sMMO operon resulted in identification of the mmoR and 
mmoG genes down stream from the sMMO operon (), unlike the upstream 
location for Ms. trichosporium OB3b mentioned above. In addition, two more 
genes; mmoS and mmoQ were identified in the opposite direction to mmoR and 
mmoG in Mc. capsulatus. A hypothetical model in Mc. capsulatus was 
suggested in this study as below; in the low ratio of copper to biomass, MmoS 
protein senes the Cu to induce MmoQ by phosphyrelation. The MmoQ protein 
was found to bind the enhancing protein MmoR, which, as described above, 
binds to ϭN to initiate the sMMO operon transcription. The roles proposed for 
mmoR and mmoG are the same as those described in Ms. trichosporium. 
Similar to the result from Ms. trichsporium the mmoR and mmoG genes were 
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found to be indispensable for sMMO expression in addition to another proposed 
role for  the putative chaperon protein MmoG in producing sMMO as a final well 
folded mature protein. No sequence motifs MxCxxC (which these authors 
expected to be metal binding residues) were identified in MmoS. This suggests 
either that MmoS detects copper indirectly or that it binds copper in a different 
way.  
From previous studies, the presence of molecules that mediated the effect 
between the copper and MMO enzyme has been suggested. Copper-binding 
compounds (cbcs) were proposed to have such role (Choi et al., 2003; Zhan 
and DiSpirito, 1996). Kim et al. (2004) identified a molecule from Methylosinus 
trichosporium OB3b similar to a siderophore and named as methanobactin (mb) 
(a siderophore is a molecule that binds iron which is able to transfer it into 
bacterial cells).  The mb was implicated in scavenging and transport of copper 
into methanotrophic bacteria in the environment or in cells growing in a medium 
with added copper. Also it was suggested that CBCs are a small degraded 
fragment from mb. The crystal structure of mb was solved (Kim et al., 2004); it 
is a chromopeptide of 1216 Daltons (C45 N12 O14 H62 Cu); it consists of a tetra-
peptides composed of seven amino acids, with two 4-thionyl-5-hydroxy-
imidazole chromophores which acquire copper. By using mass spectrometry, X-
ray crystallography and NMR, Behling et al. (2008) confirmed the crystal 
structure for mb by indicating the chemical formula and chemical construction 
as described above but suggested the presence of alkylidene oxazolone 
moieties rather than the hydroxyimidazolate rings which were suggested by the 
earlier study by Kim et al. (2004) in addition to proposing a biosynthetic pathway 
for mb in methanotrophs. 
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El Ghazouani et al. (2011) identified two types of mb from Ms. trichosporium 
OB3b; the full length form (FL-mb) and the truncated form (mb-Met), which lost 
the C-terminal Met residue.  The removal of Met was found to have a small 
effect on the structure of the Cu (I) site. Both FL-mb and mb-Met have an effect 
on switching between sMMO and pMMO in Ms. trichosporium OB3b. Since the 
discovery of mb, a number of studies have concentrated on the role of these 
molecules in copper switching in methanotrophs that produce both pMMO and 
sMMO.  By molecular genetics, Semrau et al. (2013) were able to identify the 
gene that is responsible for methanobactin precursor expression; deletion of 
this gene resulted in inactivation of mb production. Also they suggested another 
model for regulating the copper switch between pMMO and sMMO under 
copper variation in the environment or media for Ms. trichosporium OB3b. The 
model (Figure 1.10) includes the mmoD gene which encodes for a protein with 
previously unknown function. The model proposed that; under the low ratio of 
copper: biomass mmoD is transcribed to produce a protein MmoD which was 
found to suppress the transcription and expression of pmo and upregulate the 
expression of the sMMO operon and mb gene.  It was proposed that the copper 
free mb enhances the expression of sMMO operon which includes mmoD and 
consequently the increased level of MmoD leads to strict repression of pmo. 
Under the high copper: biomass ratio, the mb will engage with Cu and as such 
the activation of smo will decrease which results in less MmoD being produced. 
Decreasing MmoD results in less production of mb and alleviates supression of 
pmo by MmoD. Addition of more mb in the same study was found to increase 
the expression of mmo operon which was consistent with this hypothesis. 
In a recent study, Al-Haque et al. (2015) revealed that mb from Methylocystis 
sp. strain SB2 can regulate expression of mmo in Methylosinus trichosporium 
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OB3b which indicates that mb from different methanotrophs have similar 
structures/functions. When Ms. trichosporium OB3b was grown at a high copper 
medium, the expression of the mmoX gene which encodes the α-subunit from 
the sMMO hydroxylase was very low. When the mb from Methylocystis was 
added to the medium, the expression of mmoX in Ms. trichosporium was raised.   
 
  
 
Figure  1.10 The suggested role of methanobactin and mmoD gene in copper 
regulation by Semrau et al., (2013) in Methylosinus trichosporium OB3b.  
A: at low copper to biomass ratio, the expression of mmo will take place since mmoD represses pmo 
expression. MmoD will enhance expression of the methanobactin (mb) precursor peptide and mmo, as 
such mb will be produced. In turn, mb will enhance the expression of mmo as well. 
B: at high copper to biomass ratio, mb will bind to Cu and will not activate the transcription of mmo. In 
turn MmoD with binds Cu also; this will allow to pmo to be expressed.  
Adapted from Semrau et al. (2013). 
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1.6 Soluble diiron monooxygenase (SDIMO) 
 
Soluble methane monooxygenase is one of important member of large family of 
soluble enzymes which contains a carboxylate-bridged diiron centre that 
activate dioxygen to  oxidize C-H bonds (Leahy et al., 2003) which are called 
the soluble diiron monooxygenases (SDIMOs). This family includes other 
enzymes such as butane monooxygenase (BMO), toluene-ortho- 
monooxygenase (TOM), toluene-4- monooxygenase (T4MO), toluene o-xylene 
monooxygenase (ToMO), and deoxyhypusine hydroxylase (DOHH). The 
SDIMOs are homologous to other proteins that are not monooxygenases such 
as hemerythrin, the R2 protein of ribonucleotide reductase (Qur and True, 1990; 
Vincent et al., 1990; Nordlund and Ekland 1995) rubrerythrin (deMare et al., 
1996), and stearoyl-acyl carrier protein (ACP) Δ9-desaturase (Nordlund and 
Ekland 1995; Fox et al., 1993). Investigation and study of the molecular 
genetics of the SDIMOs and understanding their mechanism may help in 
exploiting them in industry, biotechnology and bioremediation of pollutants such 
as hydrocarbons.  
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Table 1.3  Operon organization of soluble methane monooxygenase and other diiron enzymes 
References:  
1- Stafford et al., 2003           4- Sluis et al., 2002             7- Newman and Wackett, 1995    10- Byrne et al., 1995           13- Kim et al., 2006 
2- Scanlan et al., 2009           5- Yen et al., 1991              8- Bertoni et al., 1998                   11- Carlson et al., 1984        14- Abbruzzese et al., 1986 
3- Stein et al., 2010            6- Yen and Karl 1992       9- Oslen et al., 1994                12- Park et al., 2006         15- Shanklin and Somerville, 1991
Diiron enzyme Source organism operon organization Reference (s) 
soluble methane 
monooxygenase (sMMO) 
Methylosinus trichosporium OB3b 
 
1, 2, 3 
butane monooxygenase 
(BMO) 
Thauera butanivorans 
        
4 
toluene-ortho-monooxygenase 
(TOM) 
Burkholderia cepacia G4 
     
 
5,6 
toluene/ o-xylene 
monooxygenase (ToMO) 
Pseudomonas stutzeri OX1 
 
7 
toluene-4-monooxygenase 
T4MO 
Pseudomonas mendocina KR1 
      
8 
toluene-3-monooxygenase 
(T3MO) 
Ralstonia pickettii PKO1 
 
9, 10 
Ribonucleotide reductase 
(RNR) 
Escherishia coli K-12 
      
11 
deoxyhypusine hydroxylase 
(DOHH) 
Homo sapiens 
        
12, 13, 14 
Stearoyl-ACP-desaturase Ricinis communis 
        
15 
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1.4.4 Butane monooxygenase (BMO) 
 
Butane monooxygenase is produced by the Gram-negative bacterium Thauera 
butanivorans (formerly Pseudomonas butanovora) (Dubbels et al., 2009). The 
main substrate for BMO is butane in addition to its ability to oxidize alkanes, 
alcohols, organic acids (Takahashi et al., 1980) and co-oxidation of chlorinated 
hydrocarbons (Hamamura et al., 1997). Butane is oxidized at the terminal 
position by BMO to produce 1-butanol, which is then further oxidized to 
butyraldehyde by butanol dehydrogenase (Vangnai et al., 2002). The 
butyraldehyde is then converted to butyrate (Arp, 1999), which is probably 
metabolized further via the fatty acid β-oxidation pathway to be used in building 
cell biomass and providing energy. As compared with the methane oxidation 
pathway, the steps of oxidation of butane are considered as very similar to the 
sMMO oxidation pathway. Cloning and sequencing of the BMO genes (Miriam 
et al., 2002) showed that the BMO operon consists of six genes; bmoX, bmoY, 
and bmoZ encode a multimeric hydroxylase (α 2 ȕ 2, Ȗ2) of 61, 45, 19 kDa 
respectively. The bmoC gene encodes the BMO reductase (40 kDa). The bmoB 
gene encodes a small protein of 15 kDa molecular mass considered as a 
regulator protein. The remaining gene in BMO operon, called bmoD, encodes a 
9.6 kDa protein similar to MmoD, which has a proposed role in assembling the 
metal centre in sMMO (Table1.3). As with sMMO operon there is also a gene 
encoding a putative initiation factor ϭ 54 for transcription upstream from the bmo 
genes (Miriam et al., 2002). In a study by Dubbels et al. (2007), BMO was 
purified and the properties of the purified protein confirmed the pervious 
information about the composition of BMO and proved that the purified BMO 
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has activity towards ethene with H2O2 as the oxidant via the peroxide shunt 
reaction, although the activity towards ethene was three orders of magnitude 
less than the hydroxylase of sMMO of Methylosinus trichosporium OB3b. 
 
1.6.1.1 Site directed mutagenesis studies on BMO 
 
As it was mentioned previously about the sMMO, it is likely that there are a 
number of cavities implicated in allowing the entrance of substrate or egressing 
of product. Cavity 1 in the active site of sMMO is lined with hydrophobic side 
chains and cavity 2 forms a path from the active site to the enzyme surface 
(Rowsenzweig et al., 1997). Also as mentioned above, the interaction between 
MMOH and MMOB changes the conformation of the residues in the active site 
which influences the flexibility of the active site toward substrates. Comparing 
the sequence of the α-subunit of the hydroxylase of BMO with six strains of 
methanotrophs led to the conclusion that there is a high similarity between BMO 
and sMMO (Leahy et al., 2003). In addition, there is a similarity in the versatility 
of substrates they oxidize. However, BMO has only a trace activity towards 
methane (Halsey et al., 2006).  
Exploiting the high similarity between BMO and sMMO, Halsey et al. (2006) 
designed five mutants in the α-subunit of BMO hydroxylase. The mutated amino 
acids were converted to the corresponding amino acids in the active site of the 
sMMO, near to the active site and in the place in the hydroxylase of the BMO 
where regular protein proposed to bind to establish a complex with BMOH. T. 
butanivorans which expressing G113N and L279F were found to grow slowly on 
butane compared to the wild type. Also these mutants revealed a 277- and 5.5 
fold increase respectively in the ratio of 2-butanol to 1-butanol produced 
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compared to the wild type. All the five mutants were shown to be capable of 
oxidizing methane although the methanol inhibited the enzyme. The maximum 
concentration of the methanol produced by the wild type was βγ μM, whereas it 
was 83 μM for mutant G11γN.  
There was a significant change in regioselectivity of this enzyme when the 
muatnt G113N was constructed. This mutant oxidized propane subterminally to 
produce acetone that was not further oxidized; this activity mimicked the activity 
of sMMO towards this substrate, which also produces acetone as the sole final 
product, unlike wild-type BMO, which gives a mixture of terminal and 
subterminal oxidation products.  
The ability of mutants G113N, L279F, and F321Y from T. butanivorans to 
oxidize dichloroethene (DCE) and trichloroethene (TCE) was also investigated 
by Halsey et al. (2007). It was found that the oxidation of three chloroethenes 
was lower in G113N mutant as was the rate of butane oxidation. A change in 
regioselectivity and products distribution was also observed in this study when 
the mutants were tested towards the same substrates. Unlike the wild type 
which was able to produce chloride stoichiometrically from CE oxidation, the 
mutant G113N yielded 14-25 % of avialable chloride from DCE and 56% from 
TCE oxidation.  The F321Y mutant produced 40% of avialable chloride from the 
oxidation of both 1, 2-cis-DCE and TCE. The oxidation of 1, 2-cis-DCE by 
mutants L279F, F321Y and T. butanivorans wild type resulted in production of 
1, 2-cis-DCE epoxide whereas G113N yielded only 50% of the oxidized 1, 2-cis-
DCE. Mutant F321Y and wild type were also found to be able to produce 
epoxide from TCE oxidation whereas mutants G113N and L279F were not. The 
production of less than 40% of the avialable chloride from 1, 2-cis-DCE 
oxidation by all mutants and production of a new product epoxide may be an 
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example how the regioselectivty could be changed by site directed mutagenesis 
through substitution of one or more amino acids to make BMO or other diiron 
enzymes more active towards toxic substances.  Also, this may indicate the 
value of such a study to obtain a mutant(s) able to be exploited in 
bioremediation, biotechnology and in industry. 
 
1.6.2 Toluene ortho- monooxygenase 
 
One of the SDIMOs which is able to oxidize aromatic compounds such as 
toluene and phenol is toluene ortho monooxygenase (TOM) from Burkholderia 
cepacia G4. TOM is able to oxidize toluene in the ortho position. The oxidation 
pathway of toluene by this enzyme takes place via converting toluene to o-
cresol which is then further oxidized to catechol (Shields et al., 1989; Worsey 
and Williams 1975). TOM is encoded by a 4.6 kb operon of six genes 
(tom012345); a 40-kDa NADH dependent oxidoreductase (encoded by tomA5), 
a protein encoded by tomA2 (10.4-kDa) that transfers electrons from the 
reductase into the third component, the hydroxylase (211 kDa). The 
hydroxylase is composed of three subunits α2ȕ2Ȗ2 encoded by three genes 
tomA1, tomA3, and tomA4 respectively and contains a diiron centre within the 
α-subunit (Table 1.3) (Shields and Francesconi, 1997). 
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1.6.2.1 Mutagenesis studies on Toluene ortho-monooxygenase (TOM) 
 
Shields et al. (1995) showed that the TOM genes are carried on a plasmid 
(TOL), since a mutant of Burkholderia cepacia G4 without the putative TOM 
harbouring plasmid (TOL) resulted in no growth for this mutant on toluene or 
phenol. The reconstituted mutant with the TOL plasmid resulted in restoration of 
the enzyme activity in oxidizing toluene and phenol. The 36% amino acid 
sequence similarity between TOM and sMMO led to the suggestion of a similar 
role for equivalent amino acids in the two enzymes. A DNA shuffling technique 
was employed by Canada et al. (2002) to investigate the role of residue V106 
(corresponding to L110 in sMMO which was suggested to have a role as a 
substrate gate) in playing similar role as substrate gate in the α-subunit of TOM. 
Another aim for this study was to increase the ability of TOM to produce 1-
naphthol from naphthalene oxidation and in degradation of trichloroethylene 
(TCE). Mutation of V106 to Ala (variant named TOM-Green), was expressed in 
E. coli. The activity of this mutant in oxidation of naphthalene to 1-naphthol was 
increased up to sixfold compare to the wild type. No alteration of enzyme 
regioselectivity was seen with 1-naphthol representing more than 97% of the 
product.  Also the ability of TOM-Green to degrade 1, 1-dichloroethylene was 
increased to about 2.5-fold compared to that of the wild type and nearly 1.4-fold 
more active than the wild type in oxidation of trans-dichloroethylene. In addition, 
the TOM-Green mutant was able to oxidize triaromatic compounds; 
anthrancene, phenanthrene, and fluorene more rapidly than the wild type. In a 
study by Rui et al., (2004), saturation mutagenesis was used to create mutants 
A106E and A106F within TOM, which led to an increase in the activity in 
converting naphthalene to 1- naphthol by about 2-fold more than the wild type 
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without any change in regioselectivity. Mutant A106E was found to oxidize the 
main substrate toluene 63% more rapidly than the wild type does with a shift in 
regioselectivity to produce (50%) o-cresol, (25%) p-cresol and (25%) m-cresol, 
compared to 98% o-cresol being yielded from the wild type. Also nearly the 
same result was obtained from A106F which oxidized toluene 62% faster than 
the wild type. The regioselectivity for A106F was different from A106E, since 
A106F yielded (54%) p-cresol, (28%) o-cresol, and (18%) m-cresol. The 
expression of TOM was found to be raised in mutant A106E as shown by SDS-
PAGE, whereas A106F showed similar expression level to the wild type. The 
ability of the A106F mutant to degrade chloroform was found to be 2.8 fold more 
than the wild type. The mutant V106A was showed a different colouration from 
oxidation of indole which may indicate a different product distribution from the 
wild type, since the V106A mutant produced a green colour whereas the wild 
type produced brown. Taking advantage of this observation, Rui et al. (2005) 
used saturation mutagenesis at positions A113 and V106 to create a library of 
mutants and study their properties in indole oxidation. These mutants showed 
novel products with various colours such as green, purple and orange. 
Characterization of the mutant enzymes revealed that, with indole as substrate, 
A113V produced indigo, A113I produced indirubin, and A113H as well as the 
C106A/A113G double mutant produced isatin. The wild type produced isoindigo 
through the insertion an OH group into the C-2 position in the indole pyrrole 
ring.  A113G did not produce any of the compounds listed above; instead it 
oxidized indole to 4-hydroxyindol and an uncharacterized yellow product. The 
double mutant A113G/V106A was able to oxidize indole at the C-3 position. The 
study revealed the important role for these amino acids in TOM enzyme. The 
resulting compounds are potentially valuable in industry, for example indigo, 
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which is used as a dye in textiles (Maugard et al., 2002). Also indirubin is 
important as a pharmaceutical since it is a cyclin-dependent kinase inhibitor, 
and it is one of a promising group of anticancer compounds (Hoessel et al., 
1999; Buolamwini 2000).  
In addition to the ability of TOM to oxidize toluene, it was found that TOM is able 
to oxidize phenol and benzene which also enhance the expression of TOM, so 
they were used to activate TOM expression in bioremediation of TCE (Landa et 
al., 1994; Lee et al., 2006; Kim et al., 2010). In a large area contaminated with 
TCE, it is unacceptable to add such an inducer as toluene, phenol or benzene 
which will lead to further contamination with toxic substances in addition of 
being expensive. An alternative approach was used by Kang and Doty (2014) 
by adding a ground poplar leaf (which is known to contain phenol and other 
phytochemical compounds) to the media used to grow Burkholderia cepacia G4 
as the carbon and energy source and also an inducer for TOM enzyme. Kang 
and Doty (2014) were able to detect activity in degradation of TCE by 
Burkholderia cepacia grown using the poplar leaf material. qRT-PCR showed 
that the expression of the TOM enzyme genes were upregulated, which 
confirms the activation of gene expression by these poplar derived compounds 
and the expression is higher than the wild type by 1.8 times.   
 
1.6.3 Toluene/o-Xylene Monooxygenase (ToMO) 
 
Toluene/ o-Xylene monooxygenase (ToMO) from Pseudomonas stutzeri OX1 is 
a four-component monooxygenase which is able to oxidize aromatic 
hydrocarbons such as toluene, xylene and phenol. In addition, it can co-
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metabolise a wide range of substrates at various positions. The oxidation of 
xylene by ToMO takes place in a pathway in which an intermediate compound 
results from primary oxidation of toluene and xylene such as 2, 3-
dimethylphenol (2, 3-DMP) and 3, 4- DMP. These intermediates subsequently 
will be further oxidized to produce dimethylcatechol (Bertoni et al., 1996). 
Cloning and sequencing of the ToMO genes transferred to E. coli showed that 
ToMO is encoded by an operon of six genes; touABE which encodes the α, ȕ, 
and Ȗ subunits of the ToMO hydroxylase. touD encodes the regulator protein, 
touF encodes an oxidoreductase and touC encodes a Rieske type ferrodoxin 
component(Table 1.3). Knocking out the genes that encode the regulator 
protein or the genes that encode the ToMO hydroxylase αȕȖ subunits led to 
complete abolition of enzyme activity. However, in the same study, knocking out 
the reductase encoding genes (ToMOC and F) did not abolish the whole 
enzyme activity (Bertoni et al., 1998). A crystallographic study by Sazinsky et al. 
(2004) in which crystals of ToMO hydroxylase were soaked with the surrogate 
product 4-bromophenol yielded a structure at 2.3 Å resolution that showed that 
there is a close similarity between the substrate binding sites within sMMO and 
ToMO. A wide channel with 6-10 Å width and ~35 Å in length crosses the 
distance between the enzyme surfaces and the active site within the 
hydroxylase. The detection of 4- bromophenol inside this channel led to the 
suggestion that this channel is the route for entrance of substrate or egressing 
of product. Although there is a high structural similarity between ToMOH and 
sMMO hydroxylase, ToMO is not able to oxidize methane like sMMO (Merks et 
al., 2001).  
There are a number of studies that have focused on engeneering ToMO to 
produce di- and tri-hydroxy aromatic compounds. Such di- and tri-hydroxy 
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aromatic compounds for example, catechol, resorcinol, and hydroxyquinone are 
valuable in industry (Davis et al., 1991). Catechols are used as starting 
materials in the pharmaceutical industry, and also in the food industry, whereas 
hydroquinone has been used as developer during processing of medical and 
industrial X-ray film (Davis et al., 1991; Gillner et al., 1994). 1, 2, 3- THB 
(trihydroxybenzene) has been used in the manufacture of hair dye and 
pharmaceuticals, whereas 1, 2, 4-THB has been used as an anti-corrosion 
substance (Davis et al., 1991)   
Vadar and Wood (2004) used DNA shuffling and saturation DNA mutagenesis 
in the α-subunit of ToMO hydroxylase focusing on the important residues 
identified by previouse studies such as that of Canada et al. (2002). I110 in 
ToMO was mutated because it corresponded to V106 in toluene ortho-
monooxygenase. New mutants were also created in ToMO at residues Q141, 
T201, and F205. Novel regioselectivity was obtained during the oxidation of o-
cresol by mutant F205G of ToMO when expressed in E. coli TGI/pBS (kan). The 
mutant yielded three products: 4-methylcatechol, 3-methylcatechol and 
methylhydroquinone, compared to one product 3-methylcatechol yielded by 
ToMO wild type. Also mutant F205G oxidized phenol to a mixture of catechol, 
resorcinol and hydroquinone, compared to wild type which yielded only 
catechol. Mutants I100Q and M180T/E284G (Figure  1.11) converted o-cresol to 
methylhydroquinone and 3-methylcatechol. These mutants also oxidized phenol 
to a mixture of hydroquinone and catechol.  
The I100Q mutant was able to further oxidize catechol to 1, 2, 4- 
trihydroxybenzene (THB) whereas the wild type produced 1, 2, 3-THB from the 
same substrate, which showed a marked change in regioselectivity. It was 
reported that there was an altered regioselectivity for I100Q even with the 
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original substrate of ToMO, toluene, since the I110Q mutant oxidized toluene to 
o-cresol, m-cresol, and p-cresol (reported as 22%, 44%, and 34% respectively) 
whilst the wild type produced the same products with different proportions 
(reported as 32%, 21%, and 47% respectively). 
 
Figure  1.11 Mutation of amino acids in ToMO active site centre.  
The three dimensional model was constructed based on sMMO from Methylococcus 
capsulatus. The diiron centre is represented as a green sphere, I100Q, F205G and M180T 
(showed regioselectivity), Q141C, and T201 (no noticed regioselectivity) shown in red. The 
wild type I100, F205, and M180 shown in blue (Vardar and Wood, 2004).  
 
 
The wild type ToMO was able to oxidize nitrobenzene (NB) to produce m-
nitrophenol (m-Np) and p-nitrophenol (p-Np). The m-Np and p-Np were found to 
be further oxidized by ToMO to produce 4-nitrocatechol (4-NC), whereas 3-NC 
and nitrohydroquinone (NHQ) were the products from the oxidation of o-NP. 
DNA shuffling and saturation mutagenesis were employed by Vardar et al. 
(2004) to improve the activity of the ToMO enzyme or to alter its regioselectivity.   
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Random mutation in residues I100, Q141, T201 and F205 in the active site of 
ToMO was made and the products expressed in E. coli. Mutants M180T/E284G 
and E214G/D312N/M399V were able to produce 4-NC from oxidation of p-NP 
4.5 and 20 times respectively faster than the wild type ToMO. Oxidation of NB 
by mutant A107T/E214A showed a large regioselectivity alteration by producing 
79% from p-NP compared to 28% of the same product produced by ToMO wild 
type. Mutant A107T/E214A showed a strong regioselectivity towards toluene by 
yielding 93% p-cresol unlike the wild type which produced 32%, 21%, and 47% 
of o-, m-, and p-cresol respectively with 2.3fold activity for the mutant higher 
than the wild type. Most of the chemical products from the new mutants have a 
substantial advantage either in industry or in medicine, since it was found that 
nitroaromatic compounds are used as dyes, pesticides, and solvents (Spain and 
Gibson. 1991), whereas the nitrocatechol derivatives are used as 
pharmaceutical precursors, since it was used as inactivator for catechol-o-
methyltransferase and then could be used to treat Parkinson's disease 
(Borgulya et al., 1989; Learmonth and Freitas, 2002; Learmonth et al., 2002). 
NHQ is used as a precursor for manufacturing compounds such as dephostain 
with an inhibitory activity for tyrosine phosphatase, which has been suggested 
for use in treatment of diabetes mellitus and neurodiseases such as Alzheimer's 
and Parkinson's diseases (Hamel and Girard, 1994; Umezawa et al., 2003).  
The role of the highly conserved T201 in providing a proton during the dioxygen 
activation in the catalysis cycle was further investigated in ToMO active site. 
Song et al. (2010) created four mutants in this residue by using point mutation; 
T201S, T201G, T201C, and T201V. The role of T201 was found to be 
indispensable in proton shuttling in ToMO. However, the substrate specificity 
was decreased for mutants T201C, T201G, and T201V which was attributed to 
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the loss of OH the group in these mutants which were suggested to have a role 
in the catalytic cycle. Ethylene oxide is an important compound, used to 
produce polyester and automotive antifreeze (Dever et al., 2004). Ethylene 
(which is an alkene) was found to be oxidized by alkene monooxygenase (Small 
and Ensign, 1997). ToMO from the other side was found to be able to oxidize 
wide range of aromatic compounds producing an epoxide as an intermediate 
(Whited and Gibson, 1991). Carlin et al. (2014) supposed that the ToMO or 
mutated TOM might have the ability to oxidize ethylene to ethylene oxide in E. 
coli. Based on work done by Wood's group eleven mutants were designed by 
changing amino acids with small side chains to amino acids with larger side-
chains which may have an effect on substrate size and restrict activity to small 
substrate such as ethylene; one of these mutants (V106) was found the best in 
oxidation of trichloroethylene. Since the ethylene is a small molecule, the best 
investigated mutants towards ethylene oxidation were found with the larger side 
chain mutants; A113F and V106F. A113F was able to oxidize ethylene to 
produce >99% ethylene oxide within the four incubation hours and V106F was 
found to have >170-fold higher activity than ToMO wild type.  
 
1.6.4 Toluene 4-Monooxygenase (T4MO) 
 
1.6.4.1 Structure of toluene 4-monooxygenase 
 
T4MO from Pseudomonas mendocina KR1 is one of the most important 
aromatic hydroxylase enzymes due to its specificity in oxidation of toluene to 
produce p-cresol as the main product in addition to oxidization of a wide range 
of other substrates including phenol and trichloroethylene (TCE) (Yen et al., 
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1991; van Beilen et al., 2003). The T4MO is a four component enzyme with an 
operon comprising six genes named tmoABCDEF. Genes tmoABE encode the 
T4MO hydroxylase α, ȕ, Ȗ subunits respectively (β1β kDa). The diiron active 
centre is in the α-subunit of the T4MO hydroxylase. The tmoC gene encodes a 
Rieske-type (2Fe-2S) ferredoxin (12.5 kDa). A small regulator protein (11.6 
kDa) is encoded by tmoD. The fourth component is an NADH-dependent 
oxidoreductase protein (33 kDa) encoded by tmoF gene (Table 1.3) (Pikus et 
al., 2000; Fishman et al., 2004; Tao et al., 2004). 
1.6.4.2 Mutagenesis of T4MO enzyme   
 
One of T4MO's substrates is p-xylene, which when oxidized yields 4-methyl  
benzyl alcohol as the main product. This indicates the ability of T4MO to 
catalyse benzylic hydroxylation (Pikus et al., 1997). Site-directed mutagenesis 
was employed to investigate the role of several residues within the α-subunit of 
the hydroxylase; namely Q141 (corresponding to C151 in sMMO which is 
investigated in the current study), I180 and F205 (corresponding to F192 and 
I217 in sMMO respectively). A change in regioselectivity was observed in 
mutants Q141C and F205I in oxidation of toluene, with an increase in the 
proportion of m-cresol in the product from 2.8% from the wild type to 14.5% 
produced by the F205I mutant. When Q141C mutant was tested toward p-
xylene, the results showed a change from benzylic oxidation by the T4MO wild 
type to ring hydroxylation by mutant Q141C. In contrast, mutant F205I oxidized 
p-xylene to produce an almost equimolar mixture of the benzylic and phenolic 
monohydroxylation products. However little or no shift in regioslectivity was 
observed with mutant I180F with either substrate. These results together with 
crystallographic studies on the similar diiron enzyme methane monooxygenase 
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(Rosenzweig et al., 1997; Elango et al., 1997), led to the hypothesis that the 
residues Q141 and F205 are in a position close to FeA in the active site and 
residue I180 is on the opposite side to them and near the FeB atom. The 
mutagenic studies on T4MO suggested that the amino acids in the hydrophobic 
cavity near the active site influence the orientation of substrates and so change 
the regioselectivity of the enzyme. As mentioned previously, SDIMOs generally 
have a series of cavities extending from the enzyme outer surface toward the 
active site to form a channel for substrate entry and product exit. Hosseini et al. 
(2014), by using mutagenesis combined with computational modelling, to dock 
two substrates; 2-phenylethanol (PEA) and p-tyrosol into the structure, identified 
two cavities in the T4MO hydroxylase. These cavities were described as the 
long and the short cavity both of which were found to have a role in substrate 
egression. The short channel that terminates with D285 and E214 was 
suggested to be responsible for hydrophilic product egression. The long cavity, 
which terminates with S395, was found to be important in determining substrate 
orientation by mutation of the serine to cysteine at this position. In addition 
another important role was proposed for residue F269 which lies at the junction 
between the short and long channels (Figure  1.12). Possible role for this 
residue include controlling regioselectivity and controlling the route taken by 
substrate and product entering and leaving the active site. Elsen et al. (2009) 
used X-ray crystallography to investigate the interaction between the oxidized 
and reduced form of the T201A mutant T4MO hydroxylase with, the regulator 
protein (T4moD). It was shown that in the complex which formed between the 
mutant T201A T4MO hydroxylase and the T4MOD,  several residues within the 
hydroxylase active site adopted different orientations compared to the same 
side chains in the a complex of the wild type T4moH with T4moD. 
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Figure  1.12 The two proposed routes for substrate migration out of the active 
site in T4MO. Short channel in green colour and long channel in red colour (Hosseini et al., 
2014). 
 
 
1.6.4.3 Production of industrial and pharmaceutical precursor 
compounds by T4MO 
 
A large number of monooxygenase products are valuable even though many of 
them are harmful. The monooxygenase substrate benzene is able to cause 
anaemia and leukemia in cases of long exposure (Korte et al., 2000; Smith, 
1999). The oxidation of benzene gives phenol which is also known as harmful 
and polluting. One of benzene's double hydroxylation derivatives is catechol, 
which is valuable as an intermediate in pharmaceutical manufacture in addition 
to uses in the synthesis of agrochemicals, flavours, polymerization inhibitors, 
and antioxidants (Draths and Frost 1991; Draths and Frost 1995). Tao et al. 
(2004) expressed the operons encoding T4MO, TOM and T3MO in E. coli 
TG1/pBS (Kan) controlled by the lac promoter.  This study showed that 
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recombinant T4MO, TOM and T3MO were able to hydroxylate benzene to 
produce catechol, which was then furthur oxidized to 1, 2, 3-trihdroxybenzene 
(1, 2, 3-THB). The hydroxylation products were identified by high-pressure liquid 
chromatography and mass spectrometry.The rate of hydroxylation varied 
between the three tested enzymes as detailed in (Table  1.4). 
Table  1.4 Product distribution of hydroxylation of benzene (165 µM) to phenol, 
catechol, and 1, 2, 3-THB by T4MO, TOM, and T3MO (Tao et al., 2004). 
 
Enzyme bacteria phenol 
nmol/min/mg protein 
catechol 
nmol/min/mg protein 
1,2,3-THB 
nmol/min/mg protein 
T4MO P. mendocina 19 ± 1.6 13.6 ± 0.3 2.5 ± 0.5 
TOM B. cepacia G4 0.89 ± 0.07 1.5 ± 0.3 1.7  ± 0.3 
T3MO Ralstonia pickettii 
PKO1 
3 ± 1 3.1 ± 0.3 0.26  ± 0.09 
 
1.6.4.4 Changing the regioselectivity of T4MO 
 
Nitrocatechols are considered as important compounds due to their role as 
intermediates in manufacturing of pharmaceutical compounds e.g. Flesinoxan; 
which is antihypertensive drug (Hartog and Wouters, 1988; Scharrenburg and 
Frankena, 1996). Also an application has been suggested for nitrochatechol as 
an inhibitor of the enzyme catechol-o-methyltransferase, which has been 
investigated as a target for treatment for Parkinson's disease and other 
neurological diseases (Learmonth and Freitas, 2002; Learnmonth et al., 2002). 
Work in Wood's lab showed that T4MO was able to oxidize nitrobenzene to 4-
nitrocatechol at a low rate. Fishman et al. (2004) have improved this ability by 
protein engineering using saturation mutagenesis. Mutations were introduced 
by using error-prone PCR in the α- and ȕ- subunits of T4MOH. The mutants 
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were expressed in E. coli TG1/pBS (Kan). Six mutants (TmoA Y22N, I84Y, 
S95T, I100S, S400C; TmoB D79N) yielding nitrocatechol were selected from 
550 tested variants. Based on previous work in the same group on the ToMO 
enzyme, it was proposed that the I100 position has an impoprtant role in the 
catalytic properties of T4MO. Two more mutants were identified at position I100 
after saturation mutagenesis; I100A and I100S. Mutant I100A was found to 
hydroxylate nitrobenzene to 4-nitrocatechol more than 16-fold more quickly than 
the wild type T4MO. Mutants I100A and I100S were found to hydroxylate 
nitrobenzene to m-nitrophenol and then to 4-nitrocatechol, unlike the T4MO wild 
type which hydroxylates nitrobenzene directly to p-nitrophenol with a very small 
amount of nitrocatechol. In addition, the regioselectivity is also shifted in toluene 
oxidation; the wild type produced 96% p-cresol from the oxidation of toluene 
whereas both mutants yielded a mixture of 20% m-cresol and 80% of p-cresol. 
Also the rate of toluene oxidation by mutant I100A was 65% higher than the wild 
type T4MO. The authors suggested that the change of a large residue near the 
active site in the α-subunit into a smaller one makes the space wider to 
accommodate a larger substrate and changes the substrates orientation.   
 
1.6.5 T4MO from Bradyrhizobium sp. BTAi1 (T4MO.BTAi1) 
 
A novel T4MO from Bradyrhizobium sp. BTAi1 was found to have similarity with 
members from the TMO family. It has 35%, 36%, and 38% similarity with ToMO, 
T4MO (Pseudomonas mendocina), and TpMO (toluene p-monooxygenase) 
respectively. It was classified as a T4MO due to its specificity in hydroxylation of 
the natural substrate toluene at the para position to produce p-cresol, like T4MO 
and TpMO (Yanιk-Yιldιrιm and Vardar-Schara, 2014). However the T4MO from 
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Bradyrhizobium sp. BTAi1 showed markedly different regioselectivity with other 
substrates. When it oxidized phenol, the products were 88% catechol and 12% 
hydroquinone compared to only catechol formed by the other TMO's. In 
addition, the toluene 4-monooxygenase from Bradyrhizobium sp. BTAi1 
(T4MO.BTAi1) was found also to oxidize trichloroethylene (TCE) like the other 
TMOs. Bradyrhizobium sp. BTAi1 isolated and characterized from the nodules 
of Aeschynomene indica and is a photosynthetic rhizobacterium (Giraud et al., 
2007). The TMO gene-cluster from Bradyrhizobium sp. BTAi1 was cloned and 
sequenced in E. coli TG1, which showed that the TMO is encoded by an operon 
of six genes (tmoABCDEF) (Yanιk-Yιldιrιm and Vardar-Schara, 2014). Like 
T4MO (i.e. the enzyme from Pseudomonas mendocina), the α, ȕ, and Ȗ 
hydroxylase subunits of T4MO.BTAi1 are encoded by the genes tmoABE 
respectively. The regulator protein TmoD.BTAi1 is encoded by tmoD. tmoC 
encodes TmoC.BTAi1 ferredoxin and TmoF.BTAi1 is an NADH oxidoreductase. 
 
1.6.5.1 Mutagenesis studies on T4MO.BTAi1 
 
 
From  previous mutagenesis studies (Vardar et al., β005; Sӧnmez et al., 2014; 
Tao et al., 2004; Fishman et al., 2004) and crystallographic studies (Baily et al., 
2008; Baily et al., 2012) an important role was suggested for a number of  
amino acids in the hydrophobic pocket of the α-subunit around the active site. 
These residues are almost same in most of the TMO family apart from positions 
101,103, 180, and 214 in T4MO.BTAi1. The position 101 is occupied by proline 
in T4MO.BTAi1 unlike ToMO, T4MO, and TpMO which have alanine.  The site 
103 also has proline in T4MO.BTAi1 unlike ToMO which has glutamic acid 
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whereas T4MO and TpMO both have the amino acid glycine. Mutagenesis 
studies showed an important role for these residues in enzyme activity and 
regioselectivity (Vardar et al., 2005; Fishman et al., 2005; Notomista et al., 
2001; Tao et al., 2004). Site-directed mutagenesis in T4MO at position E214 
(analogous to H214 in T4MO.BTAi1) showed an 11fold increase in the rate of 
the hydroxylation of 2-phenylethanol (Brouk et al., 2010). There are different 
amino acids in these positions in T4MO.BTAi1 compared to the other TMOs. 
Saturation and site directed mutagenesis were employed to investigate the role 
of these amino acids in T4MO.BTAi1 in the oxidation of aromatic hydrocarbons 
and TCE (Yanιk-Yιldιrιm and Vardar-Schara, 2014). Eight mutants were created 
at positions P101, P103 and H214 in the α-subunit of the T4MO.BTAi1 
hydroxylase designated as H214:P101T/P103A, P101S, P101N/P103T, P101V, 
P103T, P101V/P103V, H214G, and H214G/D278N. Phenol, nitrobenzene and 
naphthalene were chosen as substrates to evaluate these mutants. Both 
residues P101 and P103 were found to have an important role in controlling the 
enzyme conformation. The main product from oxidation of phenol was 
resorcinol (60%), unlike the wild type which was inactive toward phenol. Mutant 
P103T produced m-nitrophenol from nitrobenzene with 4-times higher rate than 
the wild type. Using naphthalene as substrate, mutants P101T/P103A and 
P101S also showed altered regioselectivity by producing 2.3 times more 2-
napthol than the T4MO.BTAi1 wild type. The same mutants gave 1.6 times less 
1-naphthol than the T4MO.BTAi1 wild type in the same reaction. The study 
confirmed the important role of these residues in holding the substrates in the 
active site in these enzymes because mutation of these residues changed the 
regioselectivity.    
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1.6.6 Toluene 3- Monooxygenase from Ralstonia pickettii PKO1 
(T3MO)       
 
Another member of the SDIMOs, which belongs to the toluene monooxygenase 
family, is toluene 3-monooxygenase (T3MO) from Ralstonia pickettii PKO1. The 
T3MO can oxidize toluene to produce m-cresol and co-oxidizes benzene and 
many other alkylaromatic hydrocarbons. It is a four component enzyme 
encoded by the tbu operon, which showed more than 60% amino acid 
sequence identity with T4MO (Leahy et al., 1997); tbuA1A2U encode the three 
subunits of the α2 ȕ2 Ȗ2 of the  hydroxylase of T3MO. tbuC encodes  an NADH 
dependent oxidoreductase. tbuV encodes  a regulator protein without prosthetic 
group.  tbuB  encodes  a Rieske-type ferredoxin protein (Table 1.3) (Kahng et 
al., 2000; Fishman et al., 2004). In addition to the tbu operon, a gene 
downstream of tbu operon was identified (tbuX) which has been found to be 
expressed in a low level in the cell. This expression was found to be increased 
when the cell was exposed to toluene such that more TbuX was produced than 
the T3MO enzyme. The way that this gene was induced led to the suggestion 
that it has a role as facilitator in toluene entry into the bacterial cells in addition 
to taking part in toluene metabolism (Kahng et al., 2000).  
 
1.6.6.1 Molecular studies on T3MO   
 
 
The commericial importance of the hydroxylation products of benzene and its 
derivatives as mentioned previously led to the investigation of T3MO in 
oxidation of benzene. It was found that like T4MO and TOM, when T3MO was 
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expressed in E. coli TG1/pBS (Khan), it was able to hydroxylate benzene to 
phenol and then catechol, which was then hydroxylated to 1, 2, 3- 
trihydroxybenzene (1, 2, 3-THB). The rate of oxidation of each substrate to the 
subsequent product is shown in (Table  1.4). The formation of catechol by T3MO 
and T4MO, and the formation of 1, 2, 3-trihydroxybenzene by TOM were found 
to occur at a similar rate to that at which cresols were formed from toluene 
oxidation by these enzymes (Fishman et al., 2004). As was mentioned 
previously, T3MO oxidizes toluene at the meta site to produce m-cresol. Olsen 
et al. (1994) and Fishman et al. (2004) found that T3MO expressed in E. coli 
TG1/pBS (Khan) oxidized toluene with an activity of 11.5 ± 0.33 nmol-1 min-1 mg-
1
 of protein to give the unexpected product distribution of 90% p-cresol and 10% 
m-cresol. Furthur oxidation subsequently yielded 4-methylcatechol. The 
reaction rate was similar to that produced from the original plasmid pRO1966 
containing T3MO that was expressed in Pseudomonas aeroginosa, which 
yielded m-cresol and p-cresol in the proportion 97% and 3% respectively. Also, 
E. coli TG1/pBS (Kan) harbouring T3MO oxidized nitrobenzene to form 66% 
and 34% of p-nitrophenol and m-nitrophenol respectively, whereas 
methoxybenzene was oxidized to 100% p-methoxyphenol by the native 
enzyme. Naphthalene was also oxidized by this recombinant enzyme to yield 1-
naphthol (62%) and 2-naphthol (38%). The tbu genes were sequenced from the 
original plasmid pRO1966 alongside pBS (Kan) T3MO to exclude any unwanted 
mutations during the recombination steps which showed no sequencing 
difference. The similarity of T3MO with T4MO and TOM may allow researchers 
to identify the roles of candidate residues in the α-subunit that are implicated in 
oxidation or product regioselectivety.  
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1.6.7 Ribonucleotide reductase (RNR) 
 
Another diiron enzyme is the ribonucleotide reductase (RNR) which catalyses 
the reduction of ribonucleotides to deoxyribonucleotides which is then used in 
DNA synthesis (Climent and Sjӧberg, 199β). RNR has been isolated from many 
organisms. One of the best characterized RNR is from E. coli which consists of 
two non-identical subunits named as R1 and R2. The R1 component comprises 
two subunits designated as the α and αޘ subunits, which are encoded by gene 
nrdA. The R2 subunits (β and βˋ) are encoded by the nrdB gene. The R2 
subunits contain the diiron centre and the free radical supplying, tyrosine 
residue (in the past, the R2 subunits were known as B1 and B2) (Table 1.3) 
(Climent and Sjӧberg, 1992; Carlson et al., 1984). The diiron centre is 
coordinated by three glutamic acid residues, two histidines and two water 
molecules (Figure  1.13) (Logan et al., 1996). R1 is implicated in 
accommodating the substrate and contains the catalytically important cysteine 
residues (Richard, 1988; Albert et al., 1989). The role of R2 is to supply a free 
radical from the conserved tyrosine residue 122 to the R1 subunit through a 
conserved cysteine residue to start the enzyme catalytic cycle.     
 
1.6.7.1 Crystallographic and mutagenesis studies on RNR 
 
 
The tight interaction between the R1 and R2 subunits in RNR has been 
investigated by mutagenesis. The effect of deletion of 30 amino acids in the C-
terminal of R2 showed an affect on the enzyme. The substitution of E350 and 
Y356 to alanine (both are along the pathway between the tyrosine122 and the 
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active site and as such implicated in transferring the electron from the Tyr122  
to the active site via C-terminal), resulted in high effect on catalytic activity. 
However, no change in the strong interaction between R2 and R1 was 
observed. There was a decrease in E350A mutant activity (240-fold lower than 
that for the native protein) whereas the whole activity was abolished for mutant 
Y356A. The results suggested a catalytic role for these residues rather than a 
structural role. 
Logan et al. (1996) has suggested a model in which a stable radical from Y122 
in the R2 component oxidizes C4γ9 in the RNR α-subunit of the R1 component 
to produce a thyil radical. The distance between Y122 and C439 is about 35 Å 
which is considered to be too long a distance. This has led to the suggestion 
that there is a different pathway that can mediate this electron transfer including 
the presence of several amino acids along the way to facilitate this transfer; 
Y122, W48, Y356 in β β, Y7γ1, Y7γ0, and C4γ9 in the αβ subunite. The role of 
tyrosine in producing the free radical for catalysis in the RNR reaction is well 
investigated by site-directed mutagenesis.  
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Figure  1.13  Crystallographic structure of diiron centre in R2 of ribonucleotide 
reductase.  
The figure shows the diiron centre of RNR coordinated by two histidines, three glutamates and 
one aspartic acid reisdue in addition to showing the site of Tyr122 which provides the free 
radical to start the catalyic cycle of the enzyme. H bonds are depicted as dashed lines; the 
distances are in Å (Logan et al., 1996). 
 
Another pathway was suggested by different research groups based on the 
crystal structure of the enzyme.The transfer of the free radical formed by 
tyrosine in R2 to the active site in R1 takes place through a series of hydrogen 
bonds including residues; Tyr 122, Asp 84, His118, Asp 237, Trp 48, and Tyr 
356 in the R2 subunit and Tyr 730, Tyr 731, and Cys439 in the R1 subunit 
(Nordlund et al., 1990; Nordlund and Sjӧberg, 199γ; Nordlund and Eklund, 
1993; Uhlin and Eklund, 1994; Eriksson et al., 1997). Asp 237 is implicated in 
connecting three helices through the residues His118, Trp 48 and Gln 43 
(Figure  1.14). This residue (Asp 237) was mutated to an asparagine or 
glutamate. The mutation D237E resulted in an enzyme with a comparable 
activity to the wild type. However, mutant D237N lost its activity due to an 
unstable tyrosyl radical (Ekberg et al., 1998), which support the hypothesis for 
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needing a chain of suitable amino acids to form a pathway to transfer the radical 
to the active site of the R1 component in order to achieve substrate catalysis. 
Due to the similarity of RNR with sMMO, it has been suggested from the 
crystallographic studies of sMMO a same role for the corresponding amino 
acids to tyrosine (C151). This hypothesis has been investigated in the present 
study by designing a mutant at this site to investigate the role of this residue in 
providing a free radical during the sMMO oxidation catalytic cycle. 
 
 
Figure  1.14  Three dimensional schematic diagram showing the hydrogen 
bond connection of residue Asp 237 with Trp 48 and His 118 in the radical 
transfer pathway. 
A: wild type shows the distance between the residue Asp 237 and the other two 
residues Trp48 and His118 which are proposed to transfer the electron to the active 
site. 
B shows the change in the distance between residue 237 and the nighbouring 
residues Trp48 and His118 in D237E mutant (Ekberg et al., 1998). 
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1.6.7.2 RNR as a target for anticancer drugs 
 
 
Cancer is a main cause for death over the world, in the United States more than 
500,000 deaths due to cancer are recorded every year. Most of the current anti-
cancer drugs have a serious side effects or lead to tumour resistance (Jordan 
and Reichard, 1998; Kolberg et al., 2004; Cerqueira et al., 2007). Due to the 
critical role of RNR in DNA synthesis, it is considered as a target for anticancer 
medications. Inhibiting of activity of RNR, which supplies the cell with DNA 
precursors prevents the cell from synthesizing DNA (Tanaka et al., 2000). The 
human RNR comprises two subunits designated as (RRM1 ~85 kDa) which 
contains the catalytic site where the substrates accommodate (analogous to R1 
in E. coli) and RRM2 ~ 45kDa which contains the diiron active site (analogous 
to R2 in E. coli) (Larsson and Sjӧberg, 1986; Ekberg et al., 1998). It was found 
that reducing the activity of RRM2 in cancer cells in vitro minimized drug 
resistance and slowed cancer cell division, which led to the proposal to 
investigate it as a drug target (Zhou et al., 1995; Goan et al., 1999; Zhou et al., 
1998; Liu et al., 2007). As mentioned for RNR from E. coli the C-terminal was 
found to be responsible for interaction between RRM1 and RRM2 and radical 
transfer. In a study conducted in the National Cancer Institute (NCI), a new 
ligand-binding cavity was identified close to the C-terminal in the RRM2 by 
computer modelling and confirmed by site directed mutagenesis. Based on this 
result, this pocket was suggested as a place for targeting by a new anticancer 
drug (Zhou et al. 2013). The drug CHO29, which binds in this position, was 
found to be effective in inactivation a number of neoplastic cell lines, especially 
ovarian and leukemia cancer cell lines.  
  73 
 
1.6.8 Deoxyhypusine hydroxylase (DOHH) 
 
1.6.8.1 Structure of deoxyhypusine hydroxylase 
 
Deoxyhypusine hydroxylase (DOHH) from human is also one of the diiron 
hydroxylase enzymes, which catalyses the hydroxylation of a specific amino 
acid lysine in spermidin (an elF5A precursor) in two steps to produce the 
unusual amino acid called hypusine (Kim et al., 2006 a). The lysine is 
hydroxylated to an intermediate compound called deoxyhypusine by 
deoxyhypusine synthase (Wolff et al., 1995; Joe et al., 1995) which is then 
hydroxylated by deoxyhypusine hydroxylase to yield hypusine in eukaryote 
initiation translation factor 5A (elF5A) (Park et al., 2006; Abbruzzese et al., 
1986). Although DOHH is a non-heme diiron enzyme like methane 
monooxygenase, toluene monooxygenase and stearoyl acyl carrier protein ∆9-
desaturase, there is no statistically significant similarity with these enzyme (Kim 
et al., 2006 b). Vu et al. (2009), by using Mӧssbauer and XAS spectroscopic on 
recombinant DOHH hydroxylase, were able to confirm that the active site is 
contains diiron and the enzyme was able to activate oxygen to produce an 
intermediate compound (μ-1, 2-peroxo) diiron (III) during the transformation of 
elF5A precursor to mature elF5A which is similar to the methane 
monooxygenase. 
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1.6.8.2 Mutagenesis studies on DOHH 
 
Like the other non-heme diiron enzymes, the diiron active site for DOHH is 
coordinated by His and Glu residues. The role of these residues was 
investigated in a study by Kim et al. (2006) who showed that the mutation of the 
diiron coordinating residues in DOHH resulted in inactive enzymes. Six of these 
eight mutants namely; H56A, H89A, E90A, H207A, H240A, and E241A showed 
less iron content compared to the wild type whereas the other two had 
comparable iron content. This study indicated that the binding ligands Glu and 
His are important for enzyme activity and to hold the Fe in the active site of the 
DOHH. An enzyme similar to human DOHH was characterized from 
Saccharomyces cerevisiae named Lia1 encoded by gene LIA1 (Thompson et 
al., 2003) which hydroxylates deoxyhypusine to hypusine (Park et al., 2006). 
Mutagenesis studies on the Lia1 active site showed a change in interaction with 
the substrate. This was added additional important role in conserving the diiron 
centre in the active site, the structure of the protein and catalysis the 
transformation of deoxyhypusine to hypusine (Cano et al., 2010). The crystal 
structure was also solved for DOHH, which revealed the presence of the 
intermediate compound peroxo-diiron (III) in the DOHH hydroxylase active site; 
after the reduced diiron centre had reacted with oxygen. These results were 
confirmed by UV/Vis and Mӧssbauer spectroscopy (Han et al., 2015). The 
understanding of the active site properties may enable more studies into the 
importance of this enzyme. Inhibitors of the two enzymes deoxyhypusine 
synthase and deoxyhypusine hydroxylase are candidates for treatment of 
HIV/AIDS, chronic myeloid leukemia, and diabetes (Kaiser, 2012). 
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1.6.9 Stearoyl ACP desaturase 
 
 
A family of diiron enzymes was isolated from plants that are able to catalyse the 
transformation of plant saturated fatty acids to unsaturated fatty acids, known as 
stearoyl acyl-carrier protein (ACP) desaturases (Lindqvist et al., 1996). Each 
enzyme from this family catalyses the introduction of a double bond in a 
particular site in the fatty acid. One of these enzymes is the soluble ∆9 stearoyl-
ACP desaturase which inserts a double bond between carbons 9-10 in an 18 
carbon fatty acid chain. The crystal structure revealed similar motifs to those 
present in the monooxygenase. The diiron in the active site in the stearoyl ACP 
desaturase is coordinated by glutamate and histidine residues in addition to two 
glutamic acids within the coordination space of both Fe ions. In addition, a long 
channel was identified starting from the enzyme surface and continuing towards 
the active site, which is thought to be appropriate in size for a fatty acid 
substrate to be oxidized at position 9. 
 
1.6.9.1 Site directed mutagenesis studies on stearoyl ACP desaturase 
 
 
Although there is little similarity in amino acid sequence between the ∆9 
stearoyl-ACP desaturase and the diiron monooxygenase (Guy et al., 2006), ∆9 
stearoyl-ACP desaturase has a similarity with the other ACP desaturases within 
the same family. Site-directed mutagenesis was performed on ∆6 palmitoyl-ACP 
desaturase based upon a comparison to ∆9 stearoyl-ACP desaturase to 
investigate the regiospecificity of these enzymes in desaturation of fatty acid 
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(Cahoon et al., 1997). Five amino acids lining the hydrophobic cavity around the 
diiron centre of ∆6 palmitoyl-ACP desaturase were substituted with the 
analogous residues in ∆9 stearoyl-ACP desaturase; A181T/ A200F/ S205N/ 
Lβ06T/ Gβ07A. The result showed that mutated ∆6 palmitoyl-ACP desaturase 
was able to behave like ∆9 stearoyl-ACP desaturase, since it could introduce 
double bonds at either the ∆6 or ∆9 position.  Based on crystallographic and 
previous mutagenic studies the replacement of two residues L118F/ P179I in ∆9 
stearoyl-ACP desaturase was performed. This led to a change in the specifity of 
∆9 stearoyl-ACP desaturase to that of ∆6 palmitoyl-ACP. Whittle et al. (2008) 
designed a triple mutant T117R/ G188L/ D280K that was able to convert the 
stearoyl-ACP substrate into an allylic alcohol. This change in catalytic properties 
was attributed to a change in the substrate binding site around the diiron centre 
that may have led to the substrate being held in a different way. Liu et al. (2015) 
designed a mutant T104K/ S202E in soluble castor ∆9 stearoyl-ACP desaturase 
to introduce a salt bridge to block one of the substrate-binding cavities of the 
enzyme. After the mutant was expressed, the protein was purified and 
characterized by X-ray crystallography, activity assay and size exclusion 
chromatography. It was shown that the one of the substrate cavities was 
occluded and mutant T104K/ S202E enzyme had an activity comparable to wild 
type full activity. 
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1.6.9.2 Mutagenesis of stearoyl-ACP desaturase converts the 
desaturation to oxidation activity 
 
 
A comparison between ∆9 stearoyl-ACP desaturase from castor with the diiron 
ruberythrin peroxidase showed a large similarity in the conformation and 
residues around the diiron centre, apart from at position 199 of the ∆9 stearoyl-
ACP desaturase. The residue 199 is threonine in ∆9 stearoyl-ACP desaturase 
whereas the corresponding residue is a glutamic acid in the ruberythrin 
peroxidase. The carboxylate group at this site was implicated in catalysis the 
oxidase activity of ruberythrin peroxidase by providing a proton to bound oxygen 
due to its close position to diiron centre. Substitution of threonine to glutamic 
acid in ∆9 stearoyl-ACP desaturase (mutant T199D) resulted in an enzyme 
which was capable of accommodating the substrate, but a decrease in 
desaturation activity was about 2 x 103 times. A change in peroxide-dependent 
oxidase activity was increased by more than 31times comparing to the wild type 
enzyme. This mutation in ∆9 stearoyl-ACP desaturase altered the enzyme 
activity to become more similar to ruberythrin peroxidase enzyme (Guy et al., 
2006).  
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1.7 Aims of the present study 
 
As illustrated by the mutants that have been made in the aromatic 
monooxygenases, mutagenesis has answered a number of questions about the 
role of specific amino acids in these enzymes. Changing some of these amino 
acids by mutagenesis has resulted in a substantial difference in yield of 
products with value to industry or uses as pharmaceutical precursors, and proof 
or disproof of hypotheses about how the enzymes function. It would be valuable 
to identify mutants of sMMO which may be used as alternative methods for 
synthesis of high value compounds from cheaper starting materials and with 
less toxic side products. In addition it may be possible to construct mutants to 
produce molecules for which no adequate chemical synthesis is avialable  
 It was intended in the present study to use this approach to investigate the 
role of selected residues in the α-subunit of soluble methane 
monooxygenase hydroxylase where the active site is situated. Residue 
C151 was chosen to investigate its possible role in radical chemistry in the 
sMMO catalytic cycle. 
  Residue (R98), which has not been hypothesized from previous 
crystallographic studies to have a role in the sMMO hydroxylase α-subunit 
is also one of the candidate residues that has been investigated as one of 
the aims in the present study.  The function of this residue was probed in 
the formation of an ionic network which was proposed to restrict the size of 
the substrate entering the active site. It was intended by changing this 
residue, to reduce the ionic network, which may make the protein more 
flexible to allow large substrates to enter and be oxidized by sMMO.  
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 A new mutant was also designed to investigate the role of one of the 
glutamate residues (E114), which ligates the diiron centre, with the intention 
of stabilizing the previously designed unstable mutant (C151Y) to allow 
further characterization of the role of this position in enzyme activity.  
 Finally, analysis of recombinant enzyme requires the purification of the 
three components of the soluble methane monooxygenase. In the present 
study it was aimed to purify and test the activity of a new affinity His-tagged 
hydroxylase created in this group, which was intended to minimize the long 
purification protocol into a one step method by using an affinity column.
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Chapter 2: Materials and Methods2 
2.1 Bacterial strains and growth conditions 
2.1.1 Bacterial strains and plasmids 
 
All methanotrophs and E. coli strains that were not constructed during this 
project were supplied by the microbiological laboratory of Biomedical Research 
Centre, Sheffield Hallam University. The methanotrophs strains used in this 
work were Methylosinus trichosporium OB3b (wild type), the recombinant wild 
type with His-tag, and three other mutants; SMDM (soluble methane 
monooxygenase deleted mutant), SMDM pT2MLY C151S, SMDM pT2MLY 
F282L, pT2MLY C151Y. The mutants SMDM pT2MLY R98A, double mutant 
SMDM pT2MLY R98A S4G, SMDM pT2MLY E114D C151Y and SMDM 
pT2MLY E114D were constructed in the present study.  
The competent strains E. coli S17.1 and E. coli BL21 were from Invitrogen and 
E. coli XL-10 gold ultra-competent cells were from Agilent technologies. 
 
Plasmids that were used in this study are described in Table 2.1.  
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Table 2.1   Plasmids used in the present study. 
 
Plasmids Main features 
 
      References 
pTJS 175 Methanotroph expression vector, pTJS140 
containing 10.1 kb insert including the sMMO 
operon. Ap rSpr Smr 
 Smith et al., (2002) 
pTJS175 C151Y Same as above in addition to mutation of the 
C151Y. 
Smith et al., (2002) 
pT2MLY It is a modified pTJS140 by removing NdeI, two 
BamHI and 516 bp to create pT2ML which then 
became pT2MLY by inserting His-tag into the ȕ-
subunit of the hydroxylase 
 Nichol, (2011) 
and Lock et al 
(unpublished) 
pT2MLY R98L Same as above in addition to mutation in R at 98 
position to L. 
Lock et al 
(unpublished) 
pT2MLY F188W Same as above in addition to mutation in F at 188 
position to W. 
Lock et al 
(unpublished) 
pGEX mmoB Plasmid with the gene encoding for protein B of 
sMMO and GST affinity tag. 
Lloyd et al., 1997 
pJET1.2 It is a 2974 bp plasmid with Apr and Multiple 
Cloning Site (MCS) to clone blunt end inserts. 
Thermo scientific 
  
 
2.1.2 Culturing the isolates and mutants 
 
Methanotrophs were grown on Nitrate Mineral Salt (NMS) (Appendix 1) liquid or 
agarat 30oC with methane as the sole source of carbon and energy. When the 
growth was in NMS liquid, the methanotrophs were grown in a 250 ml Quickfit 
flask with a subaseal and 50 ml of the headspace replaced with methane. The 
flasks were incubated at 30oC with shaking at 180 rpm. Methane was provided 
every 3-5 days. Plate cultures were incubated in sealed anaerobic jars with 
50/50 oxygen air to methane. After 2-3 weeks the methanotrophs were ready 
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for naphthalene test, which confirmed the production of sMMO when it was 
positive.  Antibiotics were used when needed at concentration of 20 μg ml-1 for 
streptomycin and spectinomycin, 50-100 μg ml-1 for ampicillin, 5 μg ml-1 for 
gentamycin and 25 μg ml-1 for nalidixic acid. Growth of large-volume cultures of 
wild-type or mutant methanotrophic strains was performed as described by 
Lloyd et al. (1999), with modifications as follows; A New Brunswick Bioflo 101 
fermentor fitted with an additional rotameter to provide a continuous 
air/methane gas with a flow rate 750 ml min-1 and 55 ml min-1 respectively at 30 
°C. Copper sulfate was added to the NMS at 0.1 mg of CuSO4 5H2O litre-1 in the 
first batch, whereafter NMS without copper was used, antibiotics were not 
added except for the first batch of medium (Smith et al., 2002). The optical 
density was measured at 600 nm using a spectrophotometer at regular periods 
to observe growth of the culture. Cells harvested from the fermenter were 
pelleted by centrifugation for 20 min at 10,000 ×g, washed once with 25 mM 
MOPS (pH 7.0), 1 mM benzamidine, 1 mM dithiothreitol (DTT) and 
resuspended in a minimum amount of the same buffer. The cells were drop 
frozen drop wise into liquid nitrogen and stored at -80 ˚C.   
Luria bertani (LB) or Nutrient broth/agar (Oxoid) (Appendix 1) was used for 
cultivation of E. coli at 37oC. LB cultures were incubated with shaking at 180-
220 rpm. Both liquid and nutrient agar cultures were incubated at 37oC 
overnight. 
 
 
 
  83 
 
2.1.2.1 Chemical reagents and media for bacterial culture growth 
 
All chemical reagents used for growing bacterial cultures in the present study 
were supplied by Sigma Aldrich and Melford Labs. Gases were supplied by 
BOC and Air liquid (formerly Scott gas). 
 
2.2 General DNA methods 
 
All restriction enzymes, phosphatase, ligase, and the high fidelity Phusion 
master mix were supplied by New England Biolabs unless otherwise stated. 
All the work concerning DNA purification, analysis and cloning in E. coli was 
done following the protocols from Sambrook et al. (1989). Plasmid DNA (pDNA) 
mini, midi and maxi preparations were performed using the Qiagen mini, midi 
and maxi prep kits and  the supplier's instructions The composition of DNA 
manipulation and analysis buffers are provided in Appendix 2. For extraction of 
plasmid DNA in a small amount (<50 ng μl-1), the QIAprep spin miniprep kit 
(QIAGEN) was used following the manufacturer’s instructions. For high DNA 
plasmid amount (>100 ng μl-1), Qiagen maxiprep kit was used. For preparing 
intermediate amount of pDNA, the Qiagen midi prep kit was used. 
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2.2.1 QIAprep spin plasmid miniprep protocol 
 
This is a modification of the alkaline lysis method of Birnboim and Doly (1979). 
A single colony of plasmid-containing bacteria was grown overnight in (5 ml) LB 
with an appropriate antibiotics at 37oC. The culture was then centrifuged at high 
speed (17170 x g) in a bench centrifuge for 1 min to pellet the cells. The pellet 
was resuspended in 250 μl from buffer P1 was and moved to a sterilized 
Eppendorf tube.  A β50 μl of lysis buffer P2 was added and mixed by inverting 
the tube 4-6 times until clear solution could be seen. The suspension was not 
allowed to stand more than 5 min before adding neutralization buffer N3. The 
tube was again inverted 4-6 times. The suspension was then centrifuged at a 
high speed (17,170 x g) for 10 min at 4oC to remove all chromosomal DNA, cell 
debris, denatured proteins and SDS. The supernatant was then applied to the 
column provided with the kit and centrifuged for 1 min at room temperature in at 
high speed to bind plasmid DNA. The flow through was discarded. The bound 
plasmid was washed with 500 μl buffer BP and centrifuged at 17170 x g (room 
temperature) for 1 min. Plasmid was washed again with 750 μl PE and 
centrifuged for one min. Flow through was discarded and the column was 
centrifuged for one more minute. The column was transferred to a clean 
sterilized Eppendorf tube. The plasmid DNA was eluted by 30-50 μl buffer EB 
(10 mM Tris-HCl, pH 8.5) or distilled water, then the column was allowed to 
stand for one min and centrifuged for one min at a high speed (13330 rpm) at 
4oC. The purified plasmid was kept at -20oC. P1, P2, N3, PB, PE and EB were 
supplied in QIAgen miniprep kit. 
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2.2.2 QIAprep spin plasmid maxiprep protocol 
 
A single colony was used to inoculate a 5 ml LB to grow for 8 hat 37oC with 
shaking at 300 rpm. The bacteria were used to inoculate a flask with 500 ml LB 
broth with appropriate antibiotics. The flask was incubated overnight at 37oC 
with shaking at 200 rpm. The bacteria were pelleted by centrifugation at 5000 x 
g for 15 min at 4oC. The pelleted cells were resuspended in 10 ml buffer P1 and 
mixed properly. An equal volume of buffer P2 was added and the suspension 
was inverted 4-6 times and left at the room temperature for 5 min. 10 ml of 
prechilled buffer P3 was added to the mixture and mixed by inverting to stop the 
lysis reaction. The suspension incubated on ice for 20 min and then centrifuged 
at ≥15000 x g for 30 min at 4oC to remove all chromosomal DNA, denatured 
protein and SDS. The clear lysate supernatant was centrifuged again for 15 min 
as above in a new sterilized tube to remove any other residues. QIAGEN-tip 
500 column was equilibrated with 10 ml of equilibration buffer QBT and left to 
pass through the column by gravity. The supernatant was applied to the 
equilibrated column and left to pass through also by gravity. The column was 
washed with 2x30 ml buffer QC. The DNA was eluted from the column by buffer 
QF and precipitated by 10.5 ml isopropanol at room temperature and 
centrifuged at ≥15000 x g for 30 min at 4oC. The plasmid DNA pellet was 
washed then with 5 ml of 70% ethanol (v/v): air dried and resuspended with 1 
ml of 10 mM Tris-HCl (pH 8.5). The plasmid DNA then kept at -20oC. P1, P2, 
P3, QBT, QB, and QF were supplied in QIAGEN Maxi prep kit. 
Pure DNA fragments for DNA sequencing, digestion, ligation and PCR 
amplification were obtained by running in 1% Agarose gel and the desired band 
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was excised and purified from the gel by using gel extraction gel. QIAquick gel 
extraction kit was used to purify the DNA< 10 kb, and QIAclean Gen II for DNA> 
10 kb (QIAGEN).  
 
2.2.3 QIAquick gel extraction protocol 
 
The desired DNA fragments were excised from gels using a scalpel and 
weighed to estimate the volume (1 mg=1 μl). The excised band was transferred 
to an Eppendorf tube. Three times volume of buffer QG was added and 
incubated in a hot plate at 50oC for 10 min or until the agarose had completely 
dissolved. One volume of isopropanol then was added and mixed. The mixture 
was carefully applied to QIAlquick gel extraction column and centrifuged for 1 
min at a high speed in a bench-top centrifuge. Flow through was discarded and 
the column was washed with 750 μl buffer PE and centrifuged for 1 min. The 
column was centrifuged for one more min to remove all residues. Finally, the 
column was transferred to a clean Eppendorf tube and the product eluted in 30-
50 μl EB buffer. QG and EB were provided with QIAquick gel extraction kit 
(QIAGEN). 
 
2.2.4 QIAEX II gel extraction kit 
 
QIAEX kit was used to purify plasmid larger than 10kb. The desired band was 
excised using a clean scalpel blade and weighed in a clean Eppendorf tube as 
above to estimate the volume. Three volumes of buffer QX1 and two of distilled 
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water were added to the gel slice. QIAEXII was mixed by vortexing before 
adding γ0 μl to the sample and mixing. The sample was incubated at 50oC or 
until the gel completely dissolved and the DNA was bound to the matrix. The 
sample was centrifuged for 30 s and the supernatant carefully removed. The 
pellet was washed with 500 μl of buffer QXI and centrifuged for γ0 s to remove 
all traces from the sample. The pellet was washed twice with buffer PE and 
centrifuged for 30 s each time. The pellet was air dried for 30 min or until the 
colour was white. DNA was eluted after that by adding β0 μl distilled water and 
re-suspended, incubated at 50oC for 10 min and centrifuged for 30 s. The 
supernatant which contains the DNA was carefully transferred to a clean tube. 
Buffer QXI and QXII were supplied in the QIAEXII gel extraction kit. 
 
2.2.5 Phenol/ Chloroform/ Isoamyl alcohol extraction 
 
An equal volume of Phenol/ Chloroform/Isoamyl alcohol 25: 24: 1 (Sigma) was 
added to the DNA sample. This was mixed gently on rocking platform for 5 min 
and then centrifuged at maximum speed for 30 min at room temperature. The 
aqueous solution (upper layer) was carefully transferred to a clean tube. An 
equal volume of sterile distilled water (s.d.w.) was added; the sample was 
mixed gently for 5 min and centrifuged as above. The upper phase was 
carefully added to the previous aqueous phase. Same volume of Chloroform: 
Isoamyl alcohol 24:1) was added and mixed for 2 min and centrifuged at high 
speed for 1 min in a benchtop centrifuge. The top layer was removed to a new 
clean tube (containing DNA). Then 0.1 µl volume of 3M sodium acetate (pH 5.5) 
and three volumes from ice cold ethanol (99-100%) were added to the aqueous 
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phase. The sample was mixed gently and incubated at -20oC overnight or at -
80oC for one h. The sample was then centrifuged at maximum speed by using a 
bench top centrifuge for 30 min at 4oC. The DNA pellet was washed with pre 
chilled 70% ethanol (50µl), mixed and centrifuged for 15 min. The ethanol was 
carefully aspirated off using a Pasteur pipette. The DNA was then air dried for 
15 min and resuspended in 50 µl distilled water. 
 
2.2.6 Electrophoresis of DNA 
 
Where necessary to separate DNA band, DNA was run in an agarose gel 1% 
(w/v) with TAE buffer (40 mM Tris-acetate, 10 mM EDTA) containing ethidium 
bromide 5 μg ml-1. The gels were run for 45-60 min at 95-110 V and visualized 
under UV light.  
2.2.7 Digestion by restriction enzymes 
 
Digestion reactions were set up in 50 µl reaction volumes. In each reaction, 1 
μg of DNA sample was used together with the desired restriction enzyme (1-10 
units), 1x digestion buffer and 1 µl of BSA (mg ml-1) when the supplied buffer 
did not contain BSA. The reactions were incubated between 1-4 h in a water 
bath at the supplier's recommended temperature, mostly 37oC.  
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2.2.8 DNA phosphatase 
 
The digested vector was de-phosphorylated using Antarctic alkaline 
phosphatase (AP) to avoid re-ligation. Digested DNA was purified from agarose 
gels by QIAEX II gel extraction kit or heat inactivated. Reactions were set up in 
50 µl including 1 μg  DNA, 1 µl AP enzyme and 5 µl enzyme buffer (10 x), the 
volume made up  to  50 µl of s.d.w.. The reactions were incubated for 30 min at 
37oC. Then the enzyme was inactivated at 65oC for 5 min according to the 
supplier's instructions. Most of the time the dephosphorylation was performed 
after digestion and before running the agarose gel. 
 
2.2.9 DNA ligation 
 
DNA ligation was performed to join two DNA molecules. When a DNA inserts 
into the vector, the ratio between the vectors: insert should be 1:1 or 1:3. 
Ligation reaction was performed either in 50 µl or 20 µl volumes according to 
the supplier's instructions: 50 µl reaction including 1 µl concentrated DNA ligase 
and 5 µl of 10 x enzyme buffer. The reaction was incubated in 4oC overnight or 
60-90 min at 16oC. Then the enzyme was inactivated at 65oC for 20 min. For 
the 20 µl reaction tube, 10 µl master mix buffer was used with 1µl DNA ligase, 
the reaction was mixed up and down by micropippete for 4-6 times and then 
stopped by putting on ice if it was not to be used or transformed directly. 
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2.3 DNA template preparation and PCR manipulation 
conditions 
 
2.3.1 Colony template preparation 
 
E. coli or transformed SMDM colonies were resuspended in 20 µl s.d.w. and 
boiled for 10 min. This suspension was used as a DNA template for PCR 
amplification in colony PCR. 
 
2.3.2 Genomic DNA extraction using Qiagen genomic tip-20 kit  
 
An Eppendorf tube contains 1 ml liquid culture (OD600: 0.5-1) or loopfull of plate 
culture in 1 ml resuspended in Phosphate Buffer Saline (PBS) was centrifuged 
at 7100 rpm (5000 x g) for 5 min to pellet the cells. The pellet was resuspended 
in 1 ml buffer B1 containing 2 µl of RNase by vortexing. 20 µl lysozyme (100 mg 
ml-1) and 45 µl of 20 mg ml-1 proteinase K were added. The content was mixed 
and incubated at 37oC for 30 min. Then 0.35 ml of buffer B2 was added and 
incubated at 50oC for 30 min. The lysed cell- containing sample was applied to 
pre-equilibrated genomic tip-20 with 2 ml of buffer QBT, the lysate was allowed 
to pass through by gravity. The column was then washed with 3 x 1 ml Qiagen 
QC buffer and left to flow through by gravity. The genomic DNA was eluted by 
using 2 x 1 ml Qiagen QF buffer then precipitated with 1.4 ml isopropanol at 
room temperature and centrifuged at 9100 rpm (8000 x g) for 20 min at 4oC to 
pellet the DNA. The DNA was washed with 1 ml cold 70% ethanol, centrifuged 
at 9100 rpm (8000 x g) for 10 mins at 4oC and allowed to dry for 10 min. Air 
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dried DNA was then resuspended in 50-100 µl of 10 mM Tris-Cl, pH 8.5 and 
placed in shaker incubator at 30oC overnight or at 55oC for 1-2 h to be dissolved 
and then kept at -20oC. Buffer B1, B2, QBT, QC and QF were prepared in the 
lab according to supplier's instructions (Appendix 2). Proteinase K and 
lysozyme were supplied by Sigma. 
 
2.3.3 Genomic DNA preparation using Qiagen QIAamp DNA Mini kit 
 
An Eppendorf tube containing 1 ml liquid culture (OD600: 0.5-1) or loopfull of 
plate culture was resuspended in 1 ml phosphate buffer saline (PBS). The 
suspension was centrifuged at 2400 x g for 5 min to pellet the cells. 
Supernatant was removed and 180 µl from Buffer ATL was added. 20 µl 
proteinase K (20 mg ml-1) was added, the content was mixed by vortexing and 
then incubated at 56oC for 1 h (tube was mixed 2-3 times during the incubation 
to assure efficient lysis). The tube briefly centrifuged and 200 µl of Buffer AL 
was added, the mixture was vortexed for 15 s and then incubated at 70oC for 10 
min. Again, the sample was briefly centrifuged and 200 µl of ethanol (95-100%) 
was added and the content was mixed by pluse vortexing for 15 s and, 
centrifuged briefly. The sample was applied carefully to QIAamp spin column 
and centrifuged at 8000 x g for 1 min. Flow through was discarding and 500 µl 
from buffer AW1 was added and centrifuged at 6200 x g for 1 min. The flow 
through was discarded and 500 µl from buffer AW2 then added, centrifuged at a 
full speed at bench-top centrifuge for 3 min. The QIAamp spin column was 
placed in a clean 1.5 Eppendorf tube, 150 µl buffer AE was added and 
incubated at room temperature for 1 min and then centrifuged for 1 min at 6200 
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x g. This step was repeated by adding AE but this time sample was incubated 
for 5 minutes at room temperature before centrifugation to elute all DNA. All 
buffers in this kit were supplied by Qiagen. 
 
2.4 Preparation of E. coli S17.1 CaCl2 competent cells 
 
This method was adapted from that of Sambrook et al. (1989). LB (10 ml) was 
inoculated with a fresh single colony from an E. coli S17.1 culture plate and 
incubated overnight at 37°C. The culture was used as an inoculum  for 500 ml 
of LB broth with MgCl2 [10 mM], MgSO4 [10 mM] and incubated at 37 °C with 
shaking at 200 rpm until the culture reached an OD600 of  0.5 - 0.6 (mid log 
phase). The cells were chilled on ice for approximately 15 min and then pelleted 
by centrifugation at 5000 × g for 10 min (4°C). Pelleted cells were resuspended 
in 25 ml ice cold, filter sterilized 0.1 M MgCl2 and pelleted by centrifugation as 
above. The cells were washed in 5 ml filter sterilized CaCl2,  incubated on ice for 
45 min and then, pelleted again and resuspended in 25 ml 0.1 M MOPS, 50 mM 
CaCl2, 20% glycerol. The cells were drop frozen in 200 µl aliquots in liquid 
nitrogen and stored at -80°C. Using this method cells could be store for several 
years. 
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2.4.1 Transformation of CaCl2 competent cells 
 
An aliquot of β00 μl of CaCl2 competent cells were thawed on ice.  The thawed 
E.coli S17.1 CaCl2 competent cells were transformed with 1-5 μl of DNA and 
incubated for 30 min on ice. The cells were heat shocked for 90 s in a water 
bath at 42oC and then incubated for more two min on ice. When other 
commercial competent cells were used such as E. coli BL-β1 “One-Shot” 
(Invitrogen) and XL-10 Golden ultra-competent cells (Agilent technologies), the 
transformation was performed according to the supplier’s instructions. The 
appropriate volume of medium was then added to the cells to complete the 
volume to 1 ml. LB was used with CaCl2 competent cells E. coli S17.1, NZY 
was used with XL-10 gold ultra-competent cells and SOC (Super optimal broth 
with catabolite repression) (Appendix 1) was used with E. coli BL-β1 “One-Shot” 
competent cells. The sample was then incubated at 37oC with shaking at 200 
rpm for one h. Aliquots of 50-β00 μl were then cultured on LB agar with 
appropriate antibiotic(s). 
 
2.4.2 Transforming Methylosinus trichosporium SMDM by 
conjugation 
 
To express recombinant Methylosinus trichosporium MMO genes in a 
homologous expression system, plasmids were used to transform   E. coli 
S17.1 (Simon et al, 1983) and then were transfered by conjugation to a soluble 
methane monooxygenase deleted Methylosinus trichosporium mutant (SMDM) 
(Borodina et al., 2007). 
  94 
 
2.4.3 Conjugation procedure 
 
E. coli S17.1 harbouring the recombinant vector containing the desired mutation 
was grown in LB broth overnight at 37oC in a shaker incubator. Meanwhile, 
SMDM was grown in 50 ml culture in NMS liquid medium to an optical density 
OD600 ~ 0.2. Both cultures were mixed together and centrifuged for 10 min at 
5000 x g to pellet the cells. The pelleted cells were resuspended in 50 ml NMS. 
The suspension was collected on a nitrocellulose filter membrane with 0.ββ μM 
pore size. The filter membrane was then cultured on NMS agar containing 
0.02% protease peptone, the plate being incubated for 24 h in anaerobic jar 
with 50/50 air: methane. The growing bacteria on the filter paper were 
resuspended in 10 ml NMS medium and centrifuged as above. The pellet was 
resuspended in 1 ml NMS medium. Aliquots (100 μl) were then cultured on 
NMS agar with four antibiotics; streptomycin (β0 μg ml-1), spectinomycin (β0 μg 
ml-1), gentamycin (5 μg ml-1) and nalidixc acid (β5 μg ml-1). The plates were 
incubated in a methane/air atmosphere at 30oC for 2-3 weeks or until colonies 
could be seen. Then selected colonies were cultured on NMS agar with three 
antibiotics; streptomycin, spectinomycin and gentamycin with same 
concentration as above. The pure colonies containing mmoX gene with a 
desired recombinant were further confirmed by positive naphthalene test or 
colony PCR for the negative colonies. 
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2.5 Sequences of primers used in the study 
 
The sequences of the primers which were used in the present study are shown 
in Table 2.2. 
Table 2.2 Sequences of primers used in the construction of the mutants in the 
present study. 
Primer Sequence 5ޘ -γޘ Description 
mmoX- p1 
 
ATT CGA GCT CAA ACG TTC GAA C Forward/ Upstream external 
primer for BamHI 
mmoX- p4 
 
GGG CTC TCG ACG CCA TAT TTG Reverse/ Downstream external 
primer for NdeI 
E114D-f (p2) CGA GGT CGG CGA CTA TAA CG  
 
Forward/ E114D mutagenic 
primer 
E114D-r (p3) CGT TAT AGT CGC CGA CCT CG  
 
Reverse/complement of primer 
E114D-f. 
R98A-f (p2) ATC CCG CCT GGG GCG AGA C Forward/ R98A mutagenic 
primer 
R98A-r (p3) GTC TCG CCC CAG  GCG GGA T 
 
Reverse/complement of primer 
R98A-f. 
Seq-f CGG TCC GAA ACA AAA GAA  AA Primer to bind downstream of 
mmoX- p1. This primer was 
used to sequence the area 
around the active site that 
contains the mutations in the 
present study 
 
Seq-r ATC GGT GTT GAG GAA CTT GG Primer to bind downstream of 
mmoX- p4. This primer was 
used to sequence the area 
around the active site that 
contains the mutations in the 
present study  
The reverse mutagenic primers (r) are complementary to the corresponding forward primers (f). 
The bold letters indicate the nucleotide bases being changed. mmoX- p1, p2, p3 and mmoX- p4 
refer to the role that the primer played in overlap-extension PCR mutagenesis as described 
below (Figure 2.4). 
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2.5.1 Standard PCR protocol 
 
PCR was run using Taq DNA polymerase (Invitrogen), or Pfu proofreading 
polymerase (Agilent technologies) or Phusion High-fidelity PCR Master Mix or 
Hot start Master Mix (Fisher scientific). The melting temperatures Tm for 
primers were calculated by using: Tm (ºC) = 2(NA + NT) + 4(NG + NC) since NA, 
NT, NC and NG are the number of adenosine, thymine, cytosine and guanine 
bases present respectively. 
The standard PCR reaction was run for 95oC for 2 minutes to denature the DNA 
and then the DNA was amplified for 30-35 cycles of: 95oC 30 sec kb-1, (Tm -5) 
oC for 30 sec kb-1, 72 oC for 1 min kb-1 with final extension time for 10 min at 
72oC and then held at 4-8oC. For colony PCR the colony was heated in 20 µl 
s.d.w. for 10 minutes at 100oC and then 5 µl was used as a template or the 
colony was heated at 95oC for 10 minutes before use. When PCRs were set up 
using individual reaction components, the following recipe was used: 
PCR Recipe 1: 
 dNTPs  (25 mM each dNTP)       0.5 µl  10 × buffer                                   5 µl  primer 1 (100-200 ng)              1 µl  primer 2 (100-200 ng)              1 µl  DNA template                         1 - 5 µl  Taq polymerase or Pfu turbo      1 µl  50 mM MgCl2 (not added for Pfu Turbo)    2 µl  BSA  (colony and culture template only)  1 µl  s.d.w. up to 50 µl 
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PCRs  using Master Mix were set up as follows (Recipe 2): 
Master Mix                                                                               25 µl 
Forward primer (100-200ng)                                                   2.5 µl 
Reverse primer (100-200ng)                                                   2.5 µl 
DNA template                                                                         1-5 µl 
Sterile distilled water (s.d.w.)                                         up to 50 µl 
 
2.5.2 Four primeroverlap PCR 
 
For each of the two mutations created, overlap PCR was used to perform the 
mutagenesis. Two PCRs were set up according to recipe 2 (Section 2.4.1.); the 
first PCR (PCR 1 in Figure 2.1) was performed by using the external forward 
primer (mmoX- p1) with the appropriate internal mutagenic primer (p3) to create 
the product AB. The second PCR (PCR 2 in Figure 2.1) was performed by using 
the reverse external primer (mmoX- p4) and the appropriate internal mutagenic 
primer (p2) which is complementary to p3 to create product CD.  ). These two 
gel purified products were mixed and used as the DNA template for the 
subsequent combinatorial follows PCR (PCR 3 in Figure 2.4.). An equimolar 
amount of each product was mixed and incubated at 96oC for two minutes and 
then left for 10 minutes to cool. The High fidelity Phusion Master Mix, was then 
added to the reaction, together with primers mmoX- p1 and mmoX- p4 (volume 
as indicated in recipe 2 in Section 2.1). The tube was then replaced into the 
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heating block of the PCR apparatus, which had been pre-heated to 98oC for 2 
minutes., then the PCR was run under the conditions recommended by the 
supplier which was as follows; an initial denaturation temperature 98oC for 30 s, 
35 cycles of denaturation at 98oC for 30 s, annealing temperature at 52oC for 30 
s and extension at 72oC for 30 s kb-1 with final extension at 72oC for 10 minutes 
and hold at 4oC. 
 
 
                   Mutated mmoX gene now is ready to be ligated into pJET1.2 
Figure2.1        Construction of mutant by overlap PCR. 
PCR 1 was performed using primers mmoX forward primer (mmoX-p1) and the mutagenic 
reverse primer (p3). The product from PCR 1 is AB. PCR 2 was run using the mutagenic 
forward primer (p2) and the mmoX reverse primer (mmoX-p4). The product from PCR 2 is CD. 
Combination of two products AB and CD and amplification using two primers mmoX- p1 and 
mmoX- p4 with phusion high fidelity DNA polymerase led to production of the mmoX gene (AD) 
with the desired mutation which was ready for cloning into pJET1.2 and then double digested 
with restriction enzymes BamHI and NdeI for cloning into the expression plasmid pT2MLY as 
detailed in Chapter 5 (Section 5.4.4.). 
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2.5.3 Ligation of mutant mmoX genes into pJET 1.2 
 
The overlap PCR product from the previous steps was ligated into the high 
efficiency pJET1.2 cloning vector (Life technology) to produce pYYL1 (Figure 
2.2). Laboratory prepared competent cells of E. coli S17.1 were transformed 
with the ligation reaction. Colony PCR was performed to detect the putative 
mutated mmoX gene by using primers mmoX- p1 and mmoX- p4.  
The transformed E. coli S17.1 which showed a band in the colony PCR with 
primers mmoX- p1 and mmoX- p4 was then recultured in LB broth with the 
appropriate antibiotic (ampicillin 100 μg -1 ml-1). A miniprep was done for the 
progeny plasmids (pYYL1) isolated from these transformed E. coli S17.1. The 
mmoX gene was then amplified by PCR using primers mmoX-p1 and mmoX-p4 
to confirm its presence in the purified plasmid. 
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Figure 2.2   Cloning steps for introduction of the mutated mmoX gene into 
vector pJET1.2 
Scheme describes the cloning of the overlap PCR product containing the desired mutation in 
the mmoX gene into the vector pJET1.2 and transformation into competent cell E.coli S17.1 to 
create pYYL1.  
rep(pMB1): Replicon (rep) from the pMB1 plasmid resposible for the replication of pJET1.2, 
eco47/R lethal gene eco47/R enables positive selection of recombinant plasmid, PT7:T7 RNA 
polymerase promoter for in vitrotranscription of the cloned insert, ApR: Ampicillin resistance. 
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2.5.4 Double digestion of purified mutated mmoX gene with BamHI 
and NdeI 
 
The mutated mmoX gene that was amplified from pYYL1 by PCR was gel 
purified by using the gel extraction kit (Qiagen) and then double digested with 
NdeI and BamHI. The desired band was then excised from the gel and purified 
for ligation with pT2MLY double digested with the same restriction enzymes 
BamHI and NdeI (Figure 2.3). 
 
2.5.5 Cloning the constructed all mutants in the present study into 
the His-tag expression plasmid pT2MLY 
 
After purification of the band that contained the desired mutation from the 
double digested mmoX gene, the purified double digested gene was ligated by 
using the Quick Instant Ligation Kit (NEB) into pT2MLY that had been digested 
with same restriction enzymes (NdeI and BamHI). The E. coli XL-10 gold ultra-
competent cells were transformed with the ligation reaction as described in 
Section 2.5.1. Colony PCR was performed and the resulting plasmid containing 
the putative mutated gene was purified from the transformants and then sent for 
sequencing from four primers mmoX- p1, mmoX- p4, Seq-f and Seq-r (Table 
2.2). After the sequencing, the purified mutated plasmids were transferred into 
E. coli S17.1 and then the mutated plasmids transferred from E. coli S17.1 into 
SMDM by conjugation as described in Section 2.5.2. The transconjugants were 
grown for three weeks on NMS agar plates with four antibiotics (streptomycin, 
spectinomycin, gentamicin and nalidixic acid) and methane as a source for 
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carbon and energy. The mutants were then tested for oxidation of naphthalene. 
Colony PCR was run for the mmoX gene for the exconjugant strains and then 
the PCR product was purified and sent for sequencing. The mutants were 
further characterized by growing on NMS medium with low copper to induce the 
production of sMMO, which was then assayed by the naphthalene oxidation 
plate test again.  
 
Figure 2.3   Diagram showing the construction of the His-tagged expression 
system pT2MLY and the cloning steps to introduce the mutated mmoX gene 
into this plasmid. 
The right hand side of the diagram shows the construction of pT2MLY, which was performed by 
Dr. M. Lock and Dr. T. Nichol before this study.The left hand side shows the cloning steps to 
introduce each mutant into pT2MLY, which were performed during the current study. The 
amplified mmoX gene with the desired mutation(s) was double digested with BamHI and NdeI 
restriction enzyme to be ligated into pT2MLY that had been digested previously with same 
restriction enzyme. The ligated plasmid was transformed into E.coli XL-10 Gold ultra-competent 
cells which then conjugated with SMDM. 
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2.6 Cell preparation for protein purification 
 
2.6.1 Preparation of the hydroxylase and reductase for purification 
 
Frozen cells were harvested by centrifugation (8900 x g, room temperature) 
then 30 g of whole frozen cells were resuspended in equal volume of 25 mM 
(MOPS)-NaOH (pH 7.2) containing 2 mM dithiothreitol (DTT) and 1 mM 
benzamidine, β00 μM Fe (NH4)2 (SO4)2, β μM cysteine, β unit ml-1 of DNaseI 
(Sigma, Aldrich), and 0.5 mM MgCl2 (buffer A). Cells were disrupted by passing 
them three times through a French pressore cell (Thermo) at 20,000 mPa 
(pressure achieved in the French press cell disrupter, 4oC) or for smaller 
amounts (≤ 5 ml) using a Sonics vibracell VCX 750 sonicator on ice using 10 × 
30 s bursts at 40 % maximum amplitude with 30 s on ice between each burst to 
allow cooling. Cells were centrifuged in pre-chilled Oakridge tubes at 10000 x g 
for 5 min to remove the majority of the cell debris. The supernatant was then 
transferred to ultracentrifuge tubes and centrifuged for 90 min at 50000 x g at 4 
°C. The debris was excluded and supernatant was aliquoted in prechilled 
Eppendorf tubes and kept in -80oC until needed.  
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2.6.2 Purification of the hydroxylase 
 
2.6.2.1 Anion exchange chromatography 
 
The supernatant from the broken cell suspension described above was loaded 
onto an anion exchange column (DEAE Sepharose CL-6B anion exchange 
matrix (Amersham-Pharmacia; 80 ml of settled bed) pre-equilibrated  with 25 
mM MOPS, pH 7.0, 8 mM sodium thioglycolate, β00 μM Fe (NH4)2 (SO4)2 and 2 
mM DTT (buffer B). After that the column was washed with 600 ml of buffer B. 
The hydroxylase and reductase were then eluted by a linear gradient of NaCl 
from 0 to 0.4 M in buffer B. The MMOH-containing samples were concentrated 
by ultra-filtration with an XM50, 50 kDa molecular mass cut-off membrane 
(Millipore- Amicon). Furthur purification was performed as described below. 
SDS-PAGE (16% and 12%) was used to analyse all protein samples of 
hydroxylase and reductase. 
 
2.6.2.2 His-tagged MMOH purification 
 
A Ni-NTA QIAGEN His-tag affinity column with 2 ml collection tube was 
equilibrated with 600 µl phosphate buffered saline (PBS) at 800 x g for 2 min. 
Then 600 µl of hydroxylase-containing soluble extract were loaded onto the 
column and centrifuged at 200 x g for 5 min (flow through was saved) The 
column washed with 600 µl of 1 mM histidine in PBS buffer (2 min 800 x g) 
followed by washing twice with 600 µl of 10 mM histidine in PBS buffer for 2 min 
at 800 x g. Finally the MMOH was eluted with 600 µl of 100 mM histidine in PBS 
buffer 2 min at 800 x g. 
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2.6.3 Purification of the reductase 
 
The MMOC (reductase) protein containing samples were concentrated by ultra-
filtration with an XM50, 10 kDa molecular mass cut-off membrane (Millipore-
Amicon). Further purification of MMOC was achieved by loading the 
concentrated fraction from DEAE Sepharose chromatography containing protein 
C onto a Superdex 75 (Amersham-Pharmacia) column (26 mm by 60 cm) and 
eluting with buffer A (mentioned in hydroxylase purification). MMOC purification 
was conducted in a cool and dark room to avoid inactivation since it is light 
sensitive (Smith et al., 2002). 
 
2.6.3.1 NADH oxidase assay for MMOR 
 
 
The assay for NADH oxidase activity was performed for the putative purified 
reductase by measuring the decrease in NADH absorbance at a wavelength of 
γ40 nm (ε=6.ββx103 M-1 cm-1) at 25oC using a Jenway 6715 UV/Vis 
spectrophotometer. Reaction mixture (1 ml) contained 50 mM sodium 
phosphate buffer (pH7.0), 0.016 μM NADH (ethanol free), 0.05 mM cytochrome 
c as alternative electron accepter in place of sMMO, and 0.10 mg-1ml-1 of 
enzyme (reductase). The concentration of protein in the reductase sample was 
measured by using Bradford reagent with bovine serum albumin (BSA) as a 
standard. 
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2.6.4 Purification of protein B 
 
2.6.4.1 Transformation of E. coli BL-21 with pGEX-2T mmoB 
 
Firstly, E. coli BL-21 was transformed with pGEX-2TmmoB plasmid following 
the Invitrogen protocol, as mentioned in Section 2.6.1 in the Materials and 
Methods Chapter. The plasmid was then purified using the QIAmini prep 
plasmid kit (Qiagen) and analysed by gel electrophoresis. After that, plasmids 
were digested using two restriction enzymes (EcoRI and BamHI) to confirm the 
presence of the gene mmoB.  
 
2.6.4.2 Induction and expression of protein B 
 
Induction and expression of protein B was performed by following the Invitrogen 
Expression Guidelines. Three to four transformed colonies were cultured 
overnight in 5 ml LB broth containing ampicillin 100 μg ml-1 with shaking until 
the OD 600 was 0.6-1.0. This overnight culture was used to inoculate LB with 
ampicillin to an OD600 of 0.05-0.1 (~1:50 dilution of the overnight culture) to 
allow the cell growth to return to the logarithmic phase. The cells were left to 
grow for a further 2-3 h to an OD600~0.4. Cells were induced by adding IPTG to 
a concentration of 0.5 mM of the bacterial culture and incubated under the 
same conditions for a further 2-3 h. Samples were taken at time zero (when 
IPTG was added) and after two and three h of incubation to detect protein 
production. Samples from different time points were centrifuged at 17000 x g for 
20 min and resuspended with 200 µl of PBS, and recentrifuged at 17000 x g for 
20 min. The supernatant from the last step was discarded and the cells from 
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each sample were resuspended in 200 µl of PBS. The suspension was mixed 
with an equal volume of SDS-loading dye, boiled for ten minutes and then 
analyzed by SDS-PAGE. 
 
2.6.4.3 Purification of protein B 
 
Protein B with the glutathione S-transferase (GST) fusion was purified from E. 
coli according to Lloyd et al. (1997) and the GE Healthcare protocol, as follows. 
The culture was centrifuged and then the cells were resuspended in 25 mM 
MOPS pH 6.8 with DTT and benzamidine. The cells were disrupted by passing 
them three times through a French pressure cell (Thermo) at 20,000 mPa 
(pressure achieved in the French press cell disrupter, 4oC). Supernatant 
containing soluble extract was obtained after centrifugation at 50400 x g for 90 
min at 4oC. Supernatant was loaded onto a 5 ml GSTrapHP (GE Healthcare) 
column pre-equilibrated with 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 
mM KH2PO4, pH 7.3 (buffer A). After protein adsorption for 2 min, the column 
was washed with approximately five column volumes of  buffer A. Fusion 
protein was eluted with freshly prepared 50 mM Tris-HCl, 10 mM reduced 
glutathione, pH 8.0. 
 
2.7 Protein quantification 
 
A standard curve was made by dissolving different concentrations of BSA in 
MOPS 25 mM pH 7.0. Then 100 μl from each concentration of BSA was mixed 
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with 3 ml of Bradford reagent (Bio- Rad), the mixture was then incubated for 5 
min at room temperature. Absorbance of the samples at 595 nm was measured 
in a Jenway 6715 UV/Vis spectrophotometer. The concentration of BSA was 
read by comparing to a negative control from Bradford reagent without BSA. 
The protein concentration was estimated according to BSA standard curve. 
 
2.8 Protein visualization via SDS-PAGE 
 
Gels for SDS-PAGE were prepared as two layers; separating and stacking gel. 
The full formulations for the buffers and other solution used in SDS-PAGE can 
be found in Appendix 3. 12 or 16% SDS-PAGE was used in this study. The 
separating gel was prepared by mixing 4.5 ml or 6 ml 40% (acrylamide: 
bisacrylamide) 37:5:1 for (12% and 16% PAGE respectively), 3 ml of 2 M Tris 
HCl pH 8.8 and 6 ml or 7.5 ml D.W. (distilled water) for (12% and 16% PAGE 
respectively). The separating gel was set up finally by adding 75 μl of 1% 
ammonium persulfate, 150 μl from 10% of sodium dodecyl sulfate and 10 μl 
TEMED and poured in the cassette. The gel was overlaid with isopropanol and 
left for 30 min to set before removing the isopropanol. Stacking gel was 
prepared by adding 0.6 ml (acrylamide: bisacrylamide) 37:5:1, 0.7 ml of 0.5 M 
Tris HCl pH 6.8 and 3.6 ml D.W. The stacking gel was set up finally by adding 
50 μl of 1% ammonium persulfate, β5 μl from 10% of sodium dodecyl sulfate 
and 5 μl TEMED and poured in the cassette. The comb was then added and the 
gel was left until set. The gel was run for 130 V for 1 hour or until the first band 
in the protein marker reached the end of the gel. The gel was stained in 0.1% 
Coomassie blue dissolved in methanol, glacial acetic acid and water (Appendix 
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3) with gentle shaking for 1 hour and then washed off, overlaid in destaining 
solution (30% methanol, 10% glacial acetic acid) overnight or until clear protein 
bands could be seen. 
 
2.9     Cell preparation and substrates oxidation assay 
 
2.9.1     Whole cell oxidation test 
 
 
To test the enzyme, frozen cells were resuspended in a minimum volume of 25 
mM MOPS pH 7.2 to a final OD600 of 5-10. As sMMO can oxidize aromatic 
compounds and these substrates could not be oxidized by pMMO, an aromatic 
compound assay was performed with the whole cell suspension. Aliphatic 
compounds can serve as pMMO and sMMO substrates; analysis of these 
compounds was performed with the soluble extract to exclude the membrane 
attached pMMO enzyme. 
 
2.9.2   Soluble extract assay 
 
 
Frozen cells were thawed in an equal volume of 25 mM MOPS (e.g: 25 g of 
frozen cells were thawed in 25 ml of MOPS) buffer pH 7- 7.2  on ice with 5 mM 
DTT (dithiotheritol), 2 mM benzamidine chloride and  DNase I (1.5 - β μl ml-1) 
(Sigma). Cells were then disrupted by either passing them through the French 
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pressure disruptor or sonication for 10 x 30 sec at amplitude at 40% (SONICS 
vibra-cell). Then the sample was centrifuged at 10000 x g to remove the debris 
and then the supernatant was clarified using a prechilled ultracentrifuge at 
50000 x g for 90 mins at 4oC. The soluble extract was then kept in -80oC until 
needed. 
 
2.9.3    Colorimetric naphthalene test 
 
The colorimetric naphthalene oxidation test was performed for liquid and solid 
cultures. A few crystals were added to the liquid culture (1 ml of liquid culture) or 
on the lid of a plate with growing culture on solid medium. In both types of 
culture, the reactions were incubated for one hour at 30oC, with shaking for the 
liquid culture at 180 rpm. The result was positive when the colour was dark pink 
to purple after adding the indicator tetrazotized o-dianisidine (TOD). The 
coloured diazo dye complex forms during the contact of TOD with hydroxylated 
product from the reaction. For the solid cultures, colonies were flooded with the 
TOD reagent (5 mg ml-1). For the liquid cultures, 100 μl ml-1 of TOD (5 mg ml-1) 
was added to the liquid culture. 
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2.10    Oxidation of mono-, di- and tri-aromatic compounds by 
Ms. trichosporium OB3b (wild type), wild type with His-tag and 
mutants.  
 
 
The ability of the wild type of Ms. trichsporium OB3b (wild type), wild type with 
His-tag and mutants in the present study to oxidise a range of mono-, di- and tri-
aromatic compounds was assayed in the present study. A universal tube with 5 
ml of bacteria suspended in MOPS buffer was prepared with different 
substrates (toluene, mesitylene, ethyl benzene, biphenyl, naphthalene, 
anthracene and phenanthrene) (Table 2.2) at different concentrations. The 
assayed cultures were incubated at 30oC with shaking at 180 rpm for different 
incubation periods as explained in Table 2.2. The reaction was stopped on ice 
for 5 minutes and then tubes were centrifuged at 17000 x g for 2 min, the 
supernatant was then extracted into 1ml diethyl ether and evaporated into ≥ 
50μl. 1μl of the resulting concentrated solution was then analysed in an Agilent 
GC-MSD 7890A/5975C. The GC was fitted with a Hewlett Packard HP-5 MS 
column with a (5% phenyl) methyl polysiloxane coating (30 m × 0.25 mm; 
coating thickness 0.β5 μm) and operated with a carrier gas (Helium) flow rate of 
1.5 ml min-1. The separation was performed without split with a column 
temperature starting at 50oC with holding for 2 min, and then ramped to 150oC 
at 10oC/ min. The temperature was then ramped from 150oC to 250oC at 
5oC/min and held for 5 minutes. 
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Table 2.3    Table shows the substrates, substrate concentrations, incubation 
period, and the internal standard (if used in the assay) to estimate the ability of 
sMMO in oxidation mono-, di- and tri-aromatic compounds. 
 
 
tested substrate amount in 5 ml of 
bacterial culture 
incubation 
time 
internal standard 
1- Toluene  5 μl toluene 48 hours β5 μmol of naphthol 
2- Mesitylene 5 μl of mesitylene 72 hours None 
3- Ethyl benzene  5 μl of ethyl benzene 48 hours None 
4- Biphenyl ~ 5 mg of biphenyl 24, 48, 72, and 
96 hours 
β5 μl of p-cresol 
5- Naphthalene ~ 5 mg of 48 hours β5 μl of p-cresol 
6- Phenanthrene   ~ 5 mg of phenanthrene 48 hours None 
7- Anthracene  ~ 5 mg of anthracene 48 hours None 
None- no internal standard was used in this assay. Incubation of all assays was run in shaker 
incubator at 180 rpm. 
 
2.11     Propylene oxidation assay  
2.11.1 Propylene oxidation assay for whole cell 
 
 
GC vials each containing 2 ml of culture were prepared as in previous assays 
(Section 2.11); DTT was added to a final concentration 5 mM. The tube was 
equilibrated in water bath at 30oC for 1 min. To test the strains toward 
propylene, 2 ml of propylene was added and incubated for 20 minutes at 30oC. 
The reactions were put on ice for 5 min and then the cells separated by 
centrifugation in a benchtop centrifuge in a maximum speed for 1 min. 
Extraction of the product was performed by using CCl4 which was then 
evaporated to ≥ 50 μl. To analyse the product, 1 μl was injected into an 
Shimadzu GC-AOC 2010 fitted with a column connected to a RTX-5 column 
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with flame ionisation detector. The GC was fitted with a Restek RTX-5 column 
with a 5% diphenyl/ 95% dimethyl polysiloxane coating (50 m x 0.32 mm; 
coating thickness 0.β5 μm) and operated with a carrier gas (nitrogen) flow rate 
of 1.5 ml min-1. Also the samples were analysed by GC-MS. 
 
2.11.2    Propylene oxidation assay for soluble extract 
 
Soluble extract for the wild type with His-tag and mutant F282L was prepared 
as described in Section 3.5.1. A negative naphthalene test on the F282L 
mutant-expressing cells (done before preparation of the soluble extract) 
confirmed that this strain lacks active sMMO. The His-tagged hydroxylase was 
purified from the appropriate wild type as explained in Section γ.5.β.β. 600 μl 
from the wild type His-tagged hydroxylase preparation was mixed with 400 μl 
from F282L soluble extract as a source for protein B and C (this mutant 
contains inactive hydroxylase). 2 ml of headspace was replaced with 2 ml 
propylene gas. The tube was equilibrated in a water bath with a 30oC; the 
reaction was started by addition of 100 μl of 100 mM ethanol free NADH 
(Appendix 4). The reaction was incubated for 20 min and then quenched on ice 
for 5 minutes. The product was extracted into 150 μl CCl4 and then 1 μl from the 
extracted sample was injected into the GC. In the case of samples extracted via 
the SPME method, the reaction tube was warmed and agitated on a magnetic 
stirrer to evaporate the propylene oxide which then became adsorbed onto the 
solid phase micro extraction apparatus. The solid phase microextraction 
apparatus consists of a modified syringe (Figure 2.4) consisting of a fibre holder 
and fibre assembly. The fibre assembly comprises a 1-2 cm long retractable 
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SPME fibre which in turn contains a thin fused-silica optical fibre, coated with a 
delicate polymer film such as polydimethylsiloxane. In order to load the sample, 
the 1 μl from the extracted sample in CCl4 or saturated SPME needle was 
injected into a Shimadzu GC2010 fitted with a RTX-5 column with a flame 
ionisation detector. The Restek RTX-5 column, which had a 5% diphenyl / 95% 
dimethyl polysiloxane coating (50 m x 0.γβ mm; coating thickness 0.β5 μm) was 
operated with a carrier gas (nitrogen) flow rate was 30 ml min-1 and a split ratio 
of 30:1.  The inlet temperature was 250oC. The temperature was ramped to 
40ºC, held  at  40ºC for 8  min-1,  and then ramped to 100ºC and held at 100ºC 
for 5 min. 
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2.12   Statistical analysis 
Statisitical analysis of results was performed by appling the Kruskal-Wallis test 
(Conover-Inman).  Data are presented as (Mean± S.E.M).
 
Figure 2.4 Solid Phase Microextraction (SPME) apparatus. The 
enlargement of the injection part shows fused silica-coated fibers which 
adsorb the product from the reaction to be injected into gas 
chromatography. The fibres are retractable and protected by the septum 
piercing needle Image is taken from (Vas and Vѐkey, β004) 
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Chapter 3: Purification and assay of 
soluble methane monooxygenase 
components  
3 Protein purification 
3.1 Purification of sMMO componenets by anion exchange 
chromatography  
 
Unlike pMMO, sMMO was purified many years ago and consequently its 
biochemistry and the crystal structure are well investigated.  Active sMMO has 
been purified to homogeneity from different methanotrophic bacteria such as 
Methylocystis sp.W114, Methylosinus trichosporium OB3b, Methylocystis sp. M, 
Methylococcus capsulatus Bath, Methylomonas sp. GYJ13, Methylobacterium 
sp. CRL-26, and Methylosinus trichosporium IMV3011 (Fox and Lipscomb 
1988; Nakajima et al., 1992; Woodland and Dalton, 1984; Grosse et al., 1999; 
Patel and Savac, 1987; Rosenzweig et al., 1997; Elango et al., 1997; McDonald 
et al., 1997; Smith et al., 2002; Shaofeng et al., 2007). The sMMO hydroxylase 
and reductase have previously been purified by using anion exchange 
chromatography followed by gel filtration (Smith et al., 2002). During previous 
studies, optimizations of protein purification conditions were made to obtain an 
active purified protein. Shaofeing et al. (2007) found that using iron, DTT at 
concentrations up to 20 mM, 15% glycerol and 5 mM sodium dithionite 
improved the purified hydroxylase activity and stability. However, purification of 
the sMMO hydroxylase or reductase by using an affinity column was not 
attempted in previous studies. 
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3.2 His-tag affinity system 
 
During previous studies in this research group, a homologous expression 
system for sMMO was developed in which recombinant sMMO genes carried on 
plasmids pTJS175 or pT2ML could be expressed in sMMO-minus mutants of 
Ms. trichopsporium OB3b known as SMDM. More details of this expression 
system can be found later in this thesis (Section 4.3.)(Lloyd et al., 1999; Smith 
et al., 2002; Borodina et al., 2007; Nichol 2011). In order to further improve the 
expression system for sMMO, a poly histidine-tag was inserted into the sMMO 
hydroxylase. A His-tag is a structure of six histidine amino acids attached to 
each other (6x His-tag or histidine hexa tag in the present study it will be 
referred to as His-tag). The His-tag was inserted in the ȕ-subunit of sMMO 
hydroxylase in the cloning vector system pT2ML to form a new system named 
as pT2MLY (Lock et al., manuscript in preparation). The His-tag forms an 
affinity tag on the hydroxylase to be used to purify it using an affinity column. 
The system pT2MLY was used in the present study to manipulate new mutants 
aiming to minimize the cloning steps and facilitate purification of sMMO 
hydroxylase, both wild type and mutants, in the homologous expression system 
in Ms. trichosporium SMDM.  
In addition, the His-tag was inserted to the sMMO reductase and cloned into the 
vector pET by a member in this group (M. Lock, personal communication).  
Although attempts in the current study were made to express and purify the His-
tagged reductase from the heterologous expression system E. coli, these did 
not result in purification of the reductase.  More investigation is needed to 
achieve this goal. 
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3.3 GST-fusion affinity system 
 
As mentioned in the introduction, protein B has many critical roles in sMMO 
activity during oxidation of methane and other substrates. Unlike the 
hydroxylase, protein B could be expressed and purified from a heterologous 
expression system from E. coli (West et al., 1992). It has been noticed that 
during the purification of protein B from Mc. capsulatus, it loses its activity due 
to cleavage that occurs between Met12 and Gly13, and Gln29 and Val30, 
resulting in formation of the truncated forms Bޗ and B˝ respectively (Lloyd et al., 
1997; Callaghan et al., 2002). It was found that fusion of protein B with 
Glutathione-S-transferase (GST) at the N-terminus of protein B resulted in more 
resistant protein against truncation, in addition to which this protein was active 
with the GST attached (Lloyd et al., 1997; Callaghan et al., 2002).  In the same 
studies, it was found that changing the E. coli expression host to strains either 
lacking ompT or being lon-deficient, or addition of protease inhibitors did not 
result in any change in truncation, which suggested that the truncation was auto 
catalytic. Mutation of Gly12 to Gln stabilized the protein but truncation still 
occurred, whereas the triple mutant G10A/G13Q/G16A resulted in a more 
stable protein with no activity (Brandstetter et al., 1999). Lloyd et al. (1997) 
found that protein B fused to GST had high activity when it was expressed and 
then purified from E. coli.  Although truncation of protein B has not been 
observed in vivo in Ms. trichosporium OB3b, it is possible that such truncation 
may happen in vitro. To avoid this possibilty, protein B that was used for 
purification in the present study was fused with GST in the pGEX-2T vector, 
which was also constructed by this group research previously.  
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3.4 Solid phase microextraction (SPME) 
 
The propylene assay has been widely used to assay purified sMMO activity. 
Usually the product from propylene oxidation, propylene oxide, is detected in a 
GC or GC/MS after being extracted by using suitable solvent. CCl4 was used as 
a solvent to extract propylene oxide from reaction mixtures in the present study. 
As an alternative to solvent extraction, a new solventless method known as 
solid phase microextraction (SPME) was used for the first time to detect 
propylene oxide in the present study. SPME decrease sample preparation 
steps, which may have led to loss of product (Vas and Vekey 2004). SPME can 
be used with gas chromatography (GC), GC/mass spectrometry (GC-MS) and 
high -performance liquid chromatography (HPLC) in addition to being used for 
volatile and semi-volatile organic compounds from food, environmental, and 
other biological samples (Vas and Vekey 2004).  
Many studies have demonstrated that all parts of sMMO are indispensable and 
critical for enzyme activity in vivo and in vitro. This Chapter will concentrate on 
(i) purification of the native sMMO reductase from Ms. trichosporium by using 
anion exchange chromatography (ii) affinity purification of protein B fused to 
GST from E. coli and (iii) purification of the His-tag hydroxylase by affinity 
chromatography from the recombinant methanotrophs. The activity of the 
purified His-tagged hydroxylase was tested in assays with the other sMMO 
components. 
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3.5 Experimental work and Results 
 
3.5.1  Purification of the His-tagged hydroxylase (MMOH) 
 
3.5.1.1  Anion Exchange chromatography 
 
The sMMO hydroxylase and reductase were purified from His-tagged OB3b wild 
type according to the protocols from (Fox et al., 1989; Pilkington and Dalton 
1990; Smith et al., 2002; Shaofeng et al., 2007) and the soluble extract was 
prepared as described in Section 2.6.1. The purification of the His-tagged 
hydroxylase by anion exchange chromatography comprised three steps: after 
cell disruption and centrifugation, the soluble extract was loaded onto DEAE-
Sepharose CL-6B anion exchange columnand then eluted by gradient of NaCl 
(0-0.4 M NaCl). The hydroxylase containing fractions that gave a peak at 0.12 
M NaCl (Figure  3.1) were pooled together and then concentrated with an XM50-
, 50 kDa, The pooled hydroxylase-containing fractions were then purified further 
by using His-tag affinity column, as detailed below. Samples were taken and 
seprated by  SDS-PAGE which revealed three bands corresponding to the 
hydroxylase α, ȕ, and Ȗ subunits with approximate sizes 58, 46, 25 kDa 
respectively (Figure  3.1), in addition to a few other faint bands.  
  121 
 
 
Figure  3.1  Purification of sMMO hydroxylase and reductase by anion 
exchange chromatography. 
After cell breakage, the soluble extract which contained the sMMO components was loaded 
onto the anion exchange chromatography column DEAE-Sepharose CL-6B attached to the 
AKTA purfication system. The proteins bound to the DEAE column were eluted by a linear 
gradient of NaCl. The hydroxylase eluted first whereas the reductase eluted at high salt 
concentration. The peaks (dark blue coloured line) representing the MMOH and MMOR are 
indicated by arrows. The green line represents the salt concentration increasing during the 
elution and the red line represents the conductivity.  
 
 
3.5.1.2  His-tag affinity column purification 
 
Samples taken from the concentrated pooled purified sample after anion 
exchange chromatography were purified using Ni-NTA affinity chromatography 
as described in Materials and Methods (Section 2.6.2.2.). The affinity purified 
His-tagged hydroxylase was run on SDS-PAGE alongside a sample of His 
tagged hydroxylase partially purified by anion exchange chromatography to 
compare them and to confirm that the affinity step enriched the hydroxylase 
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subunits. This revealed three bands corresponding to the α, ȕ, and Ȗ subunits 
with approximate sizes of 58 kDa, 46 kDa, and 25 kDa respectively, exactly as 
with the anion exchange column purified samples (Figure 3.2). In addition there 
was another faint band with size approximately 20 kDa. A separate sample of 
the His-tagged hydroxylase also purified directly by affinity chromatography 
from the soluble extract without the anion exchange step as detailed in Section 
2.6.2.2. The protein was eluted by using different concentrations of histidine 
with a larger Ni-NTA column (5-10 ml). The result also showed three bands 
corresponding to the three subunits of the hydroxylase in addition to fourth faint 
band as in the Anion exchange method (Figure  3.3). 
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Figure  3.2 SDS-16% PAGE  showing the His-tagged hydroxylase purified by 
Anion exchange and Ni-NTA affinity column from wild type with His-tag soluble 
extract, and the attemped purification of the reductase . 
M=Prestained protein marker, broad range (7-175 kDa) (New England Biolabs), lane 1 and 4=   
His-tagged hydroxylase purified by anion exchange chromatography. These show many bands 
including three bands representing MmoX, MmoY and MmoZ, i.e. the α, ȕ, and Ȗ subunits 
respectively. Lane 2= His-tagged hydroxylase purified by anion exchange chromatography and 
Ni-NTA affinity column which shows three bands representing the α, ȕ and Ȗ subunits of the 
hydroxylase. Lane 3= putative purified reductase fraction from anion exchange 
chromatography, which showed no band. 
 
Figure  3.3  SDS-12% PAGE showing the His-tagged hydroxylase purified from 
the wild type with His-tag soluble extract by using different concentrations of 
histidine dissolved in phosphate buffered saline. 
M= SeeBlue® Plus2 Pre-stained protein marker (Invitrogen). Lane 1 the run through of 
soluble extract. Lane 2= wash with phosphate buffered saline (PBS) only. Lanes 3, 4 and 5= 
elution with 1 mM, 10 mM, and 20 mM histidine respectively. Lane 6= protein eluted with 50 mM 
histidine. Lane 7= protein eluted with 100 mM histidine (the different washing and elution 
concentrations were prepared by dissolving the appropriate amount of histidine in PBS).  
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3.5.2  Purification of protein B (MMOB) 
 
3.5.2.1 Gene detection in pGEX-2T mmoB 
 
E. coli BL21 One shot was transformed with pGEX-2T mmoB as described in 
Section 2.6.1. The transformed E. coli (one colony) was grown on LB broth with 
ampicillin. The plasmid was purified from the E. coli by using Qiagen minipep as 
described in the Materials and Methods Chapter, Section 2.2.1. The purified 
plasmid was then digested with two restriction enzymes BamHI and EcoRI to 
confirm the presence of mmoB gene that encodes for protein B (mmoB was 
originally cloned into pGEX-2T using two restriction enzyme BamHI and 
EcoRI).The result from the digestion showed that there is a band with size 
approximately 500 bp representing the mmoB and 4900 bp corresponding to 
the vector pGEX-2T (Figure  3.4). 
 
 
Figure  3.4 Agarose (1%) gel electrophoresis showing restriction and analysis of 
pGEX-2T mmoB using BamHI and EcoRI. Lanes 1, 3, and 5= Purified pGEX-2T 
derivatives from three selected colonies (numbered as 1, 3and 5) containing the gene encoding 
protein B fused to GST.   
Lanes 2, 4, and 6= double digestion of the purified pGEX-2T (lanes 1, 3 and 5)   
with BamHI and EcoRI. Each digest showed two bands. The length of the mmoB gene (i.e. the  
smaller band in lanes 2,4 and 6) is approximately 500 bp.  
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3.5.2.2 Induction and expression of protein B 
 
Expression of the GST-protein B fusion was induced by adding IPTG (0.5 mM) 
to a culture of E. coli harbouring pGEX-mmoB and incubating the culture of E. 
coli for further 2-3 hours.  It can be seen from the SDS-PAGE that at time zero 
when IPTG was just added, there was no band with size equal to GST (26 kDa) 
plus protein B (16 kDa). This band started appearing 2-3 h after induction, with 
size approximately equal to that expected for the GST-protein B fusion (26 kDa 
+ 16 kDa = 42 kDa) (Figure  3.5). 
 
 
 
Figure  3.5 Time course of  IPTG induction of protein B  fused with GST expressed 
in pGEX-2T in E.coli BL-21. 
M=  SeeBlue® plus2 pre-stained protein marker (Invitrogen), cultures 1,3 and 5 correspond to the 
three different clones  of pGEX-2T containing mmoB shownin Figure 3.4. Time 0 (t0)= reading at time 
zero was taken when the IPTG was added, t2=reading was taken after 2 hours of induction, t3= reading 
was taken after  3hours of induction,  c= control culture without induction. 
Harvested cells from 1 ml samples of culture were boiled in SDS loading dye for 
10 minutes. Boiled samples were then loaded onto SDS-12% PAGE. 
The band representing the GST-protein B fusion protein is at 42kDa [GST (26 kDa) + protein B 
(16 kDa)] and is indicated by a labelled black arrow. 
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3.5.2.3 Purification of the GST-protein B fusion  
 
Purification of the GST-protein B fusion was performed by using a GSTrap HP 
column manually with a slow flow rate (5-10 ml-1 min-1), which gave an effective 
purification as show by SDS-PAGE. The gel shows a band with expected size 
after the elution step (Figure  3.6).  
 
 
 
 
 
 
Figure  3.6 Purification of protein B fused with the GST affinity tag from E. coli 
BL-21 by GSTrap affinity column chromatography. 
M= SeeBlue® plus2 pre-stained protein marker (Invitrogen). The cells induced with IPTG 
were harvested, broken and then the soluble extract which putatively contains the fusion protein 
was obtained. Lane 1= soluble extract as loaded onto the GSTrap affinity column, 10 µl from the 
run through. Lane 2= 10 µl of the washing step product mixed with loading dye. Lanes 3, 4 and 
5=10, 20 and 30 µl of purified protein respectively. 
(Each sample was mixed with loading dye and boiled for 10 minutes before loading onto SDS-
12%PAGE). 
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3.5.3  Purification of the reductase (MMOR) 
 
The attempted reductase purification like the hydroxylase purification comprised 
three steps. After breaking the cells the soluble extract was loaded onto a 
DEAE- Sepharose CL-6B anion exchange column. The putative reductase 
containing fractions, which (as described previously [Smith et al., 2002]) gave a 
peak at 0.35 M NaCl, were pooled together and then concentrated by 
ultrafiltration with an XM50, 10-kDa molecular mass cut-off membrane 
(Millipore-Amicon). The concentrated sample was then further purified by using 
a Superdex 75 gel filtration column. A possible protein peak was observed in 
the elution trace (Figure  3.7), but no band could be detected for these samples 
in SDS-PAGE (Figure 3.2).  In an attempt to improve detection of the protein, 
samples eluted from the gel filtration column were concentrated with a 10 kDa 
cut-off membrane. SDS-PAGE of the concentrated samples did not reveal any 
bands after Coomassie staining. Silver staining method, which can detect a very 
low amount of protein, showed a number of bands which may reflect the 
degradation of reductase into small fragments during the purification procedure 
(data not shown). 
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Figure  3.7    Purification of protein C in gel filtration column (Superdex 75).  
The reductase was initially loaded onto the DEAE anion exchange column and the putative eluted 
reductase was concentrated using a 10 kDa cut-off membrane. The concentrated sample was loaded onto 
a Superdex 75 column (trace shown above). Blue trace: represents the absorbance at a wavelength 280 
nm showing the elution of the protein from the column, brown trace: electrical conductivity showing the 
elution of the NaCl present in the loaded sample.  
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3.5.3.1 NADH oxidase activity 
 
It has been found previously that the sMMO reductase shows NADH oxidase 
activity, which can be used to assay the reductase in the absence of the other 
sMMO components (Lund et al., 1985).  The NADH oxidase activity of the 
putative reductase was tested in the presence of cytochrome c as the electron 
acceptor. The amount of putative reductase was measured by using Bradford 
reagent with BSA as standard. The concentration of the putative reductase was 
0.10 mg ml -1. The result of the NADH oxidase assay showed that NADH was 
oxidized by the reductase to shuttle electrons to cytochrome c without presence 
of substrate such as propylene. The rate of NADH oxidation was found 1.27 
nmol min-1 (mg of reductase)-1.  
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3.6   Enzyme activity 
 
3.6.1   Growth of mutant F282L 
 
Since the purification of the wild type reductase protein was irreproducible in the 
present study, an alternative method was used to test mutated His-tagged 
MMOH. Soluble extract containing protein B, reductase and the inactive F282L 
hydroxylase was used in place of purified protein B and reductase.  The mutant 
F282L was constructed in a previous mutagenesis study in this research group. 
The hydroxylase of this mutant was inactive even though it is expressed when 
the Cu to the biomass ratio was low. F282L was grown in a large batch in 
fermentor as described in the Materials and Methods Chapter. The OD600 was 
measured at intervals.  The cells were harvested when the growth rate began to 
slow down, which may represent the point at which production of the inactive 
sMMO began and the bacteria stopped using the pMMO enzyme to gain their 
carbon and energy. The presence of MMOH for F282L was further confirmed by 
SDS-PAGE and the cells then were kept at -80oC (Figure  3.8). Soluble extract 
was obtained as described in Materials and Methods Chapter.  
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Figure  3.8  SDS-PAGE for soluble extract and purified His-tagged hydroxylase 
subunits from mutant F282L. 
M= SeeBlue® plus2 pre-stained protein marker (Invitrogen),  
lane 1=soluble extract containing His-tagged wild type hydroxylase showing the three 
 hydroxylase subunits which was used as a control, lane 2= His-tagged F282L soluble extract 
obtained via the same procedure used for the His-tagged wild type in lane 1, lanes 3 and 4= 10 
and β0 μl respectively of the purified His-tagged hydroxylase preparation from affinity  
chromatography. The three subunits of the hydroxylase are indicated. 
 Samples were run on SDS-12%PAGE.   
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3.6.2 Propylene assay for soluble extract 
 
3.6.2.1 Propylene assay by solvent extraction 
 
 
To confirm the activity of the wild type with His-tagged hydroxylase in whole 
cells, naphthalene was used as a substrate. After being positive for the 
naphthalene test, whole cells were tested towards propylene. CCl4 was used to 
extract the propylene oxide as a product from the mixture which showed a peak 
at a retention time 3.27 minutes for the whole cell of the wild type with His-tag 
compared to the negative control (Figure  3.9 A). The rest of the cells were then 
broken by French press to obtain cell free soluble extract. A propylene assay 
was run for the soluble extract alone (Figure  3.9 B).  The His-tagged wild-type 
MMOH was then purified from the soluble extract by using His-tag affinity 
column and soluble extract from mutant F282L was used as a source for protein 
B and C in an sMMO assay using propylene as the substrate.   The propylene 
assay was performed for His-tagged MMOH under various conditions: mixture 
of MMOH with protein B, C and propylene at time zero, mixture of MMOH, 
proteins B, C and NADH without propylene, F282L soluble extract with 
propylene, and finally for wild-type purified His-tagged MMOH.  Except for the 
time zero control, all assays were incubated for 20 minutes. The wild-type His-
tagged MMOH with F282L soluble extract (at t = 20 min) showed a peak at 
retention time about 3.25-3.27 min, corresponding to propylene oxide.  None of 
the other assays showed a peak at this retention time.  All experiments were 
run alongside negative controls. The retention time for propylene oxide was 
compared to standard of pure propylene oxide. 
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Figure  3.9 GC traces showing the activity of the whole cells and soluble extract 
containing the wild type His-tagged hydroxylase toward propylene.  
A: Whole cells. The peak corresponding to the propylene oxide product is indicated by an arrow at 
retention time (RT) 3.27 minutes (black line) compared to the whole cells without propylene as a 
negative control (red line). 
B: Soluble extract.  The peak corresponding to the propylene oxide product was smaller than that 
obtained with whole cells and is indicated by an arrow at retention time (RT) 3.27 minutes (black 
line) compared to the soluble extract without propylene as a negative control (red line). 
min
min
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3.6.2.2 Propylene assay by using Solid Phase Microextraction  
        (SPME) 
 
 
Propylene assay was also performed by using the solventless method called 
solid phase microextraction (SPME). For these assays, protein B and C were 
supplied by adding soluble extract from F282L mutant and the hydroxylase was 
the purified His-tagged form. GC analysis after SPME of the products revealed 
a peak at the retention time of propylene oxide after incubation with propylene 
gas for 20 min (Figure3.10 A). This was compared to an authentic standard of 
propylene oxide, whereas there was no peak corresponding to propylene oxide 
from F282L soluble extract with NADH and propylene gas without His-tagged 
hydroxylase (Figure 3.10 B), His-tagged MMOH and F282L soluble extract and 
propylene oxide without NADH (Figure 3.10 C). Also a mixture of wild type His-
tagged MMOH, F282L, NADH and propylene gas at time zero comparing to the 
same mixture after 20 minutes, all compared with different negative controls 
(Figure 3.10 D). It is now suggested that the affinity-purified hydroxylase is 
active by combining it with the other two components of sMMO and assessing it 
has similar monooxygenase activity to the native enzyme.  
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Propylene oxidation assay for affinity purified His-tagged wild type hydroxylase. The assay 
also contained F282L soluble extract as a source of protein B and C, NADH and 2 ml 
propylene gas. The GC trace shows a peak of propylene oxide indicated by arrow (black 
trace) which has the same RT 3.40-3.50 minutes as authentic sample of propylene oxide 
(data not shown). The red trace represents the negative control without propylene. This trace 
shows no peak corresponding to propylene oxide. 
Control to show that F282L soluble extract has no activity without addition of purified wild type 
His-tagged hydroxylase. A control assay was set up the same as the assay in A except that 
the purified wild type His-tagged hydroxylase was omitted. This gave no peak corresponding 
to propylene oxide (red line). A parallel positive control assay containing all the reaction 
components gave a peak that could be assigned to the propylene oxide product (black line). 
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Figure  3.10 Propylene assay by using Solid phase microextraction (SPME) under 
 various conditions. 
A: Full assay with negative control lacking propylene.  
B: Control to show that the F282L soluble extract does not have a hydroxylase activity. 
C: Control to show that the reaction requierd NADH. 
D: Control to show that the amount of propylene oxide increases with reaction time.  
Control to show that added NADH is necessary for the reaction. A control assay was set up 
the same as the assay in A except that NADH was omitted. This gave no peak 
corresponding to propylene oxide (red line). A parallel positive control assay containing all 
the reaction components gave a peak that could be assigned to the propylene oxide product 
(black line). 
The amount of propylene oxide was increased by the increasing the time of reaction. Two 
identical assays were set up containing all reaction components as in A.Product from one 
reaction (black line) were analysed at t=0 whereas those from the other assay (red line) were 
analysed after a reaction time of 20 minutes. 
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3.7 Discussion  
 
The purification of the hydroxylase component of sMMO, which is a prerequisite 
for detailed enzymological studies and many practical applications, is 
challenging because of the large size of the protein (250 kDa) and the fact that 
multiple chromatographic steps must be used (Pilkington & Dalton, 1990; Fox et 
al., 1989; Smith et al., 2002).  The genetic manipulation of the hydroxylase to 
introduce an affinity tag to facilitate purification is also challenging because the 
genetic system needed to express the hydroxylase in active form requires the 
genetic manipulation of methane-oxidising bacteria, for which genetic systems 
are still rather cumbersome (Borodina et al., 2007; Smith and Murrell 2011).  As 
part of a previous project (Lock et al., manuscript in preparation), a 6His tag 
was added to the beta subunit of sMMO and introduced into the methanotroph 
expression system.  The activity of sMMO in whole cells confirmed that the tag 
did not prevent catalysis or the functionality necessary for interactions of the 
hydroxylase with the other component of sMMO. During the current study, the 
affinity purification of the 6His tagged hydroxylase has been optimised.   
In order to determine whether the His-tag system afforded a workable 
expression system for preparation of pure and active hydroxylase, the affinity-
purified His-tagged hdroxylase was tested in sMMO activityt assays in the 
presence of the other sMMO components and using propene as a substrate.  
The result in the present study revealed that the hydroxylase, with the His-tag 
inserted in the ȕ-subunit, was active when it was purified by using an affinity 
column. The remaining components of sMMO, protein B (the coupling/gating 
protein) and protein C (the reductase) are known to be active when expressed 
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in E. coli (Lloyd et al., 1997; West et al., 1992).  Affinity purification of protein B 
from a GST-fusion construct (Smith et al., 2002) has already been achieved 
during the current project.  Affinity purification of protein C had not been 
attempted previously.  During the current project a number of attempts to purify 
it using the GST system have been ineffective and so a His-tag fusion system is 
currently under investigation. Also attempts to express active His-tagged 
reductase were not reproducible and need to be furtherinvestigated. 
 
In a previous work by Smith's group, it has been found that mutant F282L 
contains inactive hydroxylase which motivated us to use this mutant as a source 
for protein B and C in the present study, as long as protein C purification was 
not available, to test the protein activity. The propylene oxidation assay was 
performed to detect the activity of the purified His-tagged wild type hydroxylase 
with the F282L soluble extract to provide the protein B and C components. 
Propylene oxide was extracted by solvent carbon tetrachloride (CCl4) which 
some batches showed for some instance another peak with the same retention 
time as the propylene oxide. Many other solvents (up to 12 solvents) were 
investigated for product extraction; all of the tested solvents had a peak in the 
same retention time for propylene oxide. Propylene oxidation method was 
swapped with solventless solid phase microextraction (SPME) method that 
revealed a clear and sharp peak of propylene oxide compared to the negative 
control and other method. The investigated sample needs to be warm on hot 
plate and most researchers prefer warming with shaking to allow evaporation of 
the product which will be adsorb by the fibre in the SPME apparatus, then the 
needle will inject into GC and analysed. Due to the uncontrolled conditions in 
this method during the warming on hot plate which led to different results, 
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optimization is useful in developing this method in future for propylene assay 
especially for few number of samples. 
 
During the current project, several mutants have been introduced into the His-
tag expression system with a view toward purifying and characterising them 
when the system has been implemented with the wild-type enzyme. The 
purification of these hydroxylases does not need go through anion exchange 
chromatography. Also, the fact that it has been shown in the present study that 
the active recombinant His-tagged hydroxylase can be purified by means of 
affinity chromatography suggests that the His-tag system will offer an improved 
way to purifiy mutant and wild-type hydroxylase in future.  
 
Pure protein is needed to test the hypothesis behind the mutation of the wild 
type, because methane oxidation assays are unsatisfactory in whole-cell 
methanotroph systems due to the presence of particulate form of MMO (actually 
a completely different enzyme from sMMO), which is able to oxidise methane. 
Also, the methanol produced from methane oxidation by either sMMO or pMMO 
is removed by methanol dehydrogenase, the next enzyme after MMO in the 
methane oxidation pathway in methanotrophs. However, a new method to test 
sMMO directly by adding inhibitors to pMMO is under development (will be 
more discussed in next chapters) 
 
It is also anticipated that the affinity purification system under development 
currently in large scale (10 ml column since the column used in the present 
study can purify only 600 μl of the His-tagged hydroxylase) will be valuable in 
characterising and testing additional mutants of sMMO in the future. 
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Chapter 4: The role of C151 
4 Investigating the role of Cysteine 151 in‎ MMOH‎ α-
subunit in providing free radicals during the 
catalytic cycle of sMMO 
 
4.1 Introduction 
 
As mentioned previously, the diiron centre of the active site is buried deeply in 
the α-subunit of the hydroxylase where the methane and other substrates can 
be oxidized (Rosenzweig et al., 1997; Cardy et al., 1991). This diiron centre is 
ligated with four glutamates, two histidines and surrounded by a number of 
amino acids with hydrophobic residues forming a hydrophobic cavity on the way 
of the substrate to the diiron centre (Elango et al., 1997). Like the MMO, the 
cytochrome P-450 monooxygenase enzyme can oxidize very kinetically 
unreactive C-H bonds. During the oxidation, they both activate oxygen as a 
substrate to produce a water molecule and a high valent iron compound which 
catalyses breakage of the inert C-H bonds (Ortiz de Montellano, 1986; McMurry 
& Groves, 1986; Lipscomb, 1994). In the cytochrome P-450 enzyme, the 
cleavage of the O-O bond happens with the aid of a non-ligating residue which 
transfers a proton to the active site. The similarity of MMO to Cytochrome P-450 
has led to the suggestion by Fox’s group (Fox et al., 1989; Fox et al.,1991) that 
the same mechanism operates and the only non-ligating residues that may be 
implicated in formation a hydrogen bond to provide a proton, are Cys151 and 
Thr213 (Figure ‎4.1). In addition to the roles of protein B which have been 
explained previously, before formation a complex with MMOH, Glu240 and 
Asp214 in MMOH both are occupied with water or a hydronium ion in a 
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hydrogen bond and in a position to allow free passage of solvent through to the 
active site. During the formation of the complex between protein B and the 
hydroxylase in the sMMO, the Glu240 carboxylate side chain undergoes a 
conformational change to make a hydrogen bond with the Thr213 hydroxyl 
group. Consequently, the change at Glu240 may result in proton delivery to 
active site of the sMMO (Lee et al., 1999; Tinberg et al., 2009; Lee et al., 2013). 
 
 
 
Figure  4.1 The position of Cys151 and Thr213 near the diiron centre of 
sMMO where the proposed binding site for methane and other substrates 
lies. 
The diiron centre is in silver/grey, and the bound methane molecule is shown in blue     
(George et al., 1996). 
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4.1.1 Residues corresponding to Thr 213 and Cys 151 in other 
diiron enzymes 
 
 
In a compartive study between MMO and ribonucleotide reductase (RNR), 
Nordlund et al. (1992) found that the area around the diiron active site centre is 
similar in both and the corresponding residue to Cys151 in sMMO is Tyr122 in 
RNR. It has been proved that tyrosine 122 provides a stable tyrosyl radical with 
a critical role in initiating the reaction of reduction of ribonucleotides to 
deoxyribonucleotides by ribonucleotide reductase (Sjöberg, 1997). This result 
led to the suggestion of a similar role to Tyr122 for Cys151 in sMMO in possibly 
providing a cysteinyl radical during the oxidation cycle of sMMO (Nordlund et 
al., 1992; Rosenzweig et al., 1993; Feig et al., 1994).  Cys151 is conserved in 
all well studied sMMO enzymes (Smith et al., 2002). The amino acid equivalent 
to Cys151 in alkene monooxygenase is glutamate or aspartate (Saeki and 
Furuhashi, 1994; Zhou et al., 1999) and leucine in stearoyl-ACP desaturases. 
The monooxygenases that have glutamine in the same position as Cys151, 
such as toluene ortho-monooxygenase, are capable of oxidation of aromatic 
hydrocarbons, which may suggest that Cys151 has another role or may have 
not essential role in this site (Elango et al., 1997). The amino acid Thr in 
position β1γ of the α-subunit of sMMO is the same in all known soluble 
monooxygenase enzymes with a diiron centre (SDIMOs) (Johnson and Olsen 
1995; Zhou et al., 1999). Substituting the amino acids Cys151, Thr213 and 
Ile217 around the active site in sMMO with long side chain amino acid such as 
Tyr122, Phe208 and Phe212 as in ribonucleotide reductase may make the 
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sMMO enzyme accommodate smaller substrates than it does as it has been 
proposed by Green and Dalton (1989). 
 
4.1.2 Mutagenesis of residues Cys151 and Thr213 
 
Thr213 and its equivalents in related enzymes have been implicated in 
providing a proton to the active site via hydrogen bond forming during the 
monooxygenase oxidation reaction cycle (Elango et al., 1997; Rosenzweig et 
al., 1993). In addition, the position of Thr213 in a -turn in an α-helix in both 
sMMO and cytochrome P-450 makes it a candidate in controlling the 
conformation of the active site of the enzymes (Raag et al., 1991). Replacement 
of Thr by Ala in cytochrome P-450 via site- directed mutagenesis completely 
disrupted the conformation of the enzyme. However, this result may not be 
sufficient to determine the exact role of this residue because it is not clear 
whether the mutation affects the conformation of the enzyme, or catalytic cycle, 
or maybe both (Raag et al., 1991). A similar result was obtained from a study by 
Smith et al., (2002), when Thr 213 in sMMO was substituted with Ala, and no 
sMMO components of the mutant enzyme could be seen in SDS-PAGE 
indicating that the enzyme was destabilized and possibly inactivated by the 
mutation. However, the mutation of Thr213 to Ser yielded a mutant with activity 
towards naphthalene and the SDS-PAGE verified the presence of stable sMMO 
components that were purified subsequently by the same method applied for 
the wild type sMMO. The alteration of Thr β1γ to Ala removed the OȖ functional 
group whereas changing Thrβ1γ to Ser conserved the OȖ group. The fact that 
the presence of the OȖ correlated with the presence of sMMO activity indicates 
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a critical role of OȖ in the structure and possibly also for activity of the enzyme 
(Smith et al., 2002). In the same study, Cys151 was replaced by glutamate via 
site-directed mutagenesis (as in alkene monooxygenase in Rhodococcus 
rhodochrous). Also, Cys151 was changed to tyrosine (as in ribonucleotide 
reductase). The new mutant C151Y was naphthalene negative and no sMMO 
components could be detected in SDS-PAGE, indicating a low level or unstable 
sMMO production. C151E, unlike C151Y, gave a strong naphthalene positive 
result with whole cells. However, the C151E strain did not show detectable 
sMMO subunits in the SDS-PAGE of the mutant soluble extract. Even though 
converting the Cys to Glu conserved the activity towards naphthalene, 
producing a free radical from glutamate is considered impossible due to the 
self-decarboxylation of the glutamyl radical (Nonhebel et al., 1979). In a study at 
the corresponding position in toluene monooxygenase substitution of Gln141 
with Cys (as in sMMO) showed that it preserved its activity (Pikus et al., 1997). 
Although tyrosine has been shown to produce a free radical in ribonucleotide 
reductase (RNR) (which is not a monooxygenase) (Sjöberg, 1997), converting 
Cys151 in sMMO to tyrosine like RNR diminished its activity which may be due 
wholly or partially to instability of sMMO (Smith et al. 2002). As such one of the 
mutants (C151Y E114D) in the present study was designed and constructed in 
order to stabilize the hydroxylase subunits in the unstable C151Y mutant of 
sMMO. 
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4.2 Investigation of mutant‎C151S‎in‎the‎α-subunit of sMMO 
 
As mentioned in the previous paragraph, the two mutants C151Y and C151E 
were well investigated by Smith et al. (2002). Another mutant C151S has been 
constructed by Smith and co-workers at University of Warwick previously. The 
mutant C151S was designed to probe the role of the cysteine residue at this 
position in providing a free radical or affecting the conformation and activity of 
the sMMO especially in accommodating large di- and tri-aromatic substrates. 
This mutant was constructed within pTJS175 and then transferred into the new 
expression system pT2MLY that contains a His-affinity tag in the ȕ-subunit of 
the sMMO hydroxylase as mentioned in the Materials and Methods Chapter. 
Converting the amino acid Cys151 (which was implicated in providing a 
cysteinyl radical) from the thiol group (SH) into the amino acid serine with a 
hydroxyl group was based on the rationale that a hydroxyl residue could not 
provide any free radical (Nonhebel et al., 1979) and would abolish the enzyme 
activity if a free radical at this position was essential. After the mutant was 
expressed in the new system it was shown to be naphthalene positive and was 
then tested with a number of mono-aromatic compounds namely toluene, ethyl 
benzene and mesitylene and di-aromatics namely naphthalene and biphenyl, 
since these compounds are only oxidized by sMMO and not by pMMO. Also 
mutant C151S  was tested with the tri-aromatic compounds anthracene and 
phenanthrene that up to date have not been shown to be oxidized by the wild 
type or any of previous mutants such as mutants L110G, L110C, L110Y and 
L110R (Borodina et al., 2007). These tests were performed in comparison to the 
wild type Methylosinus trichosporium OB3b and wild type sMMO with the new 
His-tag expression system. 
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4.3   Site-directed mutagenesis 
 
Investigation of the specific role of different amino acids in sMMO can be 
achieved by site-directed mutagenesis. In the past, site-directed mutagenesis 
for sMMO was inapplicable owing to many reasons such as the lack of suitable 
host for protein expression (Borodina et al., 2007). Many attempts to overcome 
this problem were made, hence West et al., (1992) succeeded in expressing 
both protein B and C in an heterologous system, E. coli, whereas the 
hydroxylase could not be manipulated in such  a system. Martin and Murrell 
(1995) were able to create the first homologous expression system by using a 
marker-exchange technique. In this method, part of mmoX gene was knocked-
out and replaced with a kanamycin resistance cassette. The resulting sMMO- 
strain was named mutant F. Although it needs a long time and many 
manipulation steps, a similar technique had been used successfully by Khalifa, 
(2012) to create mutants in both Ms. trichosporium and Mc. capsulatus. Lloyd et 
al. (1999) developed a homologous system by complementation of mutant F 
with a broad host range plasmid harbouring the sMMO encoding genes with the 
native promoter. The resulting mutant was able to grow at high copper 
concentration with high sMMO activity that was comparable to the wild type. 
This system has been developed by Smith et al., (2002) who used mutant F 
with a new vector system. The new system, created by site-directed 
mutagenesis, enabled this group to mutate some of the amino acids in the 
mmoX gene that encode α-subunit of MMOH. This system was tested by 
mutagenesis of Thr213 and Cys151 which are the only hydrophilic amino acids 
around the active site that were implicated in providing a proton during the 
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oxidizing cycle of methane and other substrates at the diiron site (further details 
about these residues will be provided later on in this Chapter). The inflexibility 
and limitation of this system in mutagenesis of other amino acids in the sMMO 
components rather than the part of MmoX encoded by the sequence deleted 
from mutant F led to development of a more tractable and efficient system by 
Borodina et al. (2007). This study created a new strain that was named SMDM 
(Soluble Methane monooxygenase Deleted Mutant). SMDM is an OB3b strain 
from which a large part from the sMMO operon has been deleted to make this 
system more amenable and give more opportunities to investigate other 
residues in the mmoXYBZD genes (Figure ‎4.2). The system was validated by 
investigation of the role of Leu110 which was a candidate gate for substrate 
entry to the sMMO active site owing to its position close to the di-iron centre 
revealed by crystallographic studies (Rosenzweig et al., 1997, Borodina et al., 
2007). 
 
 
 
Figure  4.2  Diagram explaining the order of the genes mmoXYBZDC in  
the sMMO operon, the protein that each encodes and the part of the 
operon that was deleted to create the sMMO minus strains mutant F and 
SMDM.  
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A new expression system pT2ML was developed by Nichol (2011) based on the 
previous system (Smith et al., 2002). Two unwanted BamHI sites and one NdeI 
site were removed from pTJS140 in two steps by overlap PCR to produce 
plasmid pTN2. 516 bp was then removed from the mmoX gene in pTJS175 by 
PstI restriction sites to yield pDIDI, which was carried out in the same research 
group by Dr. M. Lock (Sheffield Hallam University). The sMMO operon was then 
cloned into pTN2 to produce pT2ML with inactive sMMO. A His-tag was then 
inserted into the end of the ȕ-subunit to produce the new expression system 
pT2MLY. 
In the present study, site-directed mutagenesis by overlapping PCR and using 
the new expression system pT2MLY were used to create new mutants. These 
techniques were used to introduce point mutations into the mmoX gene which 
was then transformed into E. coli S17.1. E. coli S17.1 with the mutated plasmid 
was then conjugated into the SMDM strain which resulted in constructing new 
mutant sMMO expressing strains. 
 
4.3.1 Characterization and naphthalene test for C151S 
 
In order to confirm the presence of the C151S mutant gene which is constructed 
before this study by site-directed mutagenesis (T.J. Smith personal 
comminication), the mmoX gene that encodes the α-subunit of the sMMO 
hydroxylase with the desired mutation was amplified from the engineered 
methanotroph strain and sequenced as follows; PCR was run by  using mmoX-
specific primers (two primers; mmoX- p1 (forward) and mmoX- p4 (reverse) 
were designed to cover most of mmoX gene) with total DNA from SMDM 
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pT2MLY C151S as the template alongside Ms. trichosporium OB3b, and Ms. 
trichosporium wild type with His-tagged hydroxylase (SMDM pT2MLY wt.) which 
is identical to C151S apart from  the point mutation in codon 151. PCR products 
for positive samples were re-amplified and BSA was used to remove any 
inhibiting substances which might occur in the PCR amplification to obtain a 
clear band representing a sufficient amount of the gene for sequencing 
(Figure ‎4.3). 
 
 
 
Figure ‎4.3 mmoX gene detection by PCR for the M. trichosporium parental 
strain OB3b, wild type with His-tagged hydroxylase, and mutants C151S and 
R98L. 
M= DNA ladder, lane 1= mmoX gene from OB3b, lane 2= mmoX gene from the wild type with 
His-tagged hydroxylase, lane 3= mmoX gene from mutant C151S, lane 4= mutant R98L, lane 
5= pTJS175 which contains the sMMO operon (positive control), and lane 6= d.w. (no template 
negative control). The approximate size of the mmoX gene PCR product is 1650 bp. 
 A 1% agarose gel was used in this experiment. 
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DNA was sequenced for the whole of the PCR product of the cloned mutant 
gene by using four primers to cover the gene; mmoX-specific primers and 
mmoX mutant primers (two primers were designed to cover the mutation in the 
area around the active site). The sequenced PCR product was then aligned with 
the wild type OB3b and wild type with His-tagged hydroxylase by performing a 
DNA BLAST search provided by the National Centre for Biotechnology 
Information Service (NCBI) (http://www.ncbi.nlm.nih.gov/). This showed that 
there were two mutations in the C151S mutant gene, one in codon 145 which is 
silent because it affects only the third (wobble) position of an Ile codon, while 
the mutation in codon 151 showed conversion of Cys to Ser (Figure ‎4.4).  The 
second mutation was also made to change the restriction pattern of the gene to 
help in identify the mutant without sequencing. 
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Figure ‎4.4 mmoX gene sequencing for mutant C151S compared to the parental 
wild type OB3b and wild type with His-tagged hydroxylase (WT). 
The red colour shows a silent mutation at the position encoding amino acid 145 to remove a 
restriction enzyme site. The orange colour shows the mutanted amino acid Cys to Ser at 151. 
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4.4 Investigating the role of C151S in oxidation of aromatic 
compounds 
 
4.4.1 The C151S mutant showed regioselectivity in oxidation of the 
monoaromatic hydrocarbon toluene 
 
 
The four expected products from oxidation of toluene are benzyl alcohol, p-
cresol, m-cresol, and o-cresol. Unlike many studies which showed that the main 
product from toluene oxidation by the parental wild-type strain Ms. 
trichosporium OB3b is benzyl alcohol, in the present study strain OB3b was 
found to oxidize toluene with the main product o-cresol (96.70%) followed by p-
cresol (3.28%), and m-cresol (0.01%). The whole cells assay of mutant C151S 
revealed some alteration in regioselectivity by yielding different product percent 
from both the OB3b and wt. with His-tagged hydroxylase represented by o-
cresol as a main product with percentage 99.99% and p-cresol (0.01%) with no 
m-cresol whereas wild type with His-tagged hydroxylase showed comparable 
products to OB3b (p-cresol, 2.33% and m-cresol 0.02%) as shown in (Table 
4.1). After correction for differences of cell density, no statistically significant 
difference was observed in the amount of m-cresol produced by the mutant 
compared with the wild type OB3b (p>0.05). However, there was a significant 
difference in the amount of p-cresol and o-cresol produced between the C151S 
mutant and His-tagged wild type by using Kruskal-Wallis test (Conover-Inman) 
with (p<0.05) and (p<0.01) respectively (Figure 4.5). Also, there was a 
significant difference in p-cresol produced by C151S compared to OB3b 
(p<0.05). 
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Table ‎4.1   Products distribution percent of toluene oxidation by C151S. 
 
 
 
 
 
 
 
The distribution of the products is shown as a percentage of the total products obtained from 
triplicate technical samples, i.e. three separate aliquots were taken from the same batch of 
fermentor grown bacteria for each strain. ND indicates no detectable product. The extracted 
products were analysed by GC-MS and mass spectra of the products were compared with 
those of authentic standards and the NIST (National Institute for Standards and Technology) list 
in the software that controls the GC-MS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strains 
Product percentage % 
 
 
 
 
 
 
p-cresol 
 
 
o-cresol 
 
 
 
 
 
m-cresol 
 
 
 OB3b 3.28% 96.70% 0.01% 
 wt his-tag 2.33% 97.64% 0.02% 
 C151S 0.01% 99.99% ND 
 
 
OH OH 
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Figure  4.5 Statistical anaylsis of the toluene oxidation products (p-, o- and m-
cresol) data for mutant C151S, OB3b and wild type with. His-tagged hydroxylase.  
Statistical anaylsis was performed by applying the Kruskal-Wallis test (Conover-
Inman). 
Data from triplicate technical samples were obtained from injection and analysis of 1 μl sample of 
extracted product by using GC-MS. The amounts of product are expressed in terms of the peak 
areas obtained from GC-MS.  
Data presented as (Mean± S.E.M), statistical analysis: Kruskal-Wallis test (Conover-Inman). 
* Significant at P<0.05. 
** Significant at P<0.01. 
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4.4.2 Oxidation of ethyl benzene by C151S yields regiospecific 
products different from OB3b and His-tag wt.  
 
The oxidation of ethyl benzene has been found to produce different products 
depending on the strain is being tested (Nichol, 2011). In the present study 
when the 4-ethyl benzene was oxidized by wild type OB3b, four products were 
seen with 4-ethyl phenol being the main product (84.54%) followed by 1-phenyl 
ethanol, 4-methylbenzaldehyde, and phenyl methyl ketone with 9.81%, 4.04% 
and 1.59% abundance respectively (Table ‎4.2). Testing the wild type with His-
tagged hydroxylase in this assay resulted in production of ethyl phenol with 
highest percentage abundance (72.63%) among the four products; 4-
methylbenzaldehyde and 1-phenyl ethanol came after ethyl phenol with nearly 
comparable amount 13.78% and 13.57% respectively. No phenyl methyl ketone 
was detected among the products of the reaction catalysed by the wild type 
recombinant with His-tag. However, when C151S was investigated toward ethyl 
benzene, it produced only ethyl phenol and 1-phenyl ethanol with 81.57% and 
18.42% abundance respectively (Table ‎4.2). No 4-methylbenzaldehyde or 
phenyl methyl ketone was detected as a product from ethyl benzene oxidation 
by mutant C151S. There was no significant difference between OB3b with wt. 
with His-tag MMOH and C151S for all four products (4-ethyl phenol, 1-phenyl 
ethanol, 4-methylbenzaldehyde and phenyl methyl keton) when it was 
compared statistically by using one Kruskal-wallis (Conover-Inam) test 
(Figure  4.6).  
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Table ‎4.2 Distribution of products from oxidation of the monoaromatic ethyl benzene by parental methanotrophs OB3b, His-tag wild type 
and mutant C151S. 
 
 
 
ND refers to non-detectable product peak in GC-MS. Compounds were compared to the NIST list in the GC-MS.. The assay was performed for triplicate 
 technical samples from the same batch of frozen cells of each strain. The relative activity was obtained by  
comparing the activity of the wild type with His-tag hydroxylase and the mutant to the parental wild type OB3b,  which was considered to have 100% activity. 
  
 
 
 
Strain 
Product distribution percentage % Relative activity percentage % 
 
1-phenyl ethanol 
 
 
Phenyl methyl 
ketone 
 
4-methylbenzaldehyde 
 
4-ethyl 
phenol 
 
1-phenyl 
ethanol 
 
4-methylbenzaldehyde 4-ethyl phenol 
 
OB3b 9.81% 1.59% 4.04% 84.54% 100% 100% 100% 
His-tag wt 13.57% ND 13.78% 72.63% 13.59% 42.8% 8.6% 
C151S 18.42% ND ND 81.57% 51.35% ND 26.99% 
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Figure  4.6 Comparing the raw data for products obtained from ethyl benzene oxidation by 
mutant C151S, the parental wild type OB3b and wild type with His-tag showing no 
significant difference between them at p<0.05. 
The significance of the results was calculated for the data of each product (peak area for each product). 
Data were obtained via analysing 1μl of the extraction from each assay via GC-MS. Assays were performed 
for triplicate technical samples. 
Data presented as (Mean± S.E.M), statistical analysis: Kruskal-Wallis test (Conover-Inman). 
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4.4.3 Oxidation and product distribution from naphthalene by 
C151S 
 
The C151S mutant showed as strong naphthalene positive in both plate and 
liquid methods. To evaluate the production of naphthol and the regioselectivity 
of the enzyme, 5 ml culture of mutant cells were tested towards naphthalene for 
48 h as detailed in the Materials and Methods Chapter. The product which was 
then analysed by GC-MS after being extracted with diethyl ether, revealed that 
the products from naphthalene oxidation were 1-naphthol (83.08%) and 2-
naphthol (16.91%) (Figure ‎4.7, Table ‎4.3). This result was similar to the result 
obtained from wild type OB3b and not greatly different from the wild type with 
His-tagged hydroxylase which showed slightly more 1-naphthol (57.64%) than 
2-naphthol (42.35%). No change in regioselectivity was observed for the C151S 
mutant compared to the wild type with His-tag or parental wild type OB3b. Also 
no new unexpected products were detected for this mutant. There was no 
statistically significant difference observed at level p<0.05 when compared to 
the product distribution of OB3b with C151S or between wild type with His-
tagged hydroxylase with C151S by using Kruskal-Wallis (Conover-Inman) test. 
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Table  4.3 Distribution of products 1-naphthol and 2-naphthol from naphthalene 
oxidation by mutant C151S. 
 
strain Product percentage % Relative total activity % 
1-naphthol 2-naphthol 1-naphthol 2-naphthol 
OB3b 85.23% 14.76% 100% 100% 
His-tag wt. 57.64% 42.35% 233.66% 265.91% 
C151S 83.08% 16.91% 55.94% 81.07 % 
 
Naphthalene oxidation assays were performed for triplicate technical samples from the same 
bacterial fermentor batch for each strain. The retention times for the products peaks were 
compared with authentic standard peaks for 1-naphthol and 2-naphthol. Relative total activities 
were calculated for mutant C151S compared to the parental wild type OB3b which is considered 
as 100% activity. 
 
 
   
                   
 
Figure  4.7 Product distribution percentages from naphthalene oxidation by 
mutant C151S. 
The percentage activity was calculated from three technical replicate samples from the same 
bacterial batch of each strain harvested from cells grown in the fermentor. The figure shows the 
same product distribution information presented in table 4.3 above. 
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4.4.4 C151S showed no detectable activity toward mono-aromatic 
mesitylene, the di-aromatic hydrocarbon biphenyl, and tri-
aromatics anthracene and phenanthrene 
 
Mutant C151S was also tested toward a monoaromatic compound with three 
side chains, 1, 3, 5-trimethyl benzene (mesitylene), and the di-aromatic 
compound biphenyl. The mutant C151S was shown not to have activity towards 
these substrates since measurable peaks could not be detected by using GC-
MS. The biphenyl oxidation experiment was repeated with different incubation 
times,  48 h, 72 h, and 96 h, for the mutant C151S and also for the wild type 
OB3b and the wild type with His-tagged hydroxylase. Also mutant C151S was 
investigated to assay its ability to oxidize the tri-aromatic compounds such as 
anthracene and phenanthrene which to date have not been oxidized by OB3b 
or its mutants. Neither C151S nor OB3b nor wild type with His-tagged 
hydroxylase could oxidize either anthracene or phenanthrene after incubation 
for 48 h at 30oC according to the results obtained from GC-MS.   
 
4.4.5 Propylene oxidation assay for the C151S mutant showed the 
production of propylene oxide 
 
The propylene assay was performed for the soluble extract from the wild type 
with His-tagged hydroxylase as mentioned in the previous Chapter and it 
showed a detectable activity towards propylene. Due to the sensitivity of the 
  161 
 
sMMO in the soluble extract to inactivation by various conditions, the propylene 
assay was performed for C151S in a whole cell suspension. The whole cell 
propylene oxidation assay was based on results from experiments that were 
done by Dr. Tim Nichol (member in Smith's group in BMRC), who used DTT as 
an inhibitor for pMMO in whole cells of the SMDM mutant (SMDM can grow on 
methane by using pMMO since it is OB3b of which a large part from sMMO has 
been deleted). The result revealed that using 5 mM DTT inhibited the activity of 
pMMO from SMDM whole cells towards propylene since no activity could be 
detected for this mutant compared to the SMDM without DTT (data not shown). 
Following this result, the propylene assay was performed for the C151S whole 
cells by using 5 mM DTT as inhibitor for pMMO. Any detected activity could 
then be attributed to sMMO activity. The mutant C151S showed an activity 
toward propylene, since there was a peak corresponding to propylene oxide, 
which appeared at the same retention time to an authentic standard of pure 
propylene oxide, when the extract were run on the GC (Figure ‎4.8). Product 
from a propylene assay was also analysed by GC-MS which showed a peak at 
the retention time 1.665 min, which was the same as for the pure propylene 
oxide and also was confirmed by comparison of the spectrum to the NIST list in 
the GC-MS. The activity was measured from the GC-MS data and compared 
with a standard curve of propylene oxide. Whole cells of C151S mutant were 
able to produce propylene oxide at 1251 nmol-1 min-1 ml-1, compared with 1825 
nmol-1 min-1 ml-1 for whole cell of the wild type OB3b and 600 nmol-1 min-1 ml-1 
for the wild type with His-tagged hydroxylase. All assays were conducted in 
triplicate with the same batch of cells from each strain; the activities were 
corrected to a cell suspension OD600 of 5.. The activity for mutant C151S was 
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68% of the OB3b activity whereas it was 183% compared with the wild type with 
His-tagged hydroxylase. 
 
 
Figure  4.8  Propylene oxidation assay by C151S whole cells 
 
The traces from GC show the peak corresponding to the propylene oxide product (from 
propylene oxidation) for mutant C151S whole cells at the retention time (RT) 5.40-5.50 minutes 
(red line). The black line shows the result from the negative control without propylene (the small 
peak in black is presumed to be some other volatile species with similar retention time to 
propylene oxide). Propylene and propylene oxide are indicated by arrows. DTT was included in 
both assays to inhibit pMMO. 
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4.5 Discussion 
 
To date the expression of soluble methane monooxygenase hydroxylase has 
been unsuccessful in heterologous systems. The expression of sMMO in a 
homologous expression system was a challenge due to obstacles which have 
been explained earlier in this thesis. These issues have been overcome by 
developing several related systems (Lloyd et al., 1999; Smith et al., 2002; 
Borodina et al., 2007) including the last system by this group which shortens the 
cloning steps to one step by creating system pT2ML and then inserting the 
affinity His-tag in the ȕ-subunit of the hydroxylase (pT2MLY) (M. Lock 
unpublished paper; Nichol, 2011) to enables the purification of the cloned 
hydroxylase in one step by using Ni-NTA affinity chromatography compared to 
the anion exchange chromatography and subsequent steps which were used in 
the previous studies. Activity for the wild type with His-tag has also been 
detected in purified protein from this system as mentioned previously in Chapter 
three.  
Mutation of C151 in a previous study (Smith et al., 2002) to evaluate the role of 
cysteine as a free radical provider during the sMMO catalytic cycle, resulting in 
inactive sMMO for mutant C151Y (which were mutated to tyrosine as in the 
ribonucleotide reductase) whereas mutation of cysteine to glutamic acid as in 
alkene monooxygenase of R. Rhodochrous B-276 produce an active sMMO. 
However, according to the result from the Smith et al. (2002) study, it seems 
that the role of this residue is not essential in providing a free radical. For this 
purpose, mutation of this amino acid to other amino acids is needed to generate 
more evidence to evaluate the role of this residue. Cysteine was mutated to 
serine that has a hydroxyl side chain group that is unlikely to supply a free 
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radical in contrast to the thiol group which was previously implicated in providing 
a free radical as in the tyrosine residue of RNR enzyme (Nordlund et al., 1992). 
This mutant gene was expressed in the mutant F system (which is OB3b of 
which part from the hydroxylase α-subunit gene was deleted) and then 
transferred to the new system pT2MLY by this group as mentioned previously. 
Also, approximately 550 bp were removed from the mmoX gene in pT2MLY 
which led to loss of the sMMO activity for this recombinant.  As such any activity 
for mmoX must be due to the recombinant mutant.  
The ability of C151S to grow on NMS agar plates with a minimum copper 
concentration or copper free medium in the present study may indicate the 
ability of this mutant to grow and consume methane by pMMO and then switch 
to the mutant soluble methane monooxygenase and continue to grow. Also this 
result may indicate that this residue has an important role other than providing 
the free radical implicated in the sMMO catalytic cycle. This is further supported 
by the oxidation of naphthalene by mutant C151S when it was grown on a plate, 
since naphthalene is known to be oxidized by sMMO and not by pMMO (Colby   
et al., 1977).  
It was intended in the present study not only to investigate the role that this 
residue might have in the catalytic cycle, but also it was aimed to increase the 
ability of this enzyme in oxidation of di- and tri-aromatic hydrocarbon 
compounds. When the mutant C151S was assayed toward the di-aromatic 
compound naphthalene, it showed no significant difference from the wild type 
OB3b or the wild type with His-tagged MMOH (Table  4.3).  
The oxidation of mono-aromatic compound with one side chain such as toluene 
and ethyl benzene by this mutant showed some difference. The oxidation of 
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toluene by C151S yielded different product amounts from those produced by 
OB3b and wild type with His-tagged MMOH, with the o-cresol being the main 
product in mutant C151S with a significant difference from both OB3b and wild 
type with His-tag.  A negligible amount of p-cresol and no m-cresol was 
detected for this mutant. Also the oxidation of ethyl benzene gave two products 
rather than the four that were produced by the OB3b and wild type with His-
tagged MMOH. The products from toluene oxidation by mutant C151S may 
indicate that there is a small difference in the orientation that the mutant soluble 
methane monooxygenase holds this substrate in the active site   
In a mutagenesis study for Thr201 in toluene 4-monoxygenase, Pikus et al. 
(2000) found that the mutation of Thr201 to Ala abolished the enzyme activity 
whereas mutation of Thr201 to Ser conserved the enzyme activity. This result 
was interpreted as showing that the amino acid Ser (which contains the side 
chain HOȖ functional group) interacts with the binuclear iron centre and is 
believed to be essential in keeping the enzyme stable. The mutant C151S is in 
a close position to the diiron centre and the amino acid Ser has HOȖ group 
which might have the same role in enzyme stability.  
Propylene was used to evaluate the role of the C151S mutant in oxidation of a 
substrate with comparable conversion rate to methane when it is oxidized by 
methane monooxygenase. Also, it is known that propylene oxide is not a 
substrate for the second enzyme (methanol dehydrogenase [MDH]) in the 
methane oxidation pathway. Mutant C151S was positive in production of 
propylene oxide as mentioned previously, which may suggests that the sMMO 
is still fully active and this residue is not involved or it is not essential in radical 
chemistry. However, oxidation of methane by purified sMMO components from 
the C151S strain needs to be investigated to give a more reliable conclusion 
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concerning the involvement of this residue in radical chemistry of methane 
oxidation.  
In terms of the other di- and tri-aromatic compounds there was no measurable 
activity toward biphenyl and mesitylene up to 96 h of incubation or with 
anthracene and phenanthrene up to 48 h. It was found that the OB3b and His-
tag wild type had a measurable activity towards biphenyl, since OB3b produced 
(>97%) 4-hydroxybiphenyl, (0.16%) 2-hydroxybiphenyl and (0.38%) 3-
hydroxybiphenyl.  Mesitylene was also oxidized by the wild type OB3b in 1 h 
with 3, 5-dimethylbenzyl alcohol produced (> 99%), and  a trace of 2, 4, 6-
trimethylphenol (0.44%). However, no products were detected from mesitylene 
oxidation by OB3b when it was incubated for 24 h and 48 h (Nichol, 2011). 
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8  
Chapter 5: Investigating the role of 
hydrophobic and hydrophilic residues 
within and outside the hydroxylase 
active site. 
5  
5.1 Introduction 
 
The diiron centre where the methane and other substrates are oxidized is 
deeply buried in the active site of the α-subunit of the MMO hydroxylase 
(Rosenzweig et al., 1997; Elango et al., 1997). The substrate needs to pass 
through three hydrophobic cavities as well as the pore cavity to reach the active 
site from the protein surface (Rosenzweig et al., 1997; Rosenzweig et al., 1993; 
Whittington et al., 2001(a); Whittington et al., 2001(b); Sazinsky and Lippard 
2005). The diiron centres of most monooxygenase enzymes are coordinated by 
four glutamate residues and two histidine residues. One of these glutamate 
residues provides a bridging carboxylate ligand (Rosenzweig et al 1993). In 
addition, there are two hydroxides or one hydroxide and one water molecule 
that bind the diiron centre (Elango et al. 1997). The four glutamate residues 
Glu114, Glu243, Glu144 and Glu209 provide carboxylate group ligands to the 
diiron active centre.The presence of an environment with activated oxygen 
around the active sites of MMOH, RNR-Rβ and ∆9-ACP was suggested as 
having an important role in formation of high-valent iron intermediates. The 
high-valent iron intermediate plays a role in the catalytic cycle of these enzymes 
which has been proved by spectroscopic studies (Lee et al., 1993a; Lee et al., 
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1993b; Liu et al., 1994; Liu et al., 1995; Shu et al., 1997; Whittington and 
Lippard 2001). Moreover, structural studies for MMOH and RNR-R2 revealed 
that these enzymes have different conformations in the reduced and oxidized 
states which are characterized by a carboxylate shift in the glutamate residues 
around the active site. This carboxylate shift was observed in Glu243 in sMMO 
and also was seen in the R2 active site when it was compared in the oxidized 
and reduced forms between the native enzyme and the mutated D84E. This 
conformational change affects the Fe-Fe distances and might have an important 
role in opening some of the active sites and hence on the catalytic cycle of the 
enzymes (Whittington and Lippard 2001).  
 
5.2  Construction of C151Y E114D and E114D 
 
Considering the similarity between sMMO and RNR-R2, the amino acid in the 
corresponding site to Tyr122 in RNR is Cys151 in sMMO, as such Smith et al. 
(2002) mutated Cys 151 to Tyr. The resulting mutation (C151Y) did not produce 
an active MMOH, which might be due to the instability of the mutant enzyme, 
since no bands could be detected in SDS-PAGE. In Ms. trichosporium OB3b 
and Mc. capsulatus Bath the two Glu (114 and 209) are linked to the diiron 
centre, the His (147 and 242) are linked to two Asp (143 and 242) which have 
been suggested to make a pseudo-two-fold symmetrical complex that stabilizes 
the MMOH like RNR-R2 (Nordlund et al., 1992). The rationale behind the 
mutation of Glu114 to Asp (E114D) in the mutated plasmid C151Y (double 
mutant) was to make sMMO more similar to RNR here, in an attempt to gain a 
stable hydroxylase containing the C151Y mutation, since the hydroxylase from 
C151Y single mutant was not produced in a detectable amount and proved to 
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be inactive (Smith et al., 2002). At a structural level, the idea was to replace Glu 
with the less bulky Asp, to allow Tyr (bulkier than Cys) to be accommodated at 
this position (personal communication with Kristoffer Andersson). In addition, it 
was intended to mutate the Glu114 to Asp (single mutant E114D) to investigate 
the role of this residue in sMMO of Ms. trichosporium OB3b (Figure 5.1).  
 
 
 
 
 
Figure  5.1 The diiron centre of sMMO, and the position of residues E114 and 
C151. 
The iron atoms of the diiron site are shown in orange the associated water molecules in pink.  The 
ligands of the diiron centre are shown in light blue, apart from the sidechain of Glu114, where the 
carboxylate oxygens are red and the rest of the sidechain purple.  The sulfur atom of the C151 
sidechain is yellow.  The residues of the rest of the hydrophobic pocket adjacent to the diiron centre 
are shown in white. The image was conducted based on the structureal studies on sMMO 
Rosenzweig et al., 1997; Elango et al., 1997).  
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5.3 Mutagenesis of the proposed substrate gating residue 
Phe 188 
 
The substrate binding site in MMOH is composed of hydrophobic residues and 
surrounded by hydrophilic residues. The hydrophobic side chains around the 
active site include Leu110, Phe188, and Phe292 (Rosenzweig et al., 1997). 
Crystallographic studies suggested a role for L110 as a substrate gate to the 
active site since it is a residue with different positions in the structure between 
the oxidised and reduced states of the enzyme. This allosteric change leads to 
a connection between cavities within the protein, which is proposed to allow the 
entry of substrate and maybe egress of the product. However, previous 
mutagenesis to investigate the function of this residue showed that it has a role 
in the regioselectivity of the enzyme rather than as a gate for substrates 
(Borodina et al., 2007). Another residue Phe188 was suggested to undergo a 
movement which may lead to the formation of a connection between cavities 1 
and 2 and so Phe188 may work together with Leu110 in controlling the 
substrate gating (Rosenzweig et al., 1997). A channel has been seen in the 
crystal structure of T4MO hydroxylase, which becomes closed upon binding of 
the equivalent of protein B to prevent the connection between internal (cavities 
1 and 2) within T4MOH (Bailey et al., 2008). A similar channel like-space has 
not been identified in the α-subunit of MMOH. In contrast, hydrophobic residues 
were found including Leu110, Phe188 and Phe236, which were proposed to 
occupy this space preventing formation of such a channel. This adds another 
proposed role to L110 and Phe188 (McCormick and Lippard 2011). Nichol, 
(2011) mutated Phe188 to the smaller hydrophobic amino acid Ala, which 
produced a naphthalene positive mutant with a change in enzyme 
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regioselectivity towards aromatic substrates. Phe188 was also mutated to less 
hydrophobic residue Trp by Smith and co-workers, which inactivated the 
enzyme (manuscript in preparation). The rationale from this is to keep the 
hydrophobicity around the active site and to investigate the role of shorter 
residue amino acid in allowing the entry of large di- or tri-aromatic compounds 
to the active site. 
Recently, it has been revealed via crystallography of the MMOH-protein B 
complex that the interaction between MMOH and protein B leads to a change in 
the conformation of MMOH causing a change in the orientation of residue 
Phe188. As a result, cavities 1 and 2 become joined leaving a sufficient channel 
between cavities 2 and 3 to permit gaseous substrates to access the active site 
(Lee et al., 2013). 
 
Figure  5.2 The oxidation and reduction form of the active site showing the 
movement of residues L110 and Phe 188. 
A: Shows the L110 which in oxidised form nearly closed the the diiron centre from cavity 2. 
B: Shows the movement of L110 and F188 in the diiron of MMOH structures to make space for 
the substrate to be enter. Iron atoms are depicted as orange spheres. Carbon, oxygen, and 
nitrogen are coloured as grey, red, and blue respectively, C1: cavity 1 and C2: cavity 2  
( modified from Sazinsky and Lippard 2005) 
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5.4 Mutants R98L, R98A and R98A S4G 
 
The distance between the protein exterior and the diiron active site in the 
hydroxylase α-subunit is about 12 Å (Sazinsky and Lippard 2006). Several 
cavities are implicated in forming the pathway for substrate entry and for 
products to leave the hydroxylase active site in the SDIMOs as well as 
permitting the movement of other moieties which are critical for substrate 
oxidation namely, electron, proton and molecular oxygen (McCormick and 
Lippard 2011). In one of the hydrophobic pockets on the way of the substrate 
into the active site, there is an ionic network which might form a rigid complex 
that limits the passage of the large molecules into the active site. In a previous 
work by Smith and co-workers (manuscript in preparation, Lock et al), mutant 
R98L was constructed to disrupt this ionic network. When the mutant R98L was 
assayed towards the diiromatic substrate hydroxyphenyl, there was a change in 
the regioselectivity of mutated sMMO. Here this mutant was transferred to the 
new vector pT2MLY with the His-tag. Also, the mutant R98A was constructed, 
in which the ionic network was disrupted by converting of R98 to alanine, which 
is a hydrophobic residue with a short side chain. It was hypothesized that this 
mutant may permit access to the active site by larger di and triaromatic 
compounds than the R98L mutant. During the construction of R98A, the double 
mutant R98A S4G was produced due to an unintended second mutation. 
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Figure  5.3  sMMO hydroxylase showing the position of R98 
a- The three components of sMMO; hydroxylase (grey), regulator (dark blue), reductase (light 
blue) 
b- Enlargement of hydroxylase α-subunit showing the position of R98 which is proposed to be a 
part of an ionic network along the pathway that the substrates takes into the active site. 
c- The active site of the hydroxylase showing the diiron centre and some of the residues around 
it (Lock et al., manuscript in preparation). 
  174 
 
 
5.4.1 Construction and cloning of mutants E114D C151Y, E114D, 
R98A and R98A S4G using vectors pTJS175 and pT2MLY 
 
Apart from the double mutant E114D C151Y which was constructed by using 
pTJS175 C151Y and pT2MLY, the other mutants (E114D, R98A and R98A 
S4G) were constructed by using pTJS175 and pT2MLY. All mutants were 
constructed using the four primers as described in Materials and Methods 
Chapter (Table 2.2). 
 
Two PCRs were run, each one with two primers (the forward flanking primer 
mmoX- p1 with the reverse primer which contains the desired change and the 
reverse flanking primer mmoX- p4 was run with the forward mutation primer as 
described in Materials and Methods Section 2.3.5.) to create two PCR products; 
the first round of PCR produced products with approximate size 954 bp and 693 
bp for the mutant R98A. In a similar manner, 1002 bp and 645 bp products were 
obtained from the primary PCRs for mutant E114D (Figure  5.4). The PCR 
products which are consistent with their predicted size were then purified from 
the gel to use as a DNA template to run an overlap PCR in the next step. The 
PCR product was purified before and after the overlap PCR to be ready for the 
next step. 
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Figure  5.4  Agarose gel (1%) showing the mutagenic PCRs 
Two PCRs were run to construct each mutant, each PCR with two primers; the first PCR was run 
with one of the flanking forward primer (p1-mmoX primer) and a mutagenic reverse primer. The 
second PCR was run with the reverse flanking primer (p4-mmoX primer) and the appropriate 
forward mutagenic primer which was complementary to the reverse mutagenic primer.   
M= DNA ladder. 
PCR for construction of mutant R98A;  
Rp1+r= PCR run using p1-mmoX forward flanking primer and mutagenic reverse primer (r). 
Rp4+f= PCR run using p4-mmoX reverse flanking primer and mutagenic forward primer (f). 
PCR for construction of mutant E114D and E114D C151Y 
Ep1+r= PCR run using p1-mmoX forward flanking primer and mutagenic reverse primer (r). 
Ep4+f= PCR run using p4-mmoX reverse flanking primer and mutagenic forward primer (f). 
. 
 
 
5.4.2 Ligation of mutant mmoX genes into pJET 1.2 
 
To achieve the ligation of the mmoX gene with pT2MLY, the overlap PCR 
should be digested with two restriction enzymes BamHI and NdeI as mentioned 
previously. At the same time pT2MLY was digested with the same restriction 
enzymes and then purified from the gel. The large size of pT2MLY meant that 
the purified plasmid from the gel was present in only a very small amount which 
was not enough sometimes for a successful ligation. This caused a substantial 
challenge; because each time the cloning step failed it was necessary to repeat 
the overlap PCR and associated sequencing.  
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This problem was overcome by ligating the overlap PCR product into the high 
efficiency pJET1.2 cloning vector (Life technology) to produce pYYL1 (include 
the vector pJET1.2 with the overlap product). The ligation reaction was 
transformed into laboratory prepared competent E. coli S17.1. Colony PCR was 
performed to detect the putative mutated mmoX gene by using primers mmoX- 
p1 and mmoX- p4,  
The transformed E. coli S17.1 which showed a band in the colony PCR with 
primers mmoX- p1 and mmoX- p4 was recultured in LB broth with the 
appropriate antibiotic (ampicillin 100 μg -1 ml-1). A miniprep was done for the 
progeny plasmids (pYYL1) isolated from these transformed E. coli S17.1, which 
after digestion with BamHI and NdeI revealed fragment of the expected size 
(~2974 bp) for pJET1.2 and the mmoX gene (~1650bp)(data not shown). PCR 
was performed with primers mmoX-p1 and mmoX-p4 for mmoX gene to confirm 
its presence in the new plasmid (Figure  5.5C). 
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Figure  5.5 Representative agarose gels (1%) showing cloning steps for the 
mutated mmoX genes in pJET1.2 
Gel A- After transformation of the plasmid clones containing the R98A mutated mmoX genes 
within pJET 1.2 (pYYL1) into E.coli S17.1 competent cells, colony PCR was performed for 
selected colonies using primers mmoX-p1 and mmoX- p4. The PCR products were of the 
expected approximate size (~1650 bp) as shown in gel A. 
Gel B- Plasmid minipreps of the R98A mutant of pYYL1 from the transformed E.coli S17.1.  
Gel C- PCR was performed to detect the mutated mmoX genes within the purified pYYL1 
clones by using primers mmoX-p1 and mmoX-p4 which shows products of the expected size for 
mmoX gene.  
Similar results were obtained for mutants R98A S4G, E114D, and E114D C151Y. 
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5.4.3 Double digestion of purified mutated mmoX gene with BamHI 
and NdeI 
 
The mutated mmoX gene that was amplified from pYYL1 by PCR was gel 
purified by using the gel extraction kit (Qiagen) and then double digested with 
NdeI and BamHI. The digested PCR product revealed three bands in the gel as 
intended and as predicted by conceptual digestion using NEB cutter version 
2.0. The digested PCR product was compared with undigested PCR product 
(Figure  5.6 A&B respectively). The desired band which is about 992 bp was 
then excised from the gel and purified to be ready for ligation in the next step 
with pT2MLY double digested with the same restriction enzymes BamHI and 
NedI. The double digestion of pT2MLY was confirmed by the appearance of two 
bands; one of about 474 bp and the other part of the plasmid which was ~16893 
bp. 
 
Figure  5.6  Double digestion of amplified R98A and E114D mutant genes. 
A: 1% agarose gel showing amplified R98A and E114D mutant mmoX before and after 
digestion, M= DNA marker, 1= Undigested R98A overlap PCR, 2&3= NdeI and BamHI double 
digestion of R98A overlap PCR showing the three bands predicated by NEBcutter 2.0, 4= 
E114D overlap PCR, 5&6= NdeI and BamHI double digestion of E114D overlapPCR, 7= 
partial mmoX gene from pT2MLY without digestion (control). 
B: predicted double digestion for mmoX gene with BamHI and NdeI using program NEBcutter 
2.0. 
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5.4.4 Cloning of mutant into His-tag expression plasmid pT2MLY 
 
After purification of the band that contained the desired mutation (top band in 
lane 2, 3, 5, and 6 as shown in (Figure  5.6) from the double digested mmoX 
gene, the purified double digested gene was ligated by using the Quick Instant 
Ligation Kit (NEB) to pT2MLY that had been digested with same restriction 
enzymes (NdeI and BamHI). The ligation reaction was transformed into XL-10 
Gold ultra-competent cells as described in the Materials and Methods Chapter, 
Section 2.4.1. Colony PCR was performed and the resulting plasmid containing 
the putative mutated gene was purified from the transformants and then sent for 
sequencing with four primers mmoX- p1, mmoX- p4, Seq-f and Seq-r (Table 
2.2). After the sequence had been confirmed to show that the mutation was 
found at the intended site for each mutant and that there were no unwanted 
mutations, the purified mutated plasmids were transferred into E. coli S17.1 and 
then the mutated plasmids transferred from E. coli S17.1 into SMDM by 
conjugation as described in the Materials and Methods Chapter, Section 2.4.2 
After growth on methane on NMS agar plates with four antibiotics for three 
weeks, the mutants were tested towards naphthalene, which gave a positive 
assay for mutant SMDM pT2MLY E114D and negative for mutants SMDM 
pT2MLY E114D C151Y and SMDM pT2MLY R98A. Colony PCR was run for 
the mmoX gene and then the PCR product was purified and sent for 
sequencing. Sequencing showed that SMDM pT2MLY E114D C151Y and 
SMDM pT2MLY E114D contained the desired mutation alone, whereas the 
intended R98A mutant contained another unplanned mutation in position 4 to 
produce a new double mutant SMDM pT2MLY R98A S4G. Construction of the 
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R98A mutant was repeated to gain the intended single mutant SMDM pT2MLY 
R98A, which was also negative in the naphthalene test. The mutants were 
further characterized by growing on NMS media with low copper to induce the 
production of sMMO, which was then assayed by the naphthalene oxidation 
plate test again. Positive results were obtained for E114D. E114D C151Y, R98A 
and R98A S4G were naphthalene negative (Figure  5.7). 
 
 
 
Figure  5.7 Naphthalene oxidation assays for the new mutants. 
selected colonies of  transconjugated SMDM were subcultured in duplicate on NMS agar with 
four antibiotics and grown for approximately 3 weeks.Naphthalene tests were performed for 
mutant C151S, known to be naphthalene positive, as a positive control. The appearances of 
pink (E114D) to violet colour (C151S) is a positive result whereas the negative colonies stayed 
colourless (R98A). 
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The naphthalene negative mutant strains were further characterised by 
amplifying the mmoX gene from purified whole genomic DNA. The mmoX 
genes from all mutants were sequenced to confirm the results.  The alignments 
from BLAST searches performed via the NCBI server 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) confirmed the presence of the intended 
mutations.  The gene sequences obtained were conceptually translated into 
protein and the presence of the mutations is shown in alignments of the amino 
acid sequences below (Figure 5.8) 
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Figure  5.8   Deduced sequences of amino acid for the new mutants compared to  
the wild type OB3b and mutant C151S. 
Black colour: the sequence of the wild type mmoX. Mutagenized positions are shown in orange 
type and indicated by two stars with the original amino acid shown in red type. 
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5.4.5 Purification of His-tagged mutant hydroxylases 
 
The soluble extracts which were obtained by means of the French pressure 
disrupter (part of which were loaded onto SDS-PAGE as shown in Figure  5.9) 
were loaded onto Ni-NTA columns and purified by following the steps described 
in Materials and Methods Chapter Section (2.6.2.2). The soluble extract and the 
purified His-tagged hydroxylases were analysed via 12% or 16% SDS-PAGE 
prepared as described Section 2.8. Chapter 2. The gel for the soluble extracts 
and the purified hydroxylase revealed an almost identical banding pattern to the 
wild type; with three bands for the purified hydroxylase corresponding to the 
three hydroxylase subunits α, ȕ, and Ȗ for the wild type and each of the mutants 
as shown in (Figure  5.9). Mutant E114D was grown on NMS plates with three 
antibiotics; streptomycin, spectinomycin and gentamycin with a thick streaking 
to gain enough biomass for the subsequent experiments. In addition to showing 
three bands in the SDS-PAGE referring to the hydroxylase subunits, there was 
a fourth band which can be seen in almost all samples. The purification and 
detection of hydroxylase subunits was performed alongside C151S and His-tag 
wild type as positive controls. 
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Figure  5.9 The soluble extract and purified His-tagged hydroxylase from the 
mutants E114D and E114D C151Y compared to the His-tagged wild type and 
C151S mutant hydroxylases. 
Gel A: Soluble extract from mutants E114D and E114D C151Y showing nearly identical 
banding patterns to one another and to the His-tagged wild type and mutant C151S. 
Gel B: Purified His-tagged MMOH from the wild type and mutants shown in gel A. Each 
preparation showed three main bands corresponding to the α-, ȕ- and Ȗ- subunits of the 
hydroxylase in addition to a fourth faint band. Both gels are 12% SDS-PAGE in buffer tris-
glycine. 
The order of the lanes is the same in both gels as follows: M= SeeBlue® plus2 pre-stained 
protein standard, lane1=His-tagged wild type, lane 2= C151S, lane 3=C151Y E114D, lane 
4= E114D 
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5.4.6 No detectable naphthalene product in GC-MS for naphthalene 
positive E114D on NMS plates 
 
When the E114D mutant was tested for the oxidation of naphthalene on an 
NMS plate with three antibiotics; streptomycin, spectinomycin and gentamycin, 
it showed a positive result as explained previously (5.4.4). The E114D 
methanotroph strain expressing the mutant sMMO was then grown to high cell 
density on an NMS agar plate with three antibiotics  with dense streaking of the 
bacteria on the whole area of plate. Then after switching from pMMO to sMMO, 
which was detected by the naphthalene oxidation assay on an NMS plate, the 
cells were harvested and resuspended in 25 mM MOPS pH 7.0 and kept at -
80oC. Frozen cells were thawed and tested with naphthalene as the substrate 
and the products were analysed via GC-MS, which showed no recognizable 
peaks corresponding to either of the possible products from naphthalene 
monooxygenation (1-naphthol or 2-naphthol), even though  the same strain was 
positive for the naphthalene oxidation when evaluated via the plate colorimetric 
test. Extending the incubation period from 48 h to 72 h and 96 h did not result in 
appearance of any products detectable via GC-MS (data not shown). 
 
5.4.7 Oxidation of toluene by the E114D mutant  
 
 When the mono-aromatic compound toluene is used as a substrate to be 
oxidized by sMMO, hydroxylation can occur on three distinct positions on the 
ring or on the side chain. In the current study, when the toluene was oxidized for 
48 h  at 30oC by OB3b or the His-tagged wild type MMOH, the hydroxylation 
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was ring hydroxylation with no benzyl alcohol whereas o-cresol was the main 
product followed by p-cresol and m-cresol in a very small amount. When the 
E114D mutant was tested towards toluene, p-cresol was the only product 
observed with small activity. When the amounts of the products in the triplicate 
samples of the mutant E114D,  wild type OB3b and His-tagged wild type 
hydroxylase were compared, there was no significant difference between them  
( Table  5.1). When the assay was repeated using a different batch of E114D 
mutant cells, no measurable activity was found 
 
 Table  5.1 Distribution of toluene oxidation products by E114D compared 
to OB3b and His-tag wild type. 
 
 
 
 
 
 
Oxidation of toluene by His-tagged wild type hydroxylase and mutant sMMO-expressing cells, 
monitored by GC-MS. Peaks were assigned using the NIST list in the PC connected to the GC-
MS. ND indicates no detectable activity. The retention times for the peaks were also compared 
to authentic standards of the products. The OD600 was corrected to 5 for all of the tested strains. 
 
 
 
 
 
Strains 
Product percentage % 
 
 
 
 
 
 
p-cresol 
 
 
 
o-cresol 
 
 
 
 
 
 
m-cresol 
OB3b 3.28% 96.70% 0.01% 
wt his-tag 2.33% 97.64% 0.02% 
E114D 100% ND ND 
OH 
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5.4.8 E114D produced 1-phenyl ethanol from ethyl benzene  
 
The mutant E114D was tested towards the monoaromatic hydrocarbon ethyl 
benzene in a reaction for 48 h at 30oC. Among the possible products from ring 
oxidation, only one product, 4-ethyl phenol was observed, whereas the 
oxidation of the side chain gave the compounds 4-methylbenzaldehyde, phenyl 
methyl ketone, and 1-phenyl ethanol.  The wild type strain OB3b oxidized ethyl 
benzene giving the same 4 compounds mentioned above; 1-phenyl ethanol, 
phenyl methyl ketone, 4-methylbenzaldehyde and 4-ethyl phenol, with  4-ethyl 
phenol as the major product followed by 1- phenyl ethanol, 4-
methylbenzaldehyde and then phenyl methyl ketone. The wild type with His-tag 
hydroxylase produced 4-ethyl phenol as the major product whereas 4-
methylbenzaldehyde and 1-phenyl ethanol were produced in almost equal 
smaller amounts (Table  5.2). Ethyl benzene was oxidized to ethyl phenol as the 
major product and both 1-phenyl ethanol and 4-methylbenzaldehyde in nearly 
equal amounts.  Phenyl methyl ketone was not detected as a product from ethyl 
benzene oxidation by the His-tagged wild type. Mutant E114D gave 1-phenyl 
ethanol as the sole detectable product from ethyl benzene oxidation with a low 
activity compared to the wild type OB3b and His-tagged wild type (Table  5.2). 
No statistically significant difference was observed among the mutant E114D, 
the wild type OB3b and wild type with His-tag hydroxylase. As stated previously, 
all assays were performed in triplicate. 
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Table  5.2  Oxidation of ethyl benzene by mutant E114D, compared to the wild 
type OB3b and wild type with His-tagged hydroxylase. 
 
 
Strain 
Percent of products % Relative 
activity % 
1-phenyl 
ethanol 
 
phenyl methyl 
keton 
 
4-methylbenzaldehyde 
 
4-Ethyl 
phenol 
 
 
 
1-phenyl 
ethanol 
 
OB3b 9.81% 1.59% 4.04% 84.54% 100% 
His-tag wt 13.57% ND 13.78% 72.63% 13.59% 
E114D 100% ND ND ND 6.38% 
 
Ethyl benzene oxidation products were identified on the trace from the GC-MS by comparison  
with the NIST list (1 μl from the extraction was injected and analysed for each strain).  
ND: indicates that no product could be detected in the the extraction when analysed on the 
GC-MS. Relative activity was obtained from technical triplicates from the same batch of frozen  
cell of strains compared to the activity of the wild type OB3b which was considered as 100%  
active and the OD600 was corrected to 5 
 
 
5.4.9 Mutant E114D showed no activity towards the di-aromatic or 
tri-aromatic substrates in GC assays. 
 
Mutant E114D was also tested towards the diaromatic hydrocarbon biphenyl for 
48 h at 30 oC and the result was analysed in GC-MS as detailed in the Materials 
and Methods Chapter (Section 2.6.6). All mutants in the present study, R98L, 
E114D, wild type OB3b and the His-tagged wild type hydroxylase (including 
C151S which was explained in Chapter 4), showed no activity that could be 
detected in GC-MS towards biphenyl even when the mutants, the wild type 
OB3b and His-tag wild type incubated with the substrate for longer time; 72 h 
and 96 h instead of 48 h. The mutant E114D was also assayed with the tri-
aromatic hydrocarbons anthracene and phenanthrene, which also revealed the 
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mutant as non-active in towards these substrates. Control experiments were 
performed to compare the wild type OB3b and the His-tag wild type to the 
mutant. As observed previously, results for the wild type and the His-tag wild 
type were also negative towards these tri-aromatic substrates anthracene and 
phenanthrene. 
5.5 Transformation of E. coli S17.1 with pT2MLY F188W and 
R98L and then conjugation with Ms. trichosporium SMDM 
 
Plasmids pT2MLY F188W and pT2MLY R98L were constructed by Dr. M. Lock 
in this research group. During the current study, the plasmids were sequenced 
to confirm the existence of the desired mutation within both of them and the 
absence of unwanted mutations. E. coli S17.1 were then transformed with 
pT2MLY F188W and pT2MLY R98L. Then the transformed E. coli S17.1 
pT2MLY F188W and E. coli S17.1 pT2MLY R98L were conjugated with SMDM. 
A positive naphthalene test confirmed the activity of the His-tagged R98L 
mutant when expressed in the methanotroph. Total genomic DNA was 
extracted and PCR was performed with primers mmoX- p1 and mmoX- p4to 
detect the mmoX gene. The purified amplified mmoX gene was sequenced, 
which revealed the desired mutation at position 98. After a naphthalene 
negative result for the F188W mutant, the conjugation was repeated three 
times. After that the whole genomic DNA was extracted and the mmoX gene 
was detected in mutant F188W by PCR with mmoX- p1 and mmoX- p4 
(Figure  5.10). The PCR product was then sequenced and the mutation was 
observed at the intended site. 
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Figure  5.10 Detection of mmoX gene in R98L and F188W methanotrophs 
exconjugants. 
Gel A: 
M= DNA ladder. Lane1&2=PCR amplification of the mmoX gene from the R98L exconjugant 
using primers mmoX- p1 and mmoX- p4. Lane 3= pTJS175 plasmid DNA (positive control). 
Gel B:  
M=DNA ladder. Lane1-5= PCR amplification of the mmoX gene from the F188W exconjugant 
using primers mmoX- p1 and mmoX- p4. Lane 6= pTJS 175 plasmid DNA (positive control),  
7= No DNA template (negative control). 
 
 
5.5.1 Purification of the His-tag hydroxylase from mutants R98A 
and R98A S4G.  
 
 
The naphthalene negative mutants were further characterized by mmoX gene 
detection PCR using primers; mmoX- p1 and mmoX- p4. The PCR products 
were excised and purified from an agarose gel and then sent for sequencing. 
The results from sequencing confirmed the change of Arg to Ala in the mutant 
R98A in addition to Ser to Gly change at position 4 for the double mutant R98A 
S4G. The mutants were grown in flask cultures with four antibiotics. After three 
weeks the harvested cells were broken to release the proteins. The soluble 
extract was prepared and samples loaded onto SDS-PAGE and the rest was 
loaded onto an Ni-NTA column. The purified His-tagged hydroxylase was also 
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loaded into 12% or 16% SDS-PAGE prepared as described in Materials and 
Methods Chapter. The His-tagged MMOH for each of the three His-tagged 
mutants R98A, R98A S4G, and F188W as well as  the His-tag wild type each 
contained three bands corresponding to the three hydroxylase subunits α, ȕ, 
and Ȗ in addition to the fourth band explained previously (Figure  5.11).  
 
Figure  5.11 The soluble extract and purified His-tagged hydroxylase from 
mutants R98A and R98A S4G compared to the His-tagged wild type 
hydroxylase. 
A: Soluble extract of mutants R98A, R98A S4G and F188W shows nearly identical protein 
content to each other and to the wild type with His-tag. 
B: Purified His-tagged hydroxylase obtained via Ni-NTA column chromatography from the 
mutants R98A, R98A S4G, F188W and wild type showing four main bands.  
Samples were loaded onto SDS-12% PAGE and the gel was run in tris-glycine buffer. M= 
SeeBlue® plus2 pre-stained protein standard. On both gels lanes 1, 2, 3 and 4 
correspond to the wild type and mutants R98A, R98A S4G and F188W  hydroxylase 
respectively. Gel B shows three faint bands represents the three subunits of the hydroxylase.. 
 
 
A 
B 
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5.5.2 Oxidation of naphthalene by mutant R98L and product 
distribution  
 
The R98L mutant was tested for oxidation of naphthalene on an NMS plate with 
four antibiotics. Since the result was positive on the colorimetric plate test, the 
whole cell suspension was incubated with a few naphthalene crystals as 
described in the Materials and Methods Chapter (Section 2.6.4.). The ability of 
this mutant to oxidize naphthalene was assayed after incubation for 48 h at 
30oC with naphthalene. The result from the GC-MS trace showed that there are 
two peaks corresponding to 1-naphthol and 2-naphthol, as was shown for the 
wild type OB3b and His-tag wild type. The R98L mutant produced more 1-
naphthol than 2-naphthol in a ratio more similar to that produced by the His-tag 
wild type than that from the wild type OB3b (Table  5.3). When the original data 
for the triplicate samples for R98L were compared to the wild type OB3b and 
the His-tag wild type, no statistically significant difference was observed 
between them (p>0.05) by using Kruskal-Wallis (Conover-Inman) test.  
 
Table  5.3  Oxidation of naphthalene by mutant R98L and product distribution 
percentages. 
 
 
 
 
Strain 
Product percentage Relative activity % 
 
 
1-Naphthol 
 
2-Naphthol 
 
 
1-Naphthol 
 
2-Naphthol 
OB3b 85.23% 14.76% 100% 100% 
wt. His-tag 57.64% 42.35% 155.77% 177.18% 
R98L 57.86% 42.13% 61.88% 75.64% 
 
The assays were performed in the same day. The retention time for the products was  
compared with authentic standards, and the identification confirmed by NIST list in the GC-MS.  
Relative activity was obtained from triplicate samples from the same batch of frozen cells  
of each strain and compared to the activity of the wild type OB3b. The relative activities 
are corrected to OD600 = 5 for all samples. 
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5.5.3 Oxidation of ethyl benzene by the R98L mutant results in 
increased activity. 
 
The activity for the whole cells of R98L towards the mono-aromatic substrate 
ethyl benzene was evaluated in a reaction mixture with ethyl benzene for 48 h 
at 30oC and then the extracted product was analysed via GC-MS. The result 
showed that the mutant, like the wild type, hydroxylated the ethyl benzene 
primarily on the ring. Oxidation of ethyl benzene showed that 4-ethyl phenol is 
the main product but with less activity than OB3b and His-tagged wild type. 
Some oxidation of the side chain by R98L was observed, producing 4-
methylbenzaldehyde with an activity 7 times more than OB3b and 2 times more 
than the His-tag wild type. The other product from the side chain oxidation was 
1-phenyl ethanol with a comparable product percentage to the wild type OB3b 
and less than the His-tag wild type. Finally, the fourth product was phenyl 
methyl ketone, which was detected in smaller relative amount compared to the 
OB3b (Table  5.4; Figure  5.12). The raw data for the triplicate samples for each 
of mutant R98L with OB3b and the His-tag were compared. The result showed 
that R98L produced 1-phenyl ethanol 13.3 times more than the His-tag wild type 
and 1.8 more than wild type OB3b. Although the product phenylmethyl ketone 
was not detected for the His-tagged wild type, the amount of this product from 
the R98L mutant was higher than the wild type OB3b by 1.6-fold.  Also the 
R98L mutant oxidized the ethyl benzene to 4-methylbenzaldehyde with 6.2-fold 
greater yield than the His-tagged wild type and 2-fold more than OB3b. In 
contrast, the highest increase in yield was found in the oxidation of ethyl 
benzene to ethyl phenol with a 14-fold greater yield from mutant R98L than the 
His-tag wild type and 1.2-fold more than OB3b. However, there is no statistically 
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significant difference between mutant R98L compared to the wild type OB3b 
and His-tagged wild type when Kruskal-Wallis (Conover-Inman) test was 
applied to compare between them for all four products from ethyl benzene 
oxidation (Figure  5.13). 
 
Figure  5.12 GC trace showing peaks of products from ethyl benzene oxidation 
by mutant R98L. The oxidation of ethyl benzene shows four products indicated by arrows 
and identified based on NIST list from GC-MS. 
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Table  5.4  Distribution of products from ethyl benzene oxidation by OB3b, wild type with His-tagged hydroxylase and mutant R98L. 
 
 
 
Strain 
distribution of products % Relative activity % 
 
1-phenyl 
ethanol 
phenyl  
methyl ketone 
4-methylbenzaldehyde 
 
4-Ethyl 
phenol 
 
1-phenyl 
ethanol 
 
phenyl  
methyl ketone 4-methylbenzaldehyde 
4-Ethyl 
phenol 
 
OB3b 9.81% 1.59% 4.04% 84.54% 100% 100% 100% 100% 
His-tag wt 13.57% ND 13.78% 72.63% 13.5% ND ND 8.63% 
R98L 9.16% 1.23% 38.23% 51.36% 181.88% 83.98% 177.11% 121.05% 
ND: indicates no detectable activity peak in GC-MS for specific product. The distribution of products shows the amount of each product as a percentage of total 
product produced by each strain. Compounds were compared to NIST list in the GC-MS. The relative activity was calculated by considering the activity for wild 
type OB3b as 100% active. The results were obtained from triplicate technical samples from the same batch of frozen cells for each strain and the OD600 was 
corrected to 5. 
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Figure  5.13 Comparing the original data for  triplicate technical samples for 
mutants R98L with OB3b and wild type with His-tagged hydroxylase 
No significant difference at level p < 0.05 was detetced among mutant R98L, OB3b and the wild 
type with His-tagged hydroxylase in product distribution from ethyl benzene oxidation. The 
original data were analysed via the Kruskal-Wallis statistical test (Conover-Inman) and data 
presented as (Mean ± S.E.M.), The amounts of products were obtained by measuring the 
product peak areas from the GC-MS traces. 
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5.5.4 No recognizable activity could be seen for R98L towards the 
tri-aromatic compound anthracene or phenanthrene 
 
The ability for the whole cells of the R98L mutant to oxidize tri-aromatic 
substrates was investigated by using anthracene and phenanthrene as a 
candidate substrates over 48 h at 30oC.  Although R98L showed activity 
towards many substrates, similar to OB3b and His-tagged wild type, no 
detectable peak likely to indicate oxidation products of either phenanthrene or 
anthracene could be detected when the extracted assay reaction was injected 
onto the GC-MS. 
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5.6 Discussion 
 
5.6.1 Sequential ligation by using two plasmids for the mutated 
overlap PCR  
 
After constructing the overlap PCR by using high fidelity Phusion Taq 
polymerase to create the new mutants, sequential ligation was used. The 
overlapped PCR product firstly was ligated into a commercial plasmid pJET 1.2 
to produce pYYL1. The mutated mmoX genes were sequenced after this 
cloning step to check for unwanted (PCR -derived) mutations. Working with a 
complex shuttle and expression vector with a very large size of more than 17 kb 
makes cloning of mutant genes a challenge, especially during the purification of 
such a large plasmid from gel electrophoresis after digestion with restriction 
enzymes. The pJET 1.2 was used in the present study to clone the overlap 
PCR product before transfer into the expression vector. This two step 
sequential cloning procedure was necessary, since cloning a low abundance 
combinatorial PCR product into a large vector did not give a high enough 
frequency of recombinants to be practicable. Cloning via pJET 1.2 allowed 
preparation of a large amount of the insert to gain a tolerable cloning frequency 
with the large plasmid. 
 
5.6.2 Mutation of C151Y mutant to double mutant E114D C151Y 
 
In a previous study (Smith et al., 2002) the amino acid cysteine 151 was 
mutated into tyrosine as in ribonucleotide reductase (RNR). The tyrosine at this 
position is known to provide a free radical required by RNR. The mutant C151Y 
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lost its activity due to forming an unstable hydroxylase. It was proposed that the 
mutation of the glutamic acid residue at site 114 to aspartic acid as in 
ribonucleotide reductase may result in stabilizing the hydroxylase by replacing 
the Glu with an amino acid with smaller side chain to give more space for Tyr. In 
the present study it was found that mutation of the glutamic acid 114 into 
aspartic acid in the mutant C151Y resulted in a more stable protein that could 
be visualized on SDS-PAGE. The mutant C151Y E114D was constructed within 
the system pT2MLY to allow purification by using a His-tag affinity column. The 
mutated C151Y E114D MMOH was purified in the present study by using the 
His-tag affinity column and was shown to be present via SDS-PAGE. The SDS-
PAGE revealed that MMOH contains all three subunits but the cell expressing 
the mutant enzyme had no activity towards naphthalene. The presence of Cys 
151, Thr 213 and Ile 217 in sMMO around the diiron centre instead of Tyr122, 
Phe208 and Phe212 in RNR enzyme may make sMMO able to accommodate 
larger substrates than RNR (Nordlund et al., 1992). Replacing the cysteine at 
151 with tyrosine might make the active site too narrow to accept di-aromatic 
substrates such as naphthalene. 
 
5.6.3 Mutation of glutamic acid 114 to aspartic acid (mutant E114D) 
 
 
The single mutant E114D was created in this site by using the system pT2MLY. 
The oxidation of methane or the other substrates by MMOH is catalysed by the 
carboxylate-bridged dinuclear iron centre (Whittington et al., 2001). It has been 
seen that there is a carboxylate shift during the oxidation and reduction of the 
diiron centre during the catalytic cycle of the enzyme. This shift may have an 
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important role in the enzyme mechanism; also the oxygen-rich area around the 
active site in MMOH is implicated in having a critical role by building a high-
valent iron intermediate during the enzyme catalytic cycle (Lee et al., 1993; Liu 
et al., 1994; Liu et al., 1995; Lee et al., 1999; Shu et al., 1997). These facts and 
crystallographic studies support the importance of the presence of residues 
such as glutamate to ligate the diiron centre (Whittington et al., 2001). The 
mutation E114D in the current study was designed in order to introduce a 
change into the residues ligating the diiron centre whilst retaining the 
carboxylate group at this position. The shorter side chain of aspartic acid, 
compared with glutamic acid, might affect the way that the active site holds the 
substrate by changing in the geometry around the diiron centre. The mutant 
E114D was naphthalene positive unlike E114D C151Y, but the colour of the 
complex formed between the diazonium salt and the naphthol products was not 
as strong as it is for the wild type or mutant C151S as positive controls 
(Figure  5.7). The inactive mutant R98A was used as a negative control. When 
cells expressing the mutant E114D were assayed with naphthalene as the 
substrate, and the sample was analysed by GC-MS after solvent extraction, no 
peak could be seen in the GC-MS corresponding to 1- or 2-naphthol. This may 
be because this mutant oxidized the naphthalene to an unstable product or the 
amount of the naphthol product was not enough to be detected by GC-MS. The 
main and the only product from oxidation of toluene by this mutant was p-
cresol.. The oxidation of another substituted mono-aromatic compound ethyl 
benzene by the E114D mutant showed only one product 1-phenyl ethanol with 
low activity. The detection of the single product from toluene and ethyl benzene 
may indicate that this mutant has increased regioselectivity with these 
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substrates. Alternatively, the amount of these products may be too small to 
detect or the product may be further oxidized.  
This mutant showed no activity toward the more complex tri-aromatic 
compounds such as anthracene and phenanthrene which are not oxidized by 
the wild type OB3b or other studied sMMO mutants which may be due to the 
toxicity of these compounds for the bacteria. 
 
5.6.4 Activity of transconjugated R98L, F188W, R98A and R98A 
S4G 
 
A previous study was performed on mutant R98L (Lock et al., manuscript in 
preparation) to investigate the effect of this mutation on the way that the 
substrate interacts with the active site. The mutant F188W was constructed in 
the same study. These mutants were subsequently transferred into the new 
expression system pT2MLY (personal commnication with Nicol, Lock and 
Smith) and then cloned in E. coli (as part of the work described in this thesis) 
conjugated into the Ms. trichosporium SMDM expression host to further 
investigate these residues with the His-tag affinity system. In the previous study 
by this group, R98L showed a higher activity than OB3b towards toluene and an 
increase in regioselectivity towards biphenyl at the 4-position. A similar result 
was obtained in the current study; R98L showed an increased regioselectivity 
toward ethyl benzene with a greater proportion of 4-methylbenzaldehyde being 
produced than with the wild type OB3b and His-tag recombinant wild type. The 
present study showed that R98L was able to oxidise ethyl benzene to produce 
13.3-fold more 1-phenyl ethanol than the His-tagged wild type. Also, from the 
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oxidation of ethyl benzene, mutant R98L was able to produce 4-ethyl phenol 
and 4-methylbenzaldehyde in 6.2-fold and 14-fold, respectively, greater yield 
than the His-tagged wild type. With naphthalene as the substrate, the R98L 
mutant gave a more similar percentage of 1- and 2- naphthol to that produced 
by the His-tag wild type than was observed with the original wild type strain Ms. 
trichosporium OB3b. The tri-aromatic compounds anthracene and 
phenanthrene appear to be too large to enter the active site for this mutant. The 
changing of Arg to Leu at position 98 may limit the entry of large substrate into 
the active site. An amino acid with a smaller side chain such as Leu is expected 
to change the nature of the ion network which may allow the substrate to enter 
and be held in the active site in a different way from the wild type OB3b. This 
effect might be seen more clearly when the Arg98 was mutated to Ala, which 
was done with the intention of increasing the space in the route of the substrate 
into the active site. Changing Arg98 to a smaller uncharged residue may result 
in a complete disruption to this ion network leading to a conformational change 
in the protein geometry. The result was an inactive mutant enzyme when it was 
tested towards naphthalene. In terms of the unintended double mutant R98A 
S4G, there is no clear role for the amino acid Ser at the beginning of the α-
subunit of the hydroxylase in the enzyme activity; as such it is suggested that 
there is no substantial effect of the presence of the second mutation for mutant 
R98A S4G (Figure  5.14). 
The phenylalanine 188 is implicated in formation of the hydrophobicity layer 
around the active site. Unlike F188A which was constructed in a previous study 
(Nichol, 2011) and gave a positive naphthalene test in addition to showing some 
change in regioselectivity, mutation of phenylalanine 188 to the less 
hydrophobic though bulkier tryptophan resulted in an inactive enzyme when 
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tested with naphthalene. Crystallographic studies suggested a critical role for 
this residue in opening and closing the cavities around the active site with the 
aid of L110 (Rosenzweig et al., 1997). It was also noticed that when protein B 
attached to the hydroxylase this led to changes in the orientation of F188 
resulting in rearrangement of the helices within the enzyme and opening of 
cavities 1 and 2 to accommodate substrates (Lee et al., 2013). This mutant 
needs to be tested further towards aliphatic substrates as it showed a stable 
hydroxylase exhibiting all three subunits in SDS-PAGE (Figure  5.11) 
 
 
 
Figure  5.14 Soluble methane monooxygenase hydroxylase showing the position 
of the S4G mutant. The alpha, beta and gamma subunits are shown in green, blue and yellow, 
respectively.  The iron atoms of the two diiron sites are shown as orange spheres. The residue (S4G) 
near to the N- terminus of the alpha subunit as shown as a pink sphere (The position of S4 in sMMO 
was indicated in image conducted by other crystallographic study for Resenzweig et al., 1997) 
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Chapter 6: General discussion, 
summary and future work 
6.1 Protein purification 
 
6.1.1 Purification of hydroxylase 
 
A large number of studies have been performed on purified soluble methane 
monooxygenase from various methanotrophic bacteria, and so it is considered 
that the wild type sMMO is a well characterized enzyme (Fox and Lipscomb 
1989; Nakajima et al., 1992; Woodland et al., 1984; Grosse et al., 1999; Patel et 
al., 1987; Shen et al., 1997; Rosenzweig et al.,1997; Elango et al., 1997; 
McDonald et al., 1997; Shaofeng et al.,2007; Shigematsu et al., 1999). Soluble 
methane monooxygenase consists as mentioned previously of protein A 
(hydroxylase) with three subunits α, ȕ, and Ȗ with size 55, 4γ and βγ kDa 
respectively. Protein B (16 kDa) and protein C (reductase) with size nearly 39 
kDa. In the current study the soluble methane monooxygenase hydroxylase 
was purified in recombinant form with an attached His-tag. Three bands could 
be seen on SDS-PAGE corresponding to the hydroxylase subunits. Purification 
was performed by means of anion exchange chromatography followed by metal 
affinity chromatography using a modified protocol from Smith et al. (2002) and 
Shaofeng et al. (2007) with the addition of a metal affinity chromatography step 
after anion exchange. The hydroxylase is unstable and so some preservatives 
to stabilize it were added during the purification. Dithiothereitol was added to a 
concentration 5 mM to stabilize the hydroxylase. Shaofeng et al. (2007) found 
that increasing the concentration of DTT to 20 mM had an advantage not only in 
preserving the stability, but also led to improved hydroxylase activity by 18%. In 
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addition, it was noticed by Shaofeng et al. (2007) that adding other substances 
such as cysteine, and sodium thioglycolate during the purification could 
enhance the stability of the hydroxylase. For these reasons cysteine and 
thioglycolate were added to the buffers used for the purification of the reductase 
and hydroxylase in the current study. 
It is well estabilished that the diiron centre is critical for the catalytic cycle of the 
sMMO enzyme. A study by Shen et al. (1997) revealed different iron content of 
sMMO hydroxylase purified by two different methods; 3.78 mol/mol Fe by High 
performance liquid chromatography (HPLC) and 2.02 mol/mol by three step 
liquid chromatography (LC). This shows that different amount of iron may be 
lost during the purification protocol. However, this study found that the activity 
was not improved by adding 1-3 mM FeCl3. Nakajima et al. (1992) found that 
adding of Fe2+ enhanced enzyme activity. In the present study during the 
purification, Fe (NH4)2(SO4)2 was used as a source to provide iron. The His-tag 
affinity method has been chosen by Smith's group to facilitate the hydroxylase 
purification from soluble extract. Six Histidines were inserted in the ȕ-subunit of 
the hydroxylase by using molecular techniques by this group to be used as a 
clamp to purify the protein in the Ni-NTA affinity column. This method showed a 
successful hydroxylase purification as it was explained in the result Chapter to 
have three bands by SDS-PAGE comparing to sMMO hydroxylase purified by 
anion exchange chromatography.  
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6.1.2 Purification of protein B 
 
To achieve full sMMO activity, all three components of the enzyme are 
essential. Protein B has been found to have many important roles in addition to 
its role in coupling electron transfer from reductase to hydroxylase (Green and 
Dalton, 1989; Callaghan et al., 2002; Lee et al., 2013). Formation and 
accumulation of H2O2 by sMMO was found to be toxic for the enzyme in the 
absence of protein B, therefore it was suggested that protein B is able to inhibit 
the formation of H2O2 by sMMO (Froland et al., 1992). Strangely, it was found 
that protein B showed a truncation that happens near the N-terminal, which 
leads to the production of inactive truncated proteins known as protein Bޗ and 
B˝ (Lloyd et al., 1997; Pilkington et al., 1990), though this, was not seen in vivo 
in Ms. trichosporium. However, constructing protein B with an affinity tag 
(glutathione S-transferase [GST]) fusion and then purifying from E. coli resulted 
in a stable protein B with a high activity, comparable or higher to that of the wild 
type protein B (WTB) from Mc. capsulatus (Lloyd et al., 1997). Protein B of Ms. 
trichosporium fused with GST in plasmid pGEX-2T was used in the current 
study to obtain an active form of protein B and avoid truncation. The fused GST-
protein B was then expressed in E. coli BL-21 after the plasmid construct had 
been characterized by restriction digestion as mentioned in Chapter 3 (Section 
3.5.4.1.).  
In a study on alkene monooxygenase coupling protein (AmoB), it was found that 
the GST-AmoB fusion was six times more active than wild type AmoB from 
Rhodococcus rhodochrous B-276 (Smith et al., 1999). In the same study, 
cleavage of GST-AmoB with thrombin (which is a serine protease) was 
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attempted, which required omission of benzamidine (a serine protease inhibitor) 
from the cleaving buffer. Removing benzamidine from the buffer resulted in the 
loss of coupling protein activity, presumbly because of the presence of 
contaminating proteases. Therefore, an attempt to cleave the GST from WTB 
(wild type protein B) in the current study has not been made to preserve its 
activity. 
 
6.1.3 Purification of protein C 
 
An attempt to purify protein C, the third component of sMMO which is a light 
sensitive protein, from Ms. trichosporium OB3b was also made during the 
present study. When the soluble extract was loaded onto the DEAE anion 
exchange column used in the purification (Chapter 3, Section 3. 5. 2. 1), it 
showed a peak corresponding to the reductase-containing fractions which 
appeared at 0.35 M NaCl (Smith et al., 2002). The pooled samples were further 
purified by using Superdex 75 which also showed only one peak, corresponding 
to the reductase. The obtained sample was loaded onto SDS-PAGE which did 
not show any detectable band of protein, but when part of the sample was 
loaded onto a gel for silver staining (a more sensitive staining method than 
Coomassie blue for detecting a small amounts of protein), showed many faint 
bands in the gel which may indicate protein degradation during the purification. 
The presence of an activity for this sample when it was tested towards oxidation 
of cytochrom c supports the presence of protein C.  
Various expression systems are under investigation in this group such as GST-
MmoC in pGEX-2T. It is presumed that cleavage of GST from MmoC is 
important for reductase activity because in a study on AMO from Rhodococcus 
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rhodochrous B-276 (Smith et al., 1999), it was found that cleavage of the GST-
reductase fusion protein was necessary to obtain active reductase. As 
alternative to avoid the need for cleaving the fusion protein, the reductase of 
sMMO from Ms. trichosporium OB3b was cloned into one of the pET series 
vectors which included the presence of a poly histidine tag. It was hoped that 
use of a smaller tag would obviate the need for purification since the 6His-tag 
may be small enough to permit activity without cleavage. 
During the present study, an alternative way that was used to obtain reductase 
was by exploiting the strain expressing sMMO with the mutation F282L in the 
hydroxylase, which was found to contain inactive hydroxylase but the other 
components of the sMMO were active. Mutant F282L was tested towards 
propylene and naphthalene to confirm its inactivity toward a range of substrates.   
Soluble extract from this mutant was used to provide protein B and C when His-
tagged hydroxylase from the wild type or another mutant needed to be assayed. 
 
6.1.4 Activity of purified protein 
 
The purified His-tagged hydroxylase in combination with the protein B and C 
containing F282L soluble extract showed activity when it was tested toward 
propylene with product detection via GC, although this result was difficult to 
reproduce. The consistency in the preparation of active purified hydroxylase is 
hard to achieve even with enzyme purified with His-tag affinity column possibly 
due to many interacting reasons. The activity of the sMMO components was 
variable due to their being very sensitive to number of factors such as 
temperature. Shaofeng et al. (2007) found that the hydroxylase lost about 42% 
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of its activity when it was kept at 4oC for 48 h. In the same study it was noticed 
that the diiron centre was unstable and may be lost during the purification, 
which consequently affects the enzyme activity. Precautions against enzyme 
inactivation were taken in the current study, namely keeping the material on ice 
during the cell breakage and subsequent protein purification steps. Also the 
reducing agent DTT and the protease inhibitor benzamidine were added. The 
French pressure cell was chilled to 0-4 oC in the cold room before use and while 
it was being used it was kept on ice except when being pressurized in the 
press. Despite these precautions, it was found that the hydroxylase activity in 
purified hydroxylase was not consistent during the protein assay towards 
propylene.  
The propylene oxidation assay was employed in the current study because, 
unlike the natural sMMO substrate methane, propylene oxide (the product of 
propylene oxidation) is not oxidized by the methanol dehydrogenase (MDH) 
enzyme in these bacteria and hence accumulates and can be detected 
subsequently by gas chromatography. The His-tag purified hydroxylase showed 
an activity with F282L as a source for protein B and C in various conditions as 
explained in Chapter 3. Carbon tetrachloride was used in the present study as a 
solvent to extract the product from propylene oxidation.  Carbon tetrachloride 
was chosen as the extraction solvent because it is the only solvent known not to 
be oxidized by sMMO. The first batch used in the present study enabled clear 
results as supplied.  Unfortunately, the subsequent batches from the same 
supplier contained a contaminating substance with the same GC retention time 
as the product propylene oxide. Thirteen different solvents were investigated as 
solvents for extraction of propylene oxide. These solvent were propan-2-ol, 1-
pentanol, toluene, propan-1-ol, 1-butanone, acetonitrile, hexane, 2-phenyl 
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ethanol, 1-phenyl ethanol, mesitylene, ethyl benzene, benzyl alcohol and 
diethyle ether. Each of these solvents contained a substance with retention time 
similar to propylene oxide. An efficient solventless method named solid- phase 
microextraction (SPME) was investigated as an alternative method to detect the 
propylene oxide to avoid any peaks resulting from the solvent itself since in 
SPME the sample extracts directly into a retractable fused-silica fibre fixed into 
a needle (Vas and Vѐkey β004). The assay samples extracted by SPME 
showed a clear, well separated peak for some samples and an unresolved peak 
for others (Figure 3.11 A&B respectively). The retention time for propylene 
oxide extracted using SPME was confirmed with an authentic standard of 
propylene oxide extracted under the conditions by the SPME method. SPME 
requires warming the sample to the boiling point for the desired product to be 
evaporated, which becomes absorbed by the silica fibre, which can then be 
injected directly into the GC. This method is useful with a few samples since the 
injection is usually manual. However, running many samples at the same time 
may lead to problems with performing the extractions in a consistent way, 
especially with regard to consistency in warming of the samples and 
inaccuracies arising from saturation of the fiber with product after analysing 
large numbers of samples. However, optimizing the conditions for SPME for the 
propylene oxidation assay to overcome the problems mentioned above could 
enable a reproducible method in the future to obtain a well separated product 
peak, as well as excluding the use of a hazardous solvent such as CCl4. In 
addition, the inactivity obtained during testing the purified His-tagged 
hydroxylase could be attributed to the loss of iron during the purification steps, 
or from the buffer used in purification. An attempt to use imidazole rather than 
histidine in the elution buffer resulted in inactive hydroxylase (M.Lock personal 
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communication). A comparison study between hydroxylase purified by multi 
step method starting with DEAE anion exchange and His-tagged hydroxylase 
purified by Ni-NTA affinity chromatography is needed. 
6.2 Mutants construction 
 
6.2.1  Using two cloning steps to facilitate cloning of mutants and 
minimise PCR-derived errors 
 
Site directed mutagenesis of a gene is used to change one or a small number of 
the encoded amino acids (Heckman and Pease 2007). The overlap extension 
PCR technique was used in the present study to achieve this to create new 
mutants by site-directed mutagenesis. Four primers were used; two flanked the 
two ends of mmoX gene whereas two complementary primers to each other 
contained the desired mutation and were also used to run two different primary  
PCRs. Then overlap extension PCR was performed as explained in detail in the 
Materials and Methods Chapter (Section 2.5.3). The overlap PCR product was 
sequenced before and after cloning to confirm the presence of the mutation in 
the desired position and then amplified in plasmid pJET 1.2 to proliferate the 
mutated gene. The digested mutated gene excised from the pJET 1.2 clone, 
was then cloned into the vector pT2MLY which had been digested with the 
same restriction enzymes. The plasmid pT2MLY was created in this group to 
minimize the cloning steps, remove unwanted restriction sites, making the 
cloning in one step and reducing the number of minipreps which were used in 
previous studies to screen all the growing mutants by doing colony PCR. 
Moreover, approximately 500 bp was excised from the mmoX gene in this 
vector, so any naphthalene positive result must be due to the presence of the 
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new mutated gene. Some mutants were naphthalene negative although they 
grew well in NMS media with a low amount of or free from added copper and 
also supplied with four antibiotics; streptomycin, spectinomycin, gentamycin and 
nalidixic acid. This experiment was confirmed by repeating a further three times. 
Since the mutants were able to grow on low copper NMS medium on methane 
as their sole source of carbon and energy it is likely that the mutated sMMO 
enzymes, although inactive toward the diaromatic hydrocarbon naphthalene, 
were able to support growth on methane. The fact the mutant methanotroph 
cells were resistant to streptomycin and spectinomycin was consistent with their 
having taken up the plasmid containing the mutant genes. This was confirmed 
by extracting the DNA, performing a PCR for the mmoX gene and then 
sequencing to confirm the presence of the intended mutation.   
  
6.3 Mutation of Cys151 to Ser proved that the thiol group from 
cysteine is not essential for the oxidation of substrates tested 
in the present study 
 
 
The presence of amino acid cysteine 151 close to the sMMO active site in a 
position analogous to the tyrosine which is the free radical providing amino acid 
in ribonucleotide reductase makes this amino acid a candidate to have a similar 
role in radical chemistry in sMMO (Elango et al., 1997; Nordlund et al., 1992). 
C151 and the nearby hydrophilic residue T213 were investigated by Smith et al. 
(2002). Mutant C151E in this study showed a positive naphthalene test although 
no hydroxylase components could be seen on SDS-PAGE. Substitution of Cys 
151 to Ser in the present study was predicted to abolish the enzyme activity due 
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to the absence of a thiol group in Ser. The mutation C151S has preserved 
activity toward a range of substrates, indicating that radical chemistry at this 
position is not essential for monoxygenase activity. At the same time the Ser 
has not produced any activity in the C151S mutant towards the tri-aromatic 
compounds anthracene and phenanthrene. Methane oxidation by C151S 
sMMO soluble extract needs to be investigated to confirm that the C151S 
mutant was grown relying on sMMO and not pMMO. In order to detect the 
methanol product from the sMMO in soluble extract it will be necessary to inhibit 
oxidation of methanol by methanol dehydrogenase.  
 
6.4 Mutants R98L, R98A and R98A S4G 
 
 
In a previous study, an attempt was made to increase the ability of sMMO in 
oxidation of large di- and tri-aromatic compounds, which resulted in a mutant 
R98L with 6-fold greater activity than the wild type in oxidation of the diaromatic 
hydrocarbon biphenyl (Lock et al., manuscript in preparation). R98L was 
reconstructed in the new His-tagged expression system pT2MLY. The pT2MLY 
R98L was then transformed into E. coli S17.1 which was then conjugated with 
SMDM in the present study to compare its activity with the R98L mutant without 
the His-tag. Also His-tagged wild type was tested in parallel with this mutant. 
The pT2MLY R98L mutant showed a higher activity than His-tag wild type and 
wild type OB3b in oxidation of monoaromatic compounds, i.e. R98L showed 
higher activity than His-tagged wild type in oxidation of ethyl benzene yielding 1-
phenyl ethanol, phenylmethyl ketone, a compound assigned by the GC-MS 
analysis software as 4-methylbenzaldehyde and 4-ethyl phenol in 13.3, 1.7, 6.2, 
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and 14-fold greater amount than wt. His-tag respectively. This result showed a 
similar trend to the result that was obtained from the previous work on R98L in 
oxidizing different mono- and di-aromatic substrates. Together these results 
revealed the importance of this amino acid and suggested that the mutant in 
which the ionic interaction is disrupted allows easier access of large substrates 
into the active site. The results also indicate that the disruption of the ion 
network in the mutant not only facilitates the entry of large substrates but also, 
presumably via a conformational change, perturbs the structure of the active 
site so as to alter the regioselectivity of the enzyme.  
Another possible role for this residue was that it has a role in keeping the 
enzyme in an active conformation. Mutation of R98 to the smaller residue Ala 
was aimed at increasing the space to accommodate larger substrates such as 
tri-aromatic compounds and to disrupt the ion network. The resulting mutant 
R98A was inactive towards naphthalene. The presence of the desired mutant 
mmoX gene in the recombinant methanotroph was confirmed by PCR and DNA 
sequencing. It was also confirmed that the mutant MMOH was expressed since 
all three hydroxylase subunits were detected by SDS-PAGE. These results 
indicate that the R98A mutant enzyme is produced but it was inactive with 
naphthalene, presumably due to a conformational effect on naphthalene binding 
and / or activity of the diiron centre due to disruption of the ion network.  
The double mutant R98A S4G was unplanned and resulted from an unwanted 
second mutation S4G during an attempt to construct the R98A mutant. It has 
been found that the fidelity of overlap PCR in avoiding unwanted mutations is 
approximately 98% and unplanned mutations can occur at frequency of around 
1/4000 nucleotides (Ho et al., 1989). 
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The R98A S4G mutant was inactive towards naphthalene even though all the 
hydroxylase subunits were seen in SDS-PAGE.  This result is very similar to 
that obtained for the single mutant R98A. The amino acid Ser 4 is sited at the 
beginning of the MmoX polypeptide and from the crystallographic structure 
studies it seems that this residue is not involved in architecture of the enzyme or 
in holding the substrate in the active site. Also it is unlikely to be involved in 
formation of the ionic network or involving in formation hydrophobic cavity 
around the active site. Hence there is no evidence that this residue has a 
significant role in sMMO structure or activity.  
6.5 Mutants E114D C151Y and E114D 
 
 
The mutation of Cys to Tyr in position 151 in the sMMO  hydroxylase as in 
ribonucleotide reductase enzyme (which has been proven to provide free 
radical catalysis in that enzyme) resulted in an inactive mutant towards aromatic 
compounds such as naphthalene, which might be due the instability of 
hydroxylase or low level expression (Smith et al., 2002). Mutation of Glu 114 to 
Asp (an amino acid with shorter carboxylate side chain) in the background of 
the C151Y mutation was intended to preserve nearly the same conditions in the 
active site and make space in the core of the protein for the large tyrosine 
residue in position 151 to preserve the stability of MMOH. The result was a 
double mutant E114D C151Y which was expressed in the His-tag system. The 
affinity purified double mutant C151Y E114D hydroxylase was stable, since 
three bands resembling the hydroxylase α, ȕ, and Ȗ subunits could be seen in 
SDS-PAGE, with an extra fourth faint band. The identification of the fourth band 
by mass spectrometry (data not shown, which done by Dr. Malcolm Lock in this 
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group) revealed that this band may have a run of histidine residues which cause 
to bind to the Ni-NTA column and then appear in the purified hydroxylase 
preparation.  
Hence, it is likely that Asp at position 114 has an effect in conserving the 
architecture of the hydroxylase when Cys151 is converted to the bulkier Tyr and 
as such it stabilizes the hydroxylase for C151Y E114D. Although, the mutation 
of E144D in C151Y mutant resulted in a stable hydroxylase, the enzyme was 
still inactive towards naphthalene, which reflects the fact that the presence of 
tyrosine in this position does not mimic the tyrosine in the ribonucleotide 
reductase enzyme in providing a free radical involved in catalysis. Alternatively, 
it could produce a free radical not involved in catalysis.  
Glu 114 has a role in the enzyme activity since the single mutant E114D was 
naphthalene positive and has activity towards monoaromatic compounds such 
as toluene but the activity was very low compared to the His-tag wt. and wild 
type OB3b as it was detailed in the results Chapter. This mutant showed no 
detectable activity in the GC-MS assay for naphthalene oxidation even though it 
was naphthalene positive on NMS agar plates. It is likely that the product from 
naphthalene oxidation is not abundant enough to be detected by the GC-MS 
assay.  
It is appropriate to mention that for some aromatic substrate the reaction needs 
to be analysed after only a short period, such as mesitylene studied by Nichol, 
(2011), since the products observed from this substrate can be detected after 
incubation for only 30 minutes, but not after 24 h or 48 h incubation time. A 
similar phenomenon may explain the results from the mutant E114D where 
naphthol product from naphthalene oxidation could be detected after a short 
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time using the colorimetric assay but not using the GC-MS assay, where the 
reaction were incubated for longer. Indeed, it may be that the oxidation product 
could be detected from the mutants considered to be inactive with aromatic 
substrates if shorter incubation time was used. Nonetheless, these mutants 
must have substantialy reduced activity since the wild type produced a 
detctable product under the same conditions. The products that are lost during 
the long incubation may be metabolized or lost because they are volatile. 
Also from the previous crystallographic studies, it is likely that the substrate 
needs to pass through a number of cavities in the sMMO enzyme to reach the 
active site to be oxidised. Although many mutants during the mutagenesis 
studies have a comparable activity and some have higher than the wild type, 
such as R98L and C151S in the present study, changing one amino acid in the 
substrate access pathway may not be sufficient or the best way to allow larger 
substrates such as the triaromatic compounds anthracene and phenanthrene to 
enter to the active site. So it may be that changing more than one amino acid in 
the substrate entry pathway is needed to allow larger substrates to enter the 
active site and become oxidized.   
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6.6 Summary and future work 
 
The present study has shed light on the role of several residues in the sMMO 
hydroxylase. Combining the outcomes from the present study with the results 
from previous studies, no critical role in free radical chemistry during the 
catalytic cycle can be assigned to Cys151. In paricular the mutant C151S 
showed activity for some substrates even though it does not have thiol group 
(SH) in this residue which was implicated in the formation of a radical. Further 
mutation in this site might be useful to give more firm conclusions about the role 
of this residue near the diiron active site in MMOH.  
The His-tag affinity purification system in sMMO hydroxylase, which was 
characterized in the present study for the first time, revealed promising results 
representing by an active purified hydroxylase when it was assayed under 
various conditions. All mutants in this study were cloned with this new affinity 
system for the sMMO hydroxylase. It is likely that new optimization conditions 
may enhance high and consistent activity for His-tagged MMOH.  Further work 
is needed to gain a comparable activity of purified His-tagged MMOH compared 
to native enzyme. 
 Replacing the extraction solvent CCl4 for propylene oxide from propylene 
oxidation assay with solventless solid phase microextraction (SPME), resulted 
in a detectable activity peak on the GC reflecting the ability to use SPME as a 
new approach for measuring the amount of propylene oxide without needing to 
extract the product with an organic solvent. To the author's knowledge this is 
the first report to use this method to detect the propylene oxide produced by the 
sMMO enzyme. The handling of a high number of samples via this method may 
  219 
 
be difficult. By overcoming this limitation, the SPME may become more 
applicable for this purpose to avoid any interaction between the products with 
the extraction solvent. 
The present study also shed the light on the R98 residue which was not 
proposed by the authors of previous crystallographic studies to have a role in 
the sMMO activity. The R98L mutant showed activity up to 14 times more than 
the His-tagged wild type in oxidation of a mono-aromatic compound. It is 
proposed that the ionic network of which R98 is part is critical in limiting the 
access of large substrates into the active site although another factor, maybe 
the size of the active site itself prevents oxidation of triaromatic compounds. 
Another mutation in this residue may be needed for further investigation of the 
role of this residue.  
Mutation of Glu114, which is one of residues that ligate the diiron centre, to Asp 
resulted in a less active sMMO compared to the wild type. The same mutation 
was proved to have a role in stabilizing the unstable hydroxylase containing the 
mutation C151Y from previous work in this group. No mutant from the present 
study was able to oxidize tri-aromatic compounds phenethrene and anthracene 
which may encourage future researchers to investigate more candidate amino 
acids from crystallographic studies or from comparing sMMO with other similar 
enzymes to construct single and multiple mutants to achieve this aim. 
The mutant F188W showed a negative naphthalene result. From the previous 
crystallography studies, it was shown that during the formation of the complex 
between the MMOH and MMOB, both F188 and L110 move so as to open the 
channel into the active site somewhat. The previous single mutations at these 
two residues into amino acids with shorter side chains resulted in naphthalene 
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positive mutants such as F188A, L110C, and L110G. Based on these 
crystallography and mutation studies, a double mutation to reduce the size of 
both these amino acids may result in a mutant with a considerably more open 
passageway  into the active site to permit the accomodation of large substrates 
such as phenanthrene and anthracene. The fact that the double mutation 
E114D C151Y yielded a stable hydroxylase indicates that, at least in principle, it 
is possible to make a double mutation of nearby residues without disrupting the 
stability of the enzyme.  
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Appendixes 
Appendix 1 media preparation 
1.1) Preparation of Nitrate Mineral Salts Medium (0.1mg/L CuSO4.5H2O) 
 
Preparation of 1 x NMS Medium  100 ml 10 x NMS salts solution.  1 ml Sodium Molybdate solution   1 ml Trace Elements Solution.  0.1 ml Fe EDTA solution.  Dilute up to 1 L sdH2O  Autoclave at 15 psi for 15 minutes. 
 
For NMS agar plates 1.5% bacteriological agar (wt/v) is added to the 
medium prior to autoclaving. When the NMS is cool enough to hold in the 
hand, aseptically add 10 ml phosphate buffer. If this is done too early the 
phosphate will precipitate out.  
10 x NMS salts solution 
 10 g KNO3  10 g MgSO4.7H2O (4.8g MgSO4)  2 g  CaCl2.2H2O  up to 1 L sdH2O 
 
FE EDTA solution 
 3.8 g Fe EDTA  up to 100 ml sdH2O   
Sodium Molybdate solution 
 0.5 g NaMoO4.2H2O 
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 up to 1 L sdH2O 
 
Trace elements solution 
 0.1 g CuSO4.5H2O  0.5 g FeSO4.7H2O  0.4 g ZnSO4.7H2O  0.015 g H3BO3  0.05 g CoCl2.6H2O  0.25 g EDTA (di sodium salt)  0.02 g MnCl2.4H2O  0.01 g NiCl2.6H2O  up to 1 L with sdH2O 
Dissolve the above in the specified order in distilled water and dilute to 250 ml. 
Store in the dark (wrap around with Aluminium foil). 
 
Phosphate Buffer 
 49.7 g Na2HPO426 g   39 g KH2PO4  Up to 1 L sdH2O  
pH should be 6.8 without altering. Sterilise by autoclaving in 100 ml aliquots and 
store at room temp. 
1.2) Liquid LB media: 
 10 g Tryptone  5 g yeast extract  10 g NaCl  100 l 5M NaOH  up to 1 L sdH2O  Autoclave at 15 psi for 15 minutes 
For solid agar plates 1.5 % bacteriological agar (wt/v) is added to LB medium 
prior to autoclaving  
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1.3) SOC and NZY media 
SOC Broth  
(Prepared immediately before use) 
 2 ml of filter-sterilized 20 % (w/v) glucose or 1 ml of filter-sterilized  2 M glucose  SOB medium (autoclaved) to a final volume of 100 ml 
 
NZY media 
 10 g of NZ amine (casein hydroxylase)  5 g of yeast extract   5 g of NaCl 
      Deionized water to a final volume of 1 litre 
     The pH was adjusted to 7.5 and then autoclaved. 
      The following supplements were sterilized by filtration and added before 
using 
 12.5 ml of 1 M MgCl2  12.5 ml of 1 M MgSO4  20 ml of 20% (w/v) glucose (or 10 ml of 2 M glucose)
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Appendix 2 Buffer preparation 
1.1) Preparation of buffers for genomic tip-20 protocol 
 
B1 buffer  
 18.61 g Na2EDTA·2H2O   6.06 g Tris base   800 ml distilled water.  50 ml 10% Tween-20 solution (v/v)  50 ml 10% Triton X-100 solution. (v/v)  Adjust the pH to 8.0 with HCl.  Up to 1 L sdH2O 
 
B2 buffer 
 286.59 g guanidine HCl   700 ml sdH2O  200 ml 100% Tween-20 (v/v)  Up to 1 L sdH2O 
 
QBT buffer  
 43.83 g NaCl,   10.46 g MOPS  800 ml distilled water.  Adjust the pH to 7.0 with NaOH.   Add 150 ml pure isopropanol   15 ml 10% Triton X-100 solution (v/v)  Up to 1 L sdH2O 
. 
 
QC buffer 
 58.44 g NaCl,   10.46 g MOPS (free acid)    800 ml distilled water.  Adjust the pH to 7.0 with NaOH.   Add 150 ml isopropanol.   Up to 1 L sdH2O 
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QF buffer 
 73.05 g NaCl   6.06 g Tris base   800 ml distilled water.   Adjust the pH to 8.5 with HCl.   Add 150 ml pure isopropanol.  Up to 1 L sdH2O 
 
 
Appendix 3 SDS PAGE reagents and protocol 
 
RUNNING BUFFER 
 7.2 g Glycine   1.5 g Tris   0.5 g SDS  dH2O up to 500 ml 
 
RESOLVING BUFFER (3 M Tris-HCl pH 8.8) 
 
STACKING BUFFER (0.5 M TrisHCl pH 6.8) 
 
RESOLVING GEL (12.5 %) 
 4.84 ml 40 % acrylamide/bis solution   2.5 ml resolving buffer                        2.65 ml H2O   0.1 ml 10 % glycerol (v/v)                     0.1 ml 10 % SDS                                  0.5 ml 10 % APS (fresh made)            5 µl TEMED (add last) 
 
STACKING GEL 
 0.83 ml 40 % acrylamide/bis solution     1.36 ml stacking buffer                           2.8 ml H2O                                            50 µl 10 % SDS(v/v)                                     50 µl 10 % glycerol (v/v)                             0.5 ml 10 % APS (wt/v)                                    5 µl TEMED (add last) 
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SAMPLE BUFFER (2x) (gel loading) 
 250 µl stacking buffer         200 µl 100% glycerol           80 µl 0.5% bromophenol blue     100 ˊl ȕ-mercaptoethanol (100 %)  1.2 ml 10% SDS (wt/v) 
 
STAIN SOLUTION 
 450 ml methanol  450 ml sdH2O  100 ml glacial acetic acid  2.5 g Coomassie brilliant blue R 
 
DESTAIN SOLUTION 
 300 ml methanol  100 ml glacial acetic acid  600 ml sdH2O 
 
 
SDS PAGE Protocol 
 
 clip together glass plates including rubber lining  pour resolving gel until few mm below level of wells   overlay gel with 700 µl ethanol or isopropanol  after gel has set (~30 min) wash off ethanol with water and blot off 
excess  assemble stacking gel and pour over resolving gel  allow to set  remove clips and rubber seal, assemble gel tank and add running buffer  boil 10 µl sample for 10 min  add 10 µl sample buffer to each sample  run at 130 V 150 mA for 30 min turn to 150 V for 1h or until dye reaches 
bottom of gel. 
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Appendix 4 Ethanol free NADH preparation 
Preparation of 100mM NADH 
 0.7635 g NADH  10 ml sdH2O  Divide into 1 ml aliquots 
 
Ether extraction of NADH 
 Add 250 µl diethyl ether to 1ml NADH  Remove top layer  Add 250 µl diethyl ether  Remove top layer  dry overnight in Eppendorf 5301 concentrator   Add 1ml sdH2O and vortex till dissolved. 
Store at in foil at -15˚C, use within 1 week.
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